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Preface
On September 22 and 23, 1986, the National Institute on Drug Abuse
held a technical review meeting entitled "The Role of Neuro-
plasticity in the Response to Drugs" to review those factors that
may alter the response of the central nervous system to a drug.
Historically, researchers investigating the development of an
increased or decreased response to a drug of abuse after its
initial dose or after chronic administration have related these
response changes to the continued presence of the drug. The
mechanisms by which these adaptations were produced have remained
largely unknown. In the last few years, however, there have been
significant advances in understanding the plastic capacities of
neural tissue, both in the developing nervous system and in the
adult brain, that may shed light on the ability of the nervous
system to alter its response to drugs. Adaptation in both the
central and peripheral nervous systems may occur in milliseconds
or take months, will differ from one discrete brain area to
another, and will be specific for the external or internal stimu-
lus evoking the response. Because one purpose of this technical
review was to encourage the use of new ideas and methods from
neuroscience in studies of abused drugs, participants included
speakers who are interested in neural plasticity per se, those who
are applying these concepts to response changes induced by neuro-
transmitters and modulators, as well as those studying drug abuse
problems directly. In the hope that this commingling would
encourage neuroscientists to enter the drug abuse field, and to
stimulate the use of new methodologies by researchers already in
the field, material generated by this meeting has already been
incorporated into a program announcement by the Neurosciences
Branch, Division of Preclinical Research.
The first group of speakers discussed plasticity in the developing
nervous system. Because of the constant change taking place in
the nervous system during development, and because the timing of
developmental events depends on events that have already occurred,
it is during development that the nervous system is most vulner-
able to drugs. Some of the reasons for this vulnerability and
v
some of the consequences resulting from manipulation of the
developing organism during this vulnerable period were described.
B. MCEWEN ("External Factors Influencing Brain Development") dis-
cussed the relative contributions of genetic and environmental
factors in the development of the nervous system. Because envi-
ronmental stimuli can act on the genome, however, the distinction
between the two types of influences may, in some cases, not be
particularly important. Steroid hormones, which are released by a
variety of environmental stressors, act on the genome through spe-
cific brain steroid receptors linked to a second messenger that
causes repression or derepression of gene activity. Through this
mechanism, extrinsic or intrinsic hormones can affect the develop-
ment, cyclic activation, adaptation, amount of damage, and degree
of reinnervation of the nervous system. Thus, epigenetic factors
found in the environment can alter the phenotypic expression of a
variety of neuronal traits.
Drugs that alter the contribution of the genome to the adaptabil-
ity of the nervous system will have long-term effects, whereas
drugs that do not alter the normal contribution of the genetic
complement will have actions of shorter duration.
J. LICHTMAN ("Rearrangement of Synapses During Development") con-
tinued the discussion of the vulnerability of the developing brain
to external factors, such as drugs of abuse, by reviewing the way
in which synaptic connections are made. Since synapses in differ-
ent regions of the nervous system follow different rules of devel-
opment, he described typical examples. At the neuromuscular
junction, where, in the adult, a single nerve synapses on each
muscle fiber, the maturing muscles have several axon terminals
competing to occupy the end plate. As development progresses, all
but one nerve retract to form the adult pattern. Similarly, in
parts of the parasympathetic nervous system, each developing gang-
lionic neuron is initially innervated by several axons, each of
which arises from a different neuron. In this system also, multi-
ple innervation becomes single, or at least reduced, by elimina-
tion of some of the original afferents.
In some areas of the central nervous system, a similar phenomenon
is observed. Many climbing fibers impinge upon a single cerebel-
lar Purkinje cell in young brains, but only one fiber innervates
the adult cell. An analogous but more complex arrangement exists
in the visual cortex, where, in the adult, information from each
retina dominates alternating bands of cortex in a pattern called
ocular dominance columns.
nal inputs overlap.
In the developing brain, however, reti-
If input from one eye is eliminated during a
short critical period during development, the ocular dominance
columns fail to develop. Thus, in the changing patterns of devel-
opment, there can be many sites and times at which the developing
nervous system is vulnerable to external stimuli.
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L. SPEAR ("Drug-Vulnerable Events in Neuronal Development:
Implications for the Selection of Test Methodologies") categorized
the ways in which drugs influence development into nonspecific,
general, and specific effects. External (stress, nutrition) and
internal (hormonal or body temperature changes) stimuli, or drugs
that alter these stimuli, can influence the development of the
nervous system. A general effect on development can be produced
by agents that will have quite specific effects later on. For
example, drugs that alter monoamine neurotransmitter systems will
have profound effects if given early in development, because mono-
amines play an important role in closing the neural tube and lead-
ing to the generation of neurons. Later, these drugs will only
alter the specific system on which they act. An example is the
action of neuroleptic drugs, which produce specific blockade of
dopamine receptors but have different effects in the adult and
fetus. In the adult, chronic haloperidol administration increases
the response to dopamine agonists, whereas prenatally, the chronic
administration of haloperidol decreases the response to dopamine
agonists. Thus, several parameters of drug action may be differ-
ent in the adult and fetus.
J. WEST ("Alcohol and Brain Development") addressed another set of
factors that must be considered when examining the effects of
drugs on the developing nervous system. When considering the
possibility of morphological damage, one must be aware that both
regional and temporal vulnerabilities may exist. These vulner-
abilities will interact with both the dose of the administered
drug and the pattern of administration. Thus, certain brain
regions will be vulnerable only at certain times, if at all, and
the same amount of drug that has no effect when administered over
the course of a day may have a profound effect if given as a
single dose. In addition, because different brain regions grow at
different times in different animals, one must be careful to com-
pare equivalent periods of development when examining drug effects
in various species.
I. ZAGON ("Endogenous Opioids, Opioid Receptors, and Neuronal
Development") examined the gross effects of endogenous opioids on
various growth indices by administering an opiate antagonist,
naltrexone, to rat pups. Body, brain, and organ weight, and the
appearance of behavioral landmarks such as the righting reflex and
walking, were employed in this study. Interestingly, if naltrex-
one was administered at a low dose of 1 mg/kg/day, there was a
decrease in growth rate, but at a high dose of 50 mg/kg/day, there
was an increase, as indicated by augmented body and organ weights.
A low dose of 3 mg/kg/day given in three equal doses throughout
the day, however, also produced a growth increment like that seen
with the high dose. This suggests that the crucial requirement
for faster development was constant occupation of opiate receptors
by the antagonist, whether achieved by intermittent administration
of low doses or by a single high dose. These findings illustrate
the crucial role that dose and pattern of drug administration play
in producing an effect.
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C. KUHN ("Endocrine Consequences of Perinatal Methadone Exposure")
described the effects of administering drugs chronically on the
release of anterior pituitary hormones. Chronic methadone pro-
duced an increased release of growth hormone (GH) that persisted
for 25 days of treatment. This persistent response to methadone
differed from that to chronic pentobarbital or clonidine. The
latter two drugs produced biphasic effects, first inhibiting GH
release, then enhancing It, but at different times during chronic
drug treatment.
Methadone had no effect on the secretion of luteinizing hormone
(LH). Naloxone, however, increased its secretion, supporting the
prevailing hypothesis that opioids control LH secretion by tonic
inhibition of its secretion. The role of serotonin in the release
of GH was investigated by administering cycloheptadene, an antago-
nist of serotonin, to neonates and adult rats. Cycloheptadene did
not affect GH release following opiate administration in the neo-
nate, but did alter the response to opiates in the adult. The
conclusion is that the serotonin control of release has not yet
developed in the neonate.
On the second day of the conference, plasticity in the adult nerv-
ous system was the topic of discussion. In contrast to the global
types of effects seen during development, drugs administered to
adults tend to have much more limited and specific effects, some
of which are clearly reversible. The mechanisms of some of these
effects were described by the second group of speakers.
D. JOHNSTON ("Cellular Mechanisms of Noradrenergic Enhancement of
Long-Term Synaptic Potentiation in Hippocampus") described long-
term potentiation (LTP). This important model for learning in the
central nervous system is seen in the hippocampus, where a given
response can be augmented by previous stimulation of the same
pathway. Because this response facilitation can be graded, and
because the underlying anatomical substrates are well described,
this model is an important tool for the study of neuroplasticity.
Norepinephrine (NE) and its second messenger cyclic AMP specifi-
cally enhance LTP, and, using patch clamp techniques, a calcium
conductance in the neuronal membrane was also implicated in its
generation. Because brain NE systems contain large numbers of
opiate receptors, endogenous and exogenous opioids are strategi-
cally placed to alter profoundly the modulating effects of NE on
hippocampal activity.
D. WALKER ("Neural Adaptation in the Hippocampus Induced by Long-
Term Ethanol Exposure") described the effects of chronic alcohol
administration in adult animals. Whereas all animals show a
decrement in LTP following chronic alcohol administration, there
may be genetic regulation of the vulnerability to some other ef-
fects of alcohol. Some animals, for example, show a greater loss
of neurons in the hippocampus than others. Moreover, alcohol
reduces the ability of the brain to regenerate following damage.
This last finding illustrates the important point that many drugs
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cause both destructive and compensatory changes. As a result, a
functional deficit may be due more to the compensatory changes
than the original damage. Because the relative importance of the
destructive and compensatory changes will vary with time, it is
important to distinguish between them when studying the effects of
chronic drug administration.
P. GROVES ("Amphetamine Changes Neostriatal Morphology") described
the normal ultrastructure of the striatum and how this is changed
by amphetamine. After amphetamlne administration, dopamine termi-
nals in the striatum become swollen and distended and are subse-
quently lost altogether. The terminals that are lost are those
that were predominantly on the necks of dendritic spines, a par-
ticularly efficacious position on the spine from which to influ-
ence neuronal activity. This loss of terminals could explain why
some effects of amphetamine weaken with repeated exposure. Inter-
estingly, amphetamine also changed the shapes of dendritic spines,
shortening their necks. Thus, terminals at the ends of the spines
would be closer to the neuron and have greater potential to alter
its activity. This finding could explain the potentiation
(sensitization) of some other effects seen after repeated amphet-
amine exposure.
P. LANDFIELD ("Delta-9-Tetrahydrocannabinol-Dependent Alterations
in Brain Structure") described the morphological changes that take
place in the hippocampus due to normal aging and described how
adrenal glucocorticoids play a key role in mediating these
changes, which include cell loss. Because THC causes a large in-
crease in glucocorticoid secretion, Landfield examined the effects
of long-term THC administration on hippocampal structure. Rats
chronically exposed to THC showed a loss of neurons and other
changes indicative of neural damage. This study and the work of
Dr. Groves, both of which used electron microscopic techniques,
illustrate the importance of long-term studies relying on rigorous
morphological analysis to examine the subtle effects produced by
drugs.
M. CHRISTIE ("Mechanisms of Tolerance to Opiates in Locus Coeru-
leus Neurons") reviewed some of the problems that attend the
electrophysiological study of drug effects when whole animals or
tissue preparations are used. These include the possibility of
multiple receptors, a response that is remote from the binding
site, and the development of tolerance. By contrast, if one looks
only at isolated membranes, there is no response, or the response
that exists may not be coupled to the normal physiology of the
organism. These considerations lead to the use of single neurons
for many types of studies. Christie then described studies of
opiate-tolerant locus coeruleus neurons. These studies indicate
that the site of tolerance is in the coupling of the µ opiate
receptor that exists on these neurons to the G(-) protein that
controls the activity of adenyl cyclase. The cyclase produces
cyclic AMP, an intracellular messenger whose level is ultimately
responsible for the opiate effect.
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J. DONOGHUE ("Cholinergic Modulation of Sensory Responses in Cere-
bral Cortex") described the importance of using intact animals and
activating existing input systems to verify the effects of applied
drugs. He reported that acetylcholine changed the response prop-
erties of neurons to tactile inputs. Thus, some neurons that were
not spontaneously active and did not respond to tactile inputs
under control conditions became active and had a vigorous response
to tactile inputs after acetylcholine was applied to them. These
kinds of neurons would normally have been overlooked in a study
that only examined neurons with spontaneous activity, as Is
commonly done.
R. DYKES ("Control of the Neuronal Receptive Field in Somato-
sensory Cortex") reported that acetylcholine, in addition to
potentiating the responses of some cortical neurons to tactile
inputs, may cause a prolonged increase in responsiveness in these
neurons. Thus, not only is the response enhanced while acetyl-
choline is being applied, but it remains enhanced for many minutes
after the drug has been removed or inactivated. This finding
highlights the important caution that the effect of a drug may
actually change even while it is being studied during acute
administration.
In summary, the material presented in this volume makes clear that
simple, straightforward analyses of drug action can only be accom-
plished with great caution. Studies of chronic drug exposure,
especially in the developing organism, must take into account a
wide variety of complicating factors when determining the actions
of a drug. Some of these factors have been alluded to here and
are described more fully in the chapters that follow. The growing
awareness of the complexity of this kind of analysis represents an
opportunity to enrich our understanding of how drugs act on the
nervous system and to study, at a high level of resolution, the
mechanisms by which their actions are mediated.
David P. Friedman, Ph.D.
Doris H. Clouet, Ph.D.
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External Factors Influencing Brain
Development
Bruce S. McEwen
INTRODUCTION
In the history of biology, the "nature-nurture" controversy refers
to the question of whether genetic constitution or environment
holds the key to the development of the individual. For much of
its history, this argument has occurred in the absence of knowl-
edge about the essential question: What is the link between the
environment and the genome? Nowhere is this issue more important
and current than in the study of the brain.
For many years, the focus of neurobiology was on how nerve cells
conduct and transmit electrical signals, and the brain was fre-
quently modelled as a device which stores information like a com-
puter. However, the influence of the environment on the nervous
system, occurring through both sensory input and chemical signals,
could not be ignored. For example, studies on environmental en-
richment revealed structural changes in cortical thickness and
cellularity produced by environmental manipulations, even in fully
adult animals (Bennett et al. 1964; Greenough 1975). Moreover,
investigations of the hereditary disease phenylketonuria revealed
that diet, i.e., withholding phenylalanine, could control the on-
set and severity of the mental retardation caused by the disease
(Brady 1976). Furthermore, studies of the influence of the gonads
and adrenals revealed long-term effects of hormonal secretions on
sexual and aggressive behaviors and sensory detection and recog-
nition thresholds, as well as brain chemistry and structure
(Leshner 1978; Henkin 1970; McEwen et al. 1979; Arnold and Gorski
1984). The connection between long-term influences of steroid
hormones and the genome was further strengthened by the finding
that steroid hormones bind to intracellular receptors which inter-
act with the genome and affect gene expression (McEwen et al.
1979). Thus, whereas the controversy between "nature and nurture"
placed genetic and environmental influences on two parallel lines
and then argued about the relative magnitude of their respective
effects (figure 1A), the current view of this Issue allows for a
considerable plasticity in the ability of environmental influences
to modify cellular biochemistry and morphology (figure 1B). In
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FIGURE 1. Models of interaction between genome and environment
in affecting individual traits
this current view, the role of the genetic constitution of each
individual is to set the limits for the effects of external agents
on variable gene expression.
It is increasingly evident that the genome is in two-way communi-
cation with the cytoplasm and with the external environment. Ste-
roid hormones affect cellular functions via the receptor-mediated
activation and repression of genes. Other peptide and amino acid
hormones and neurotransmitters can also influence the genome
through second messenger systems. Both of these mechanisms are
represented in figure 2. It is also apparent that steroids and
other hormones interact with each other to produce their effects.
On one hand, steroids regulate the ability of certain other hor-
mones or neurotransmitters to act; on the other hand, neuro-
transmitters appear to influence the ability of steroid hormones
to produce their effects upon brain cells (see figure 3). Insofar
as drugs interact with either neurotransmitter receptors or ste-
roid receptors, their long-term influences may be understood, at
least in part, through the general scheme outlined above. This
article addresses the issue of variable gene activity in brain
cells as it is influenced by steroid hormones. These examples may
help to provide insights into how drugs can produce or modulate
nervous system function over a long time-course.
VARIABILITY OF GENE EXPRESSION THROUGH THE LIFE CYCLE
Background
Understanding how external factors such as hormones turn on genes
is not the only important goal in relation to the interaction
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FIGURE 2. Model of how steroid hormone and cell surfacs acting
hormone may affect genomic activation
FIGURE 3. Models of how neurotransmitters and steroid hormones
interact with eaah other
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between the environment and the genome. Equally important is the
fact that genes are turned on and off at various times during the
life cycle, and the same chemical signals may have different ef-
fects at different stages of development and maturity. We now
recognize five distinct categories of hormone actions during the
life cycle. During early development, gonadal and adrenal ste-
roids direct the differentiation and development of populations of
neurons which have expressed intracellular steroid receptors as
part of their differentiation. In mature nerve cells, on the
other hand, circulating hormones mediate cyclic and behaviorally
induced changes in function which are largely reversible, even
though they may last for many hours. In contrast, in the aging
organism, steroid hormones of adrenals and gonads play a role in
promoting neural damage and neuronal loss. Such deleterious
influences also occur with prolonged exposure to hormone at virtu-
ally any stage of development. Surprisingly, however, hormones
are also instrumental in promoting plastic changes in damaged
neural tissue which result in replacement of lost synaptic connec-
tions. In such cases, the hormone appears to act on developmental
programs which are reactivated by the damage. Let us briefly
consider some examples of these five categories.
Developmental Effects
During perinatal development in rats and prenatal development in
guinea pigs and primates, testosterone secretion in the male fetus
leads to sexual differentiation of the reproductive tract and the
brain (Goy and McEwen 1980). These effects are mediated by andro-
gen and estrogen receptors that are laid down in both sexes during
embryonic life, and it is the secretion of testosterone only in
the male during a sensitive or "critical" period of development
which is responsible for the male's becoming different from the
female. Testosterone is actually a prohormone: its metabolftes,
estradiol (E) and dihydrotestosterone (DHT), produced locally
in target cells, are the actual agents which bring about sexual
differentiation. Thus E, normally thought to be a "female" hor-
mone, is partially responsible for the masculfnizatfon (enhance-
ment of male traits) and defeminization (suppression of female
traits) of the brain. E and DHT are believed to produce some of
their principal effects by inducing neurite outgrowth and pro-
moting neuronal survival (Toran-Allerand 1984; Arnold and Gorski
1984). In dofng thfs, E and DHT are undoubtedly acting in concert
with other morphogenetic substances such as the various nerve
growth factors, and some of these possible interactions will be
described below. What results from the actions of E and DHT
during the critical period is a nervous system in which discrete
neuroanatomical loci have undergone morphological and biochemical
differentiation in the two sexes. Brain sexual differentiation is
perhaps the clearest and most important example of the developmen-
tal effects of hormones, not only because of the insights thus far
obtained into cellular mechanisms but also because of the implica-
tions which a sexually differentiated neural substrate has for
adult neural functions.
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Cyclic Activation of Neuronal Characteristics
After early development, when neuron populations are reduced to
adult numbers and stable synapses are formed, hormones have some-
what different effects on neuronal biochemistry and function which
are largely reversible. The gonadal and adrenal hormones are each
secreted cyclically (diurnally, monthly, or seasonally), and this
produces cyclic effects on neuronal activity and biochemistry.
One example is the synaptic efficacy for long-term potentiation
(LTP) within the hippocampus, which varies with the time of day
and peaks during the waking period following prewaking elevation
of glucocorticoids (McEwen and Brinton, in press). Adrenalectomy
causes this rhythm to shift 12 hours to peak during the sleeping
period (Dana and Martinez 1984). Another example of a cyclic
hormone effect is the sexual behavior of the female rat, which
varies cyclically during the estrus cycle. The cyclic elevation
of E followed by progesterone (P) is responsible for inducing
sexual receptivity in female rats, and E and P do this by acting
on a specific group of neurons in the ventrolateral/ventromedial
nuclei (VMN) of the hypothalamus and inducing changes in genomic
activity involving multiple gene products associated with neuro-
transmission (McEwen et al., in press a). An important connection
to sexual differentiation exists, because male rats fail to show
lordosis behavior when castrated and primed with E and P, even
though it can be demonstrated that the female sexual reflex
(called lordosis) is present in males. Males castrated at birth
(thus escaping the postnatal "defeminization") show female recep-
tivity when primed with E and P as adults. The "defeminizing"
actions of testosterone (T) durfng the critical period involve the
generation of E as the active metabolite (McEwen et al., in press
b). Thus, the actions of E on the developing genome of the VMN
have consequences which prevent E from acting on the same adult
neurons to activate lordosis behavior in adult males. This exam-
ple of differential actions of the same hormone in immature and
adult neurons further emphasizes the point made above regarding
the shifts in gene expression with development.
Behaviorally Induced Adaptive Responses
Another facet of reversible hormone effects in the mature nervous
system involves the responses elicited by hormones secreted as a
consequence of behavioral events. For example, aggressive encoun-
ters between males in defendfng territory prior to mating season
elevate T levels, then T activates neural and reproductive tract
systems, leading to successful mating and reproduction. This type
of behavioral control results in much the same consequences as
those produced by cyclic changes in hormone levels. In fact, in
the realm of reproduction, the seasonal and behavioral regulatfon
of hormone secretion are causally linked and, thus, not really
different from each other. However, a form of behaviorally
induced hormone secretion that is distinctly different from cyclic
hormone release is the phenomenon of stress. Stress encompasses a
variety of behavioral states or situations that induce a massive
outpouring of CRF and vasopressin from the hypothalamus, ACTH and
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ß-endorphin from the pituitary, and glucocortfcoids and epineph-
rine from the adrenals. The immediate impact of stress-induced
hormone secretion appears to activate restorative and protective
mechanisms in relation to emergencies. When stress is recurrent,
the stress hormones help to bring about "adaptive" changes in the
nervous system. One example of this is the stress-induced sup-
pression of noradrener fc-stimulated generation of the second
messenger, cyclic AMP McEwen and Brfnton, in press). This sup-
pression occurs only after repeated stress and involves, in the
cerebral cortex, a glucocorticoid-mediated suppression of the
a-adrenergic contribution to CAMP generation (Stone et al. 1986).
The fact that such a mechanism exists illustrates the specializa-
tion of means by which environmental signals of diverse types,
intensities, and durations can bring about situation-specific
changes in the central nervous system (CNS).
Degenerative Consequences of Hormone Action
When stress or glucocorticoid exposure is prolonged, the normally
adaptive processes may give way to deleterious effects. Outside
of the nervous system, these include fmmunosuppression and
enhanced susceptibility to infectious agents and tumors; osteo-
porosis; muscle wasting; and steroid diabetes. The classic exam-
ple of wasting away from too much glucocorticoid is the migrating
salmon, which dfes after a crisis of elevated glucocorticoids
brou ht on by the stress of migration upstream (Robertson et al.
1961). In a less dramatic way, glucocorticoids contribute signif-
icantly to loss of neurons in the hippocampus with age in the
rat. This loss of neurons, together with a reduction in gluco-
corticoid receptors, leads to progressively elevated glucocorti-
coid levels because of lessening negative feedback capability
(Sapolsky et al. 1986). It is conceivable that the same "feed-
forward cascade" may be instigated by persfstent stress in younger
individuals. and, in this connection, one may speculate that indi-
vidual differences in stress susceptibility that are developmen-
tally determined can predispose individuals to faster or slower
entry into such a "feed-forward cascade." Indeed, neonatal han-
dling of rats produces higher than normal glucocorticoid levels in
the hippocampus and a better than normal capacity to shut off
glucocorticoid secretion after stress (Meaney et al. 1985). It
remains to be seen whether such early experience has the expected
effect of retarding the aging process. Although incomplete, thfs
example serves to illustrate the insights we are now beginning to
have into the impact of the environment on the developfng nervous
system and how it responds to the environment after it is mature.
Repair of Neural Damage
Strange as it may seem after the discussion of damage produced by
steroids, the hormones of the gonads and the adrenals also have
the capability of promoting new synapse formation. For example,
homotypical sprouting of serotonfn nerve fibers in the hippocampus
after damage of other serotonin projections results in reinnerva-
tion of vacant synaptic sites; this repair process is markedly
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attenuated by bilateral adrenalectomy and restored by glucocorti-
coid administration (Zhou and Azmitia 1985). Furthermore, in the
hypothalamus, cutting of major inputs to the arcuate nucleus
results in marked loss of synapses; collateral sprouting and re-
innervation of vacant synaptic sites is markedly facilitated by
estrogen treatment (Matsumoto and Arai 1979). In both of these
examples, it can be argued that developmental programs which were
active in the embryo are once again called into play by the dam-
age. Here is another example of the varfability of gene expres-
sion in the nervous system and how actions of hormonal sfgnals are
dependent on the state of the genome.
INTERACTIONS BETWEEN NEUROTRANSMITTERS AND HORMONES
In addition to being dependent on the state of dffferentfatfon of
the target cell, steroid hormone action is also dependent to some
extent on other chemical messengers such as neurotransmitters. In
development, such effects have been inferred on the basis of
pharmacological studies in which neurotransmitter drugs are admin-
istered together with testosterone (T) during the critical period
for sexual differentiation. The rationale for supposing that
developmental effects of T may be dependent on neurotransmitters
is that monoamine neurotransmftters are implicated in a wide range
of developmental events in the nervous system (Lauder 1983). In-
deed, administration of reserpine and phenoxybenzamine, drugs
which deplete or block actions of monoamines, respectively, inhib-
its the developmental actions of T (Gorski 1973; Nishizuka 1976).
With respect to catecholamfnes, tyramine (which releases noradren-
aline from terminals) as well as the receptor blockers phenoxy-
benzamfne and phentolamine inhibit the defeminfzing actions of T
to suppress ovulatory cyclfcity in female rats (Raum and Swerdloff
1981). In these experiments, the fact that the ß blocker pro-
pranolol reversed the blockade of defemfnfzation led these authors
to propose that noradrenaline suppresses masculinfzation via ß
receptors, and presynaptfc a receptor blockade facilitates thfs
mechanism (Raum and Swerdloff 1981). A subsequent study, using
other drugs, provided evidence partially confirming this hypoth-
esis, showing that ß receptors appear to mediate inhibition of T
action, but the -2-blocking drug yohimbine has no effect on T
action (Vidal and Aguilar 1985). A plausible mechanism for
ß-receptor-mediated inhibition of T action is the reported ß-
receptor-mediated inhibition of the conversion of T to estradiol,
which underlies defeminization (Vaccaro et al. 1980).
Serotonin is also implicated in developmental actions of T, and
most of the evidence suggests that, in contrast to noradrenaline,
serotonin may be involved in promoting the defeminftfng actions of
T. For example, postnatal treatment of female rats with para-
chlorophenylalanfne (pCPA) protects agafnst the defeminizing ac-
tions of T on anovulatory sterility (Reznikov et al. 1979). In
the absence of T, pCPA does not affect cyclicity, but it does re-
duce the amount of spontaneous proceptive behavior in females
(Hyyppa et al. 1972). Conversely, tryptophan administration
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postnatally potentiates T actions to suppress lordosis behavior,
although in this study pCPA did not interfere with T-induced de-
feminization (Jarzab and Dohler 1984). Not all the evidence
implies a protestosterone effect of serotonin, however. For ex-
ample, 5-hydroxytryptophan administration delays anovulatory ste-
rility induced by T (Shirama et al. 1975). and prenatal treatment
with pCPA actually increases the volume of the androgen-dependent
sexually dimorphic nucleus of the preoptfc area in female rats
without altering circulating hormone levels (Handa et al. 1986).
Moreover, forebrain levels of serotonin are higher in female rats
than males at the end of the second postnatal week of life, and T
administration to females or castration of males reverses the sex
differences (Ladosky and Gaziri 1972; Giulian et al. 1973). Thus,
serotonin may have diverse effects on brain development and sexual
maturation which are brain region specific and also dependent on
the time of postnatal life.
It is our view that global treatments of rats with drugs affecting
the whole brain may not give sufficient information pertaining to
neurotransmitter control of specific behaviors, and we have been
exploring region-specific aspects of serotonin action. Since the
basal hypothalamus is involved in control of lordosfs behavior in
the female rat, we have concentrated our efforts on serotonin
function in this brain region. Lesions of the serotonin innerva-
tion of the basal hypothalamus with 5,7 dihydroxytryptamine pro-
duce facilitation of lordosis behavior in female rats iven
estradiol (E) plus progesterone (P) (Luine et al. 1983). Male
rats with the same lesion show facilitation of lordosis behavior
from a baseline which is close to zero; furthermore, 5,7 di-
hydroxytryptamine lesions unmask sensitivity to P which is not
evident in unlesioned males (Moreines et al., unpublished). This
unexpected result implies that serotonin plays an important role
in the sexual differentfatfon of the male brain and is responsi-
ble, in part, for the lack of display of the lordosis reflex after
E plus P priming. These results are consistent with the data,
summarized above, which show that serotonfn potentiates the de-
feminizing aspect of T action, but it is also possible that sero-
tonin is not directly involved in T action, but rather that T
action increases the outgrowth of serotonin fibers into the basal
hypothalamus and/or changes the regulatory effects of E plus P
treatment which normally remove serotonin inhibitory influences
and allow lordosis to be displayed.
The effects of serotonin to inhibit the actions of E and P in
adult female and male rats imply that there may be other inter-
actions between the neurotransmftter and the hormone. What are
they? One type of interaction is the ability of E and P to alter
monoamine oxidase activity and thus to change the turnover of
monoamines such as serotonin (Luine and Rhodes 1983). Another
type of interaction may be at the level of the E and P receptors
themselves. Although evidence is lacking for serotonin, other
monoamine neurotransmitters are implicated in influencing the
level or availability of E and P receptors, For example, dopami-
nergic stimulation increases estrogen receptor numbers in the
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pituitary, overcoming the effects of disconnection from hypothala-
mic input (Carrillo et al. 1983; DeNicola et al. 1981; Weisenberg
et al. 1979). Stimulation of dopamfnergic receptors by bromcryp-
tine also results in increased cell nuclear uptake of 3H-E in vivo
in the hypothalamus and the pituitary, an effect which is evident
in female rats but not in males (Thompson et al. 1983; Gietzen et
al. 1983; Gietten and Woolley 1986). In a related study, inhibi-
tion of dopamine-ß-hydroxylase results in increased numbers of
hypothalamic nuclear estrogen receptors even in the absence of
endogenous E, implying a conversion of E receptors to a nuclear
binding form (Blaustein 1986). The opposite effect, a decrease in
the number of nuclear E receptors in the hypothalamus, is reported
in guinea pigs following a-l blockade by prazosin (Clark et al.
1985). Finally, prazosin or other a-receptor-blocking drugs re-
duce progestin receptor levels in the E-primed guinea pig hypo-
thalamus, an effect which is restricted to the ventromedfal
nucleus region that controls lordosis behavior (Nock et al. 1981;
Nock and Feder 1984; Thornton et al. 1986). a-l Receptor blockade
also inhibits the display of lordosis behavior under the same con-
ditions, implying that there may be a causal connection (Nock and
Feder 1984). It remains to be established whether serotonin may
have sfmilar effects on E and P receptors.
The interaction between neurotransmitters and steroid hormones,
outlined above, is represented in figure 3. In this figure, ste-
roid hormones can induce specific protein gene products which may
include enzymes and receptors involved in neurotransmitter action
(panel A); alternatively, transmitters may modify steroid hormone
action and may do so by modifying the hormone receptors themselves
or the ways in which they produce their gene regulatory effects
(panel B).
CONCLUSIONS
This paper began with the thesis that long-term effects of drugs
on the brafn involve changes in genomic activity, and we have
illustrated the general topic of environmental influences on the
genome by examples pertaining to adrenal and gonadal hormone ef-
fects on the brain. We have seen that steroid effects involving
the genome are diverse, and this diversity is the product not only
of the heterogeneity of the target brain cells but also of their
state of differentiation. In other words, the same hormonal sig-
nal can influence target cells in different ways depending on
which sets of genes are available to be acted on by the hormone-
receptor complex. By analogy with steroid hormones, we know that
many neurotransmitters and surface-acting hormones can also influ-
ence genomfc activity via second messenger systems which alter
phosphorylation of proteins that interact with genes (figure 2).
If we extrapolate from hormones to neuroactive drugs, we can make
a number of general observations about the mechanism of long-term
drug effects. First, the diversity of drug actions in develop-
ment, adult life, aging, and after brain damage may be similarly
based on the state of differentiation of target cell genomes at
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the time of drug administration. Secondly, drugs may act in part
by modifying the secretion of hormones, thus producing long-term
effects via the actions of these hormones. Thirdly, drugs which
act via neurotransmitter systems may modify the actions of hor-
mones which are acting on the same cells. Finally, it is conceiv-
able in a few instances that psychoactive drugs may actually mimic
hormones by interacting directly with hormone receptors. Such
interaction with estrogen receptors has been reported for a number
of classes of psychoactive drugs, including phenothfazfnes such as
chlorpromazine, ergot alkaloids such as bromcryptine, digftoxin
and reserpine (Shani et al. 1971; Campbell and Clark 1984; Lie1 et
al. 1982; Levy et al. 1980).
In the case of two drugs of current interest, alcohol and narcot-
ics, it is possible to point to long-term effects on aspects of
sexual development. In rats, prenatal alcohol exposure has been
shown to abolish sex differences in saccharin preference and
Lashley III maze performance, even though it does not evidently
masculinize or feminize reproductive behavior (McGivern et al.
1984). The mechanism for this rather selective effect is there-
fore unlikely to involve wholesale alterations in gonadal hormone
secretion or actions but rather more selective effects on neural
development. In contrast to alcohol, morphine has been reported
to affect reproductive behavior in rats when administered pre- and
postnatally. Prenatally, morphine treatment results in precocious
vaginal opening and inhibition of feminine sexual behavior; male
offspring, on the other hand, showed minimal impairment of repro-
ductive behavior (Vathy et al. 1985). Postnatal treatment of rat
pups with morphine produced the opposite effect to prenatal treat-
ment; namely, enhanced feminine sexual receptivity and less
inhibition of receptivity by acutely administered morphine in
adulthood (Meyerson and Berg 1985). Because there are no major
aberrations in other aspects of sexual development, it appears
that major effects of morphine on testosterone action and/or se-
cretion are unlikely explanations. Rather, more direct influences
of morphine on neural development are suggested (Zagon, this
volume).
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Rearrangement of Synapses
During Development
Jeff W. Lichtman
INTRODUCTION
During the development of the nervous system, neurons and their
targets establish appropriate synaptic connections in two re-
spects. First, each nerve cell innervates particular postsynaptic
cells, avoiding other potential synaptic partners which are in
some sense qualitatively incorrect. Second, appropriate neural
connectivity depends on precise regulation of the numbers of con-
nections established: each axon must innervate an appropriate
number of target cells, and each target cell must be innervated by
an appropriate number of axons. The regulation of quantitative
aspects (convergence and divergence) is based on competitive
interactions, the outcomes of which are not preordained. Because
of this, these interactions are exquisitely sensitive to environ-
mental stimuli. The aim of this paper is to describe a variety of
systems which provide information about how quantitative aspects
of innervation are regulated. It seems likely that a relatively
small number of principles may underlie the diversity of the pat-
terns of innervation found in the nervous system, the most salient
of which is the importance of competitive interactions in estab-
lishing the immutable pattern of connections found in maturity.
SYNAPTIC MALLEABILITY AT THE DEVELOPING NEUROUUSCULAR JUNCTION
In the early part of this century, neuroanatomists noted the
different appearance of silver-stained neuromuscular junctions in
neonatal and mature muscles (Boeke 1932; Tello 1917). They found
that, whereas adult mammalian muscle fibers are contacted by a
single axon terminal, several different axons converge at the end-
plate of each neonatal fiber. More recently, Redfern (1970)
showed by electrophysiological means that skeletal muscle fibers
in neonatal animals are in fact innervated differently from adult
cells. Intracellular recordings from individual muscle fibers in
neonatal animals showed multiple steps in the postsynaptic poten-
tial elicited by gradually increasing the strength of motor nerve
stimulation. In adult animals, only one step was seen. These
results have been confirmed in many vertebrate muscles. They
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provide evidence for transient innervation by several different
axons at the same muscle fiber (Bennett and Pettigrew 1974; Brown
et al. 1976). Furthermore, morphological, electrophysiological,
and pharmacological studies imply that all the initial synaptic
contacts (each fiber receives synaptic input from at least two to
three axons) are located at approximately the same place along the
fiber length; namely, the eventual site of the mature endplate
(Bennett and Pettigrew 1974; Bennett and Pettigrew 1976; Brown et
al. 1976; Korneliussen and Jansen 1976; Riley 1976; Riley 1977a;
Riley 1977b; Riley 1981).
Because the transition from the neonatal to the adult pattern of
muscle innervation occurs by the removal of some initial neuro-
muscular synapses, this process is called synapse elimination.
For technical reasons, the time of onset of elimination has been
difficult to assess. In some mammalian muscles, it certainly be-
gins before birth (Dennis et al. 1981) but continues into the
first few weeks of postnatal life. On the other hand, in some
reptilian muscles, neuromuscular synapse elimination is complete
by birth (Lichtman et al. 1985). Because there is little evidence
of nerve terminal degeneration in neonatal muscles (Bixby 1981;
Korneliussen and Jansen 1976; although see Rosenthal and
Taraskevich 1977), it seems likely that the terminals which are
lost are withdrawn into the parent axon. Indeed, profiles of what
appear to be retracting processes are often observed in neonatal
muscle (Bixby 1981; Riley 1981). New techniques in which the ter-
minals of different axons can be labelled different colors suggest
that the transition from multiple to single innervation occurs by
the gradual occupation of the endplate site by one axon as the
other axons gradually lose their synaptic contact (Lichtman,
unpublished).
Synapse elimination generally occurs without an obvious change in
the number of innervating motor neurons or target fibers (Bagust
et al. 1973; Brown et al. 1976; Oppenheim and Majors-Willard 1978;
see, however, Nurcombe et al. 1981). This means that the number
of muscle fibers contacted by each motor axon (the motor unit)
must be sharply limited during early postnatal life. Motor unit
size can be measured by estimating the percentage of total tension
in a muscle that is developed by each axon; such measurements show
that there is a several-fold decrease in the average size of motor
units during the first few weeks of life. The largest motor units
tend to undergo more elimination than smaller ones.
Most studies of synapse elimination have looked at skeletal muscle
fibers that are ultimately innervated at a single point along
their length; a few studies have also examined synapse elimination
from muscles that are multiply innervated in maturity. Such mul-
tiply innervated muscle fibers in vertebrates are usually contact-
ed at more or less regular intervals by a number of different
synaptic endings (Wilkinson and Lichtman 1985). These muscle
fibers are slowly contracting (tonic) in which there are no propa-
gated action potentials. Each endplate site along such fibers in
a snake muscle is contacted by several axon terminals early in
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life, and, interestingly, multiple innervation is maintained
(Lichtman et al. 1985). The inability of the target cells to fire
action potentials may be the reason for the absence of synapse
elimination in tonic fibers (see below).
SYNAPTIC REARRANGEMENT IN THE PERIPHERAL AUTONOMIC NERVOUS SYSTEN
A similar reduction in the number of axonal inputs to target cells
occurs at the synaptic junction between neurons. Probably the
simplest neuronal system in which synapse elimination has been
studied is the submandibular ganglion of the rat (Lichtman 1977;
Lichtman 1980). Cells in this parasympathetic ganglion are simi-
lar to skeletal muscle fibers in that most of them are strongly
innervated by a single axon in maturity. As in muscle, these
ganglion cells at birth are innervated quite differently: each
neuron is initially contacted by about five different pregangli-
onic axons. A further similarity to mammalian muscle is that the
initial convergence of several different axons onto each target
cell is reduced to the adult pattern over the first few weeks of
postnatal life. Finally, in another parasympathetic ganglion, it
is clear that the innervating population of preganglionic neurons
remains constant during the period of synapse elimination (Johnson
and Purves 1981). Thus, neural units are decreasing in size at
the same time as motor units are decreasing.
The remarkable congruence of synaptic rearrangement in muscle and
simple parasympathetic ganglia raises the question of whether the
phenomenon of synapse elimination is a special strategy restricted
to those muscular or neural targets in which there is ultimately a
need for a one-on-one pattern of innervation. However, some
classes of neurons that remain multiolv innervated in maturitv
also undergo some degree of synaptic rearrangement in early life.
In the hamster suoerior cervical ganglion, for instance. in which
each adult neuron remains innervated by a number of different ax-
ons (about seven), neonatal ganglion cells are innervated by about
twice as many different axons (Lichtman and Purves 1980). Inter-
estingly, however, the vigor of the elimination process seems less
in ganglia in which neurons remain multiply innervated.
At first glance, one feature of synaptic rearrangement in auto-
nomic ganglia appears different from that in muscle: the number
of identifiable synapses actually increases during the period when
syna ses are being eliminated (Lichtman 1977; Johnson and Purves
1981 .P In fact, a gradual accumulation of synapses during early
postnatal life appears to be characteristic of many parts of the
nervous system (see Purves and Lichtman 1985a for review). Be-
cause new synapses more than compensate for the numerical loss of
synapses during this period, the phrase "synapse elimination"
obscures the important features that synaptic rearrangements in
muscle and autonomic ganglia have in common: a reduction in the
number of target cells contacted by an axon and a reduction in the
number of axons contacting each target cell. Thus, it appears
that each innervating axon initially establishes a relatively
small number of synapses on a relatively large number of target
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cells. As development proceeds, these initial synaptic contacts
are redistributed and additional synapses are formed, so that more
and more synaptic endings are established by each axon on fewer
and fewer postsynaptic cells. The essence of this process, then,
is a focusing of innervation rather than elimination.
On the face of it, the innervation of muscle provides an exception
to this rule: if each mature muscle fiber is innervated by a
single synapse in maturity, and several different axons innervate
each fiber at birth, surely there must be a net loss of synapses.
Although referred to as a single synapse, the vertebrate neuro-
muscular junction actually comprises a number of individual bou-
tons. Since the size and complexity of the boutons clustered
within an endplate increase postnatally (Davey and Bennett 1982;
Nystrom 1968), increasing numbers of synaptic boutons are probably
elaborated on muscle fibers, just as on the surface of autonomic
ganglion cells (and other neurons) during this period. Thus, in
muscle as well, the synaptic connections from the remaining axon
become progressively larger as the number of cells they remain in
contact with declines.
It is also important to point out that, in all the systems stud-
ied, it is very unlikely that the purpose of synapse elimination
is to remove erroneous connections. The earliest connections
formed between presynaptic neurons and vertebrate muscle fibers or
ganglion cells are largely correct. Thus, relatively few errors
are ever present (Landmesser 1980; Lichtman and Purves 1980; Rubin
1984). Moreover, during synaptic rearrangement an axon loses its
contacts with some target cells but retains contacts with other
nearby cells whose function seems the same; it is difficult to see
how one set of connections in a muscle or functionally homogeneous
parasympathetic ganglion is in some qualitative sense more appro-
priate than any other. On the other hand, synapse elimination in
some autonomic ganglia is weakly influenced by the segmental ori-
gin of the innervating axons (Lichtman and Purves 1980). A simi-
lar influence during muscle innervation would not be surprising
given the fact that cholinergic axons show a weak se mental
erence in muscle innervation (Wigston and Sanes 1982) . Indeed,
pref-
some evidence for selective synapse elimination has been presented
(Miyata and Yoshioka 1980; see, however, Gordon and Van Essen
1983; Thompson 1983b). It is probably true that, to the extent
that qualitative criteria influence synaptogenesis, they will also
influence synaptic elimination.
SYNAPTIC REARRANGMENT IN THE CENTRAL NERVOUS SYSTEM
Similar phenomena have been described in several parts of the
central nervous system (CNS). For example, in the avian auditory
system, neurons in the nucleus magnocellularis are also innervated
by more axons before birth than after (Jackson and Parks 1982).
As in the peripheral nervous system, the decline in axonal conver-
gence is accompanied by a decrease in the number of terminal
branches arising from the innervating axons. The innervation of
Purkinje cells by climbing fibers in the cerebellum of newborn
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rats undergoes a similar rearrangement. Whereas multiple climbing
fibers innervate each Purkinje cell in neonatal rats, in mature
animals each Purkinje cell is contacted by only a single climbing
fiber (Crepe1 et al. 1977).
On the other hand, not all synaptic connections in the CNS are
susceptible to elimination. The connections from stretch sensi-
tive sensory afferents (Ia) to muscle fibers do not seem to under-
go elimination. This is inferred from the fact that no sensory
connections that are not also present in adults are found in
development (Frank and Westerfield 1983), and, in the adult, vir-
tually every appropriate stretch sensitive axon innervates every
appropriate motor neuron, meaning that none of these appropriate
connections were eliminated either (Lichtman and Frank 1984). In
contrast to synapses where synapse elimination has been document-
ed, the Ia connections are quite weak; no single Ia axon can drive
a motor neuron to threshold.
The best studied and most informative example of rearrangement of
initial innervation in the CNS is the developing visual cortex.
In adult cats and in some species of monkey, neurons in the pri-
mary visual cortex are segregated into columns dominated alter-
nately by the right and left eye (Hubel and Wiesel 1965; Hubel et
al. 1977; LeVay et al. 1978; Rakic 1977; Shatz and Stryker 1978;
Wiesel and Hubel 1962; Wiesel and Hubel 1965). In contrast to the
adult, at birth (and in late embryonic life) there is considerable
overlap of adjacent columns from the right and left eye (Hubel et
al. 1977; Rakic 1977). Thus, initially the arborfzations of
geniculate axons driven by each eye overlap in layer IV of the
primary visual cortex. The outcome of this rearrangement is very
sensitive to neural activity (see below).
Similar segregative phenomena occur in other cortical and sub-
cortical areas. For instance, inputs are gradually segregated
into upper and lower cortical layers in the olfactory cortex of
developing mammals (Schwab and Price 1984). In the lateral genic-
ulate nucleus, retinal afferents from both eyes are initially
distributed throughout the nucleus but are eventually restricted
to particular laminae (Rakic 1977; Sretavan and Shatz 1984;
Sretavan and Shatz 1986).
Under experimental conditions, segregation can even be induced
between afferents that would not normally encounter one another.
Thus, if optic nerve fibers from two eyes of lower vertebrates are
forced to innervate the same side of the tectum, the two sets of
inputs tend to segregate into discrete patches (Constantine-Paton
and Law 1978; Law and Constantine-Paton 1981; Law and Constantine-
Paton 1982; Fawcett and Willshaw 1982).
Other rearrangements have been described in the CNS which are less
clearly related to the sorts of rearrangements of synaptic connec-
tions that have been studied in the peripheral nervous system and
the primary visual system. For example, many axons extend across
the corpus callosum to the contralateral hemisphere in mammals.
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Studies using retrograde and anterograde tracer methods show that
these crossing projections are more diffuse in young animals than
in adults (Innocenti 1981; Innocenti 1982; Innocenti et al. 1977;
Ivy and Killackey 1981; Ivy and Killackey 1982; Ivy et al. 1979).
Many of the neurons that lose their interhemisphere connections
survive into maturity; therefore, this restriction is the result
of terminal retraction rather than cell death (Innocenti 1981;
O'Leary et al. 1981; Stanfield et al. 1982). Whether synapses are
eliminated during these retractions is not known.
FACTORS REGULATING SYNAPTIC REARRANGMENT
The final result of synaptic rearrangement during development is
very different for different types of cells. As already men-
tioned, some target cells are ultimately innervated by a single
axon, as is the case for the motor neuron input to twitch muscle
fibers, some autonomic ganglion cells, and the climbing fiber
input to Purkinje cells, whereas other cells are innervated by
literally thousands of axons, as is the case for many classes of
cells within the CNS. This wide range of convergence raises a
fundamental question: Why does synapse elimination sometimes
continue until only one axon remains in contact with a target
cell, whereas in other instances multiple innervation persists?
In autonomic ganglia, an obvious difference between cells that are
singly innervated and neurons that remain multiply innervated is
their geometry. Thus, mature neurons in the submandibular gangli-
on (which are singly innervated) lack dendrites altogether, where-
as neurons in the mammalian superior cervical ganglion (which are
multiply innervated) have a number of different dendrites whose
number is roughly proportional to the average number of ganglion
cell inputs (Purves and Lichtman 1985b).
The relation between target cell shape and number of inputs has
been explored directly in the rabbit ciliary ganglion in which the
cells have more or less the same function and display both a range
of geometries and a range of inputs (Johnson and Purves 1981;
Johnson and Purves 1983). Cilfary ganglion cells that are inner-
vated in maturity by a single axon usually lack dendrites al-
together, as do submandibular ganglion cells. Conversely, ciliary
ganglion cells innervated in maturity by more than one axon have
geometries that on average increase in complexity in
the number of innervating axons (Purves and Hume 1981 P
roportion to
. The adult
geometry of ganglion cells does not appear to be a result of the
number of axons which initially contact each cell. All rapid
ciliary ganglion cells are multiply innervated at birth. Yet the
geometry of ciliary ganglion cells at birth shows the same range
of complexity as the adult: some cells lack dendrites altogether,
other cells have modest dendritic arborizations. and still others
have arborizations as complex as the dendritic trees in mature
ganglia (Hume and Purves 1981). Apparently, the confinement of an
initial set of inputs to a limited postsynaptic surface (the cell
body) forces a resolution in which synaptic contacts from only one
axon can survive. Conversely, the presence of dendrites in an
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early stage somehow confers immunity from these interactions be-
tween axons, so that innervation by a number of different axons
persists. Immunity from synapse elimination might be conferred
because the presence of dendrites allows inputs from different
axons to become segregated to some degree (Forehand and Purves
1984). On the other hand, synapses from different axons persist
side by side on ciliary ganglion cells (Forehand, submitted for
publication). Thus, dendrites might mitigate elimination in other
ways, perhaps analogous to the way in which tonic fibers maintain
multiple innervation, because in both cases the target membrane is
inexcitable (see below).
COMPETITIVE ASPECTS OF SYNAPTIC REARRANGEMENT
Competition between different axons innervating the same target
cells seems to be an important feature of the process of synaptic
rearrangement: terminals are withdrawn from a target cell because
in some sense other terminals have been more successful. Several
lines of evidence support this view. When motor unit size is
measured in very small muscles in which only a single axon has
been left to innervate the entire muscle, the remaining motor unit
fails to decrease in size (Betz et al. 1980). In some developing
muscles, there is also evidence for an intrinsic tendency for
axons to withdraw a portion of their initial arborization. For
instance, if a substantial fraction of the innervation to rat
soleus muscle is removed at birth, in this muscle an appreciable
reduction in motor unit size still occurs (Brown et al. 1976).
This may occur because axons are, as already described, in fact
redistributing (rather than eliminating) synaptic "machinery"
which may be limited in total amount. A further argument for com-
petition derives from the end result of rearrangement in muscle
and some autonomic ganglia. It is difficult to imagine how a
process that did not involve competition could produce the one-on-
one relationship observed between these target cells and their
innervation. If the withdrawal of axons were simply random, then
some target cells would be expected to receive no innervation,
whereas others should end up with more than one axon supplying
them. A further indirect argument for competition is the push-
pull nature of the rearrangement that takes place in the periph-
eral nervous system: labelling of motor nerve terminals shows
that, as one axon increases its hold on the postsynaptic cells,
others apparently let go (Lichtman, unpublished).
If competition is a central feature of synaptic rearrangement,
what do axons compete for? One possibility is trophic factors
produced by the target cells. Trophic interactions between target
cells and the neurons that innervate them is a basic feature of
neural development. Thus, the death of many neurons in early
embryonic life apparently results from failure to obtain trophic
support from peripheral targets or, in some cases, to provide it
(Oppenheim 1981). In at least two parts of the nervous system,
there is good evidence that this trophic support is provided by a
specific protein (nerve growth factor) which may be produced by
target cells (Levi-Montalcini and Angeletti 1968; Thoenen et al.
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1982). It is attractive to suppose that axons also compete for
target-produced factors during the synaptic rearrangements. In
this view, the number of target cells innervated by each axon is
regulated in large measure by the presynaptic cells' requirement
for a particular level of trophic support. Since axons gradually
reorganize their initial connections to innervate a smaller number
of target cells, an axon presumably receives more trophic support
by innervating a few cells strongly than many cells weakly.
NEURAL ACTIVITY’S ROLE IN SYNAPTIC REARRANGEMENTS
The scenario in which target cells supply limited amounts of
trophic molecules to competing presynaptic cells does not entirely
account for what is observed. For example, the number of synaptic
boutons actually increases during the period of interaxonal compe-
tition in early life. Therefore, trophfc support must be avail-
able for a much larger number of synaptic connections than is
initially present; what seems to be lacking is support for connec-
tions arising from many different axons contacting the same target
cell. Moreover, the idea of competition for a limited supply of
trophic factor in the local environment of nerve terminals does
not explain the striking capture of individual cells in both the
neuromuscular and autonomic nervous systems. If presynaptic axons
simply required a threshold level of trophic factor to be main-
tained in a particular region, there would be no reason for the
sharp focusing of innervation on a few target cells during synap-
tic rearrangement.
These considerations all suggest that the synapses which ultimate-
ly innervate a muscle cell or neuron are somehow treated as "sets"
during the process of innervation. Evidently, all the synaptic
boutons arising from one axon are identified during competition as
being different from the synaptic boutons arising from a competing
axon. How is this identity of sets accomplished? An obvious
property held in common by synaptic boutons arising from a partic-
ular axon is their pattern of neural activity. There is, in fact,
considerable evidence that synaptic rearrangements are influenced
by activity. For example, in both muscle and autonomic ganglia,
chronically paralyzing nerves with a local anesthetic (or other-
wise decreasing activity) decreases the rate of synapse elimina-
tion (Benoit and Changeux 1975; Benoit and Changeux 1978; Caldwell
and Ridge 1983; Jackson 1983; Riley 1978; Srihari and Vrbova 1978;
Thompson et al. 1979). Conversely, increasing the level of activ-
ity of innervating axons by chronic stimulation speeds up elimina-
tion (O'Brien et al. 1978; Thompson 1983a). Additional evidence
for the influence of neural activity on synaptic rearrangement
comes from the development of the visual system. If one eye of a
monkey is occluded during the first few weeks of life, the normal
segregation of ocular dominance columns is dramatically altered
(Wiesel and Hubel 1963; Wfesel and Hubel 1965). The columns nor-
mally activated by the deprived eye shrink, whereas the columns
activated by the nondeprived eye persist. Finally, chronic block-
ade of visual activity with tetrodotoxin impedes the segregation
of ocular dominance columns (Meyer 1982; Stryker and Harris 1986).
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The overall amount of neural activity during synaptic rearrange-
ments may be less important in synaptic rearrangement than the
pattern of neural activity. If both eyes are occluded (presumably
retusing activity equally in both ocular pathways), then a sub-
stantial shift in ocular dominance columns is not observed (Wiesel
and Hubel 1965; see, however, Stryker and Harris 1986). Addition-
al evidence for the importance of the pattern of activity in
establishing innervation of the visual system is that profound
changes occur in the visual cortex without deprivation if the two
eyes are simply made disconjugate by cutting one or more eye
muscles, or if the two eyes are occluded alternately during the
critical period (Hubel and Wiesel 1965). In both these cases,
each eye receives the same amount of stimulation, and at maturity
the animals appear to see normally with either eye. Yet record-
ings of single units from the visual cortex of animals with stra-
bismus or alternating occlusion show a marked reduction in the
number of binocularly driven cells. These results led Wiesel and
Hubel to suggest that asynchronous activity enhances competition
between axons innervating the same cortical neuron, whereas syn-
chronous activity of axons innervating a cell somehow impedes
their competitive interaction (Wiesel and Hubel 1965). A similar
result has been described in the development of the auditory
system (Sanes and Constantine-Paton 1983).
A simple idea that may explain the relationship between trophic
factors and activity is that the release and uptake of trophic
factors (for which innervating axons evidently compete) occurs
most effectively when the pre- and postsynaptic cells are active
together (Lichtman and Purves 1981; Purves and Lichtman 1980). In
this view, boutons which are simultaneously active on the same
postsynaptic cell will get a larger share of positive reinforce-
ment than boutons which are asynchronously active. Such a link
would reduce competition between synchronously active terminals
and enhance competition between asynchronous inputs. For example,
it would promote the innervation of a muscle fiber or ganglion
cell lacking dendrites by the terminals of the single presynaptic
axon during the period of synaptic rearrangement that normally
occurs in developing autonomic ganglia. The protection from com-
petition afforded by synchronous activity might also help explain
why several systems (such as the Ia-motor neuron system) show
little evidence of focused innervation or synapse elimination. If
the afferents were largely activated together, then there would be
no way of establishing differences between different sets of ter-
minals, and the positive feedback provided by trophic support
would not distinguish different inputs. Tonic muscle fibers
(without action potentials) would also not be sites of synapse
elimination, because the target cells would never be active when
the motor axons were. A similar argument might be made for
synapses on dendrites.
SUMMARY
Synaptic rearrangements in early postnatal life are widespread.
These rearrangements probably reflect the operation of the few
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fundamental rules that govern quantitative apportionment of inner-
vation. It seems likely that axons and target cells in various
regions of the nervous system obey the same rules, although this
obedience may sometimes be obscured by the anatomy of the particu-
lar situation (as in the comparison of muscle fibers and autonomic
ganglion cells). A number of influences are evidently at work in
this process, including those aspects of target cells that provide
for qualitative recognition of appropriate synaptic partners.
Competition between axons, however, seems a fundamental theme as
well as a driving force in establishing patterns of innervation.
The object of terminal competition may be a trophic factor sup-
plied by the target cell, although the arguments for this view
remain circumstantial. The outcome of competition between termi-
nals innervating the same target cell evidently depends on the
geometry of postsynaptic cells and the pattern of neural activity
among the competitors. The nature of the rearrangements that are
observed in most systems that can be carefully studied strongly
suggests a link between the positive feedback supplied by the
postsynaptic cells and patterns of activity. Some linkage of this
sort is required to explain the identification of a set of syn-
apses which arises from a single axon and the unitary capture of
individual postsynaptic cells. The immense range of convergent
synaptic strength and neural unit configuration in the nervous
system is presumably generated by varying a mix of these several
influences.
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Drug-Vulnerable Events in
Neuronal Development:
Implications for the Selection of
Test Methodologies
Linda Patia Spear
INTRODUCTION
Exposure to psychoactive drugs early in life may induce long-term
behavioral effects resulting from subtle alterations in neural
functioning. The developing organism appears to be vulnerable to
potential neurobehavioral consequences of drug exposure throughout
much of the period of neural development, ranging from the begin-
ning of neural tube closure (occurring on embryonic day 8 (E8) in
rats) to the termination of the major brain growth spurt, ending
in the rat at about 10 days postnatally (Dobbing and Sands 1979).
While gross structural malformations are the frequent hallmark of
exposure to chemicals during organogenesis (E8 to 14 in rats),
neurobehavioral teratogenic effects may also be observed during
this period, even at doses below those required to produce gross
teratogenic effects (Hutchings 1978). However, neurobehavioral
teratogenic effects are particularly prevalent following drug
exposure during the fetal period (El5 to birth in rats) (Hutchings
1978; Buelke-Sam et al. 1985) and the early postnatal period in
rats (Diaz and Samson 1980; West et al. 1984; West and Hamre 1985;
West et al. 1986), ages refractory to an insult-induced production
of gross structural defects.
During the developmental span from neural tube closure to the end
of the major brain growth spurt, a multitude of ontogenetic events
occur in the nervous system, including much neuronal generation
and migration of neuroblasts to assume appropriate positions, the
onset of both neurotransmitter synthesis and the formation of re-
ceptors for neurotransmitters/neuromodulators, the initial elabo-
ration of axonal and dendritic processes, and the beginnings of
gliogenesis (Jacobson 1978). The exact sequencing and scheduling
of these events vary markedly with the neuronal population under
consideration, with critical variables including basal or alar
plate derivation, final location of neuronal group or terminal
projections, size of neurons within population, neurotransmitter
substance utilized, etc. (Rodier 1980; Lauder and Krebs 1984).
Because of the diverse complexity with which these events unfold,
an insult sustained at any particular point in ontogeny may have
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the potential to disrupt a number of these processes concurrently
in different neural regions throughout the nervous system.
Although cells that are actively proliferating appear to be
particularly vulnerable to disruption by chemical insults at any
particular developmental stage (Hutchings 1978; Rodier 1980),
other processes of neuronal development and differentiation also
appear to be susceptible to drug-induced alterations early in
ontogeny.
There are a number of different ways in which a chemical insult
can influence neurobehavioral development. These mechanisms can
be divided into three categories: (a) "nonspecific" mechanisms;
(b) general influences on neuronal generation and differentiation;
and (c) specific influences on the development of the neuro-
transmitter system(s) upon which the drug exerts its central ef-
fects (as well as closely related neural systems) (Lauder and
Krebs 1984; Boer and Swaab 1985).
NONSPECIFIC MECHANISMS BY WHICH CHEMICAL INSULTS MAY INDUCE
NEUROBEHAVIORAL TERATOGENIC EFFECTS
"Nonspecific" mechanisms include those that influence neuro-
behavioral development through indirect effects of the drug, as
opposed to direct action of the drug on the developing nervous
system. Exposure to the test substance may induce hormonal and
physiological reactions in the treated dams, which could lead to
alterations in offspring neurobehavioral development; even rela-
tively mild stress of dams during pregnancy has been shown to
alter subsequent behavior, hormonal responsiveness, and neuro-
chemical function in offspring (Ader and Plaut 1968; Meisel et al.
1979; Peters 1982). Drug-induced hormonal reactions, including
but not restricted to those associated with stress reactions, may
also serve to alter subsequent neurobehavioral development in off-
spring. For instance, ethanol-induced increases in maternal
corticosterone levels have been suggested to be a major contribut-
ing factor to the behavioral, neurochemical, and physiological
alterations observed in offspring thereby exposed to the hormone
through the placenta or milk (Angelucci et al. 1985). Given that
the developing organism itself is capable of secreting corticos-
terone from the later days of gestation, it is possible that
chronic drug treatment in late gestation or postnatally may also
directly stimulate corticosterone release in the offspring, which
also could contribute to the observed pattern of neurobehavioral
alterations induced by early drug exposure. Many drugs induce
alterations in body temperature, including hyperthermia. Such
hyperthermia could also contribute to the pattern of neuro-
behavioral alterations induced by a test substance, given that
hyperthermia per se is known to induce teratogenic and behavioral
teratogenic effects (Edwards 1968). Drugs that induce vaso-
constriction, such as cocaine, may result in constriction of the
umbilical artery, resulting in some degree of fetal hypoxia
(Mahalik et al. 1984). which is known to induce behavioral alter-
ations in offspring (Mactutus and Fechter 1986).
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There are a number of ways in which drug exposure may alter the
nutritional status of the offspring, which could contribute to the
pattern of observed effects, given that early life undernutrition
has been observed to induce marked neurobehavioral alterations in
offspring (e.g., Morgane et al. 1978). Drug-induced alterations
in placental blood flow may alter not only the passage of oxygen
to the fetus, as discussed above, but also the passage of other
nutrients to and wastes from the fetus, with subsequent long-term
effects (Mahalik et al. 1984). Certain psychoactive drugs may
also lead to a reduction in food intake by gravid dams, and hence
malnourishment in the pups. For this reason, in cases where a
drug is expected to reduce ingestion , experimenters often use a
pair-feeding regimen in which some control animals are given re-
stricted feedings based on the consumption of diet by drug-treated
animals. It should be realized, however, that although such pair-
feeding designs control for nutritional factors to some extent,
this design does not permit detection of potential interactions of
the drug treatment with nutritional deprivation. A final way in
which drug exposure may alter the nutritional status of the off-
spring is via alterations in efficacy of the suckling process,
either by influencing the nutritional content of milk or the pro-
clivity of the dams or pups to engage in the process of suckling.
As discussed below, these possibilities can be largely, but not
completely, eliminated by fostering gestationally exposed off-
spring to surrogate dams at birth.
Early exposure to drugs may influence neurobehavioral development
of offspring indirectly by altering maternal/offspring inter-
actions, with subsequent long-term effects on offspring behavior
and brain function. This is a particular problem when the drug
treatment is given postnatally, either to the dams or the off-
spring, where even subtle alterations in the behavior of pups or
the dam may lead to marked disruptions in maternal behavior. For
this reason, some investigators using postnatal administration
regimens have resorted to rearing pups artificially (Diaz and
Samson 1980; West et al. 1984; West et al. 1986; West and Hamre
1985). In a prenatal treatment regimen, pups can be fostered to
surrogate dams shortly after birth to eliminate potential treat-
ment effects upon maternal behavior or milk production. However,
behavioral differences between drug-treated and control pups may
still influence the amount of maternal attention given to the pups
even with fostering. The two different procedures for fostering
currently in use are cross-fostering (mixing drug-treated and con-
trol animals within a single litter) and surrogate fostering
(placing an entire litter of pups with a foster dam). Given that
subtle behavioral differences between prenatally drug-treated and
control pups (leading to differential maternal attention) may be
relatively magnified in a cross-fostering design because of the
"contrast" effect of having both normal and drug-treated pups in
the same litter, surrogate fostering has been suggested to be the
preferred method for rearing prenatally treated pups (Hutchings
1985).
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A final indirect way in which early drug exposure may influence
long-term neurobehavioral functioning is through altering the
interaction of brain and behavior during development (Swaab and
Mirmiran 1985). The primary neural effects of a teratogen may
lead not only to secondary disruptions in the development of other
neural substrates but also to alterations in the ability of the
young organism to emit behaviors and interact and adapt appropri-
ately to its immediate environment. These indirect neural and/or
behavioral effects of the neurobehavioral teratogen may further
alter the prospectus for future development, contributing to the
pattern of alterations in neurobehavioral functioning observed as
the animal matures. Only a few examples will be given to illus-
trate the diversity of this type of indirect effect. Early drug
insults may interfere with the development of critical fetal or
infant behavior patterns necessary for normal subsequent develop-
ment. For example, even low levels of alcohol administered acute-
ly have been observed to markedly depress motor movements in fetal
rats (Smotherman et al. 1986) and breathing in human fetuses (Fox
et al. 1978; McLeod et al. 1983); such fetal movements (Burns
1986) have been suggested to be critical for normal maturation
(Hofer 1981; Smotherman et al. 1986). Postnatally, deficits in
suckling behavior in neonates potentially induced, for example, by
early insult-induced depressions in serotonergic activity (Adrien
1978; Isaacson et al. 1977; Spear et al. 1985; Riley et al. 1985)
may affect the nutritional status of the offspring, which may lead
to additional neurobehavioral complications only indirectly relat-
ed to the drug treatment per se. Drug-induced electrophysiologi-
cal alterations may also influence neurobehavioral maturation.
For instance, a number of drugs (e.g., clonidine, clomipramine)
have been observed to suppress "active" (REM) sleep during devel-
opment; such drugs induce marked behavioral alterations later in
life, along with disturbed sleep patterns and reductions in corti-
cal size, perhaps in part related to the drug-induced suppression
of this predominant state of sleep in young organisms (Swaab and
Mirmiran 1985).
DRUG-INDUCED ALTERATIONS IN CENTRAL NERVOUS SYSTEM (CNS)
GENERATION AND DIFFERENTIATION
Through such diverse mechanisms as those discussed above, drugs
administered early in life may influence neurobehavioral function-
ing of exposed offspring. Drugs may also directly influence brain
development through altering functional levels of neurotransmitter
substances suggested to play an important role in the modulation
of neural tube closure, cell generation, migration, and differen-
tiation, beginning even prior to the developmental onset of neuro-
transmission (Lanier et al. 1976; Tomkins 1975; Lauder and Krebs
1984). For instance, drugs that depress monoamine levels have
been reported to disrupt neural tube closure and early stages of
neurulation long before nascent adult-typical monoaminergic-
containing neurons are formed (Lawrence and Burden 1973; Jurand
1980; Palen et al. 1979). Later in ontogeny, monoaminergic neu-
rons, among the earliest forming neural populations in brain
(generated between E12 to 14 in rats), have been suggested to
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modulate the genesis and differentiation of later developing neu-
ronal systems (Lauder and Krebs 1984). For example, pharmaco-
logical treatments that lower serotonin levels in fetuses have
been reported to delay or reduce neurogenesis of neurons destined
for a variety of later forming brain regions (Lauder and Krebs
1984). Postnatal cell replication in brain has also been observed
to be reduced following pharmacologically induced increases or
decreases in catecholamine levels in infant rats (Barochovsky and
Patel 1982). Endorphins (Zagon and McLaughlin 1983) and other
neuropeptides, such as adrenocorticotrophic hormone, thyrotrophic-
releasing hormone, and somatostatin (Boer and Swaab 1985;
Handelmann 1985), have also been suggested to play a role in brain
growth and neuronal proliferation.
Exposure to drugs early in life may also directly alter function-
ing of specific neurotransmitter systems that may serve to regu-
late neuronal differentiation processes per se. For instance,
histamine and norepinephrine have been suggested to be trophic
factors during a critical postnatal period because of their role
in modulating the activity of ornithine decarboxylase, an enzyme
involved in the synthesis of polyamines which play key roles in
the regulation of cellular development and differentiation (Morris
et al. 1983). Norepinephrine has also been suggested to play a
critical role in maintaining neural plasticity in the visual cor-
tex during a critical postnatal period, with reports that drug-
induced disruptions in norepinephrine levels lead to a loss of
normal developmental plasticity in this brain region (Kasamatsu et
al. 1984; Kasamatsu 1985).
DRUG-INDUCED ALTERATIONS IN THE DEVELOPMENT OF NEUROTRANSMITTER
SYSTEMS
Chronic drug administration may also directly influence develop-
ment of the specific neurotransmitter system(s) upon which the
drug exerts its central effects and closely related neural systems
via transsynaptic mechanisms (Lauder and Krebs 1984; Boer and
Swaab 1985; Kellogg 1985). Although the available data are some-
what limited, it appears that in many, but not all, instances the
neural systems altered by administration of drugs during gestation
are often some of the same neural systems affected by acute or
chronic administration of these drugs in adult animals. The
nature of these changes in the affected neural systems after
chronic gestational administration, however, may be in the oppo-
site direction from, and relatively permanent when compared to,
compensatory responses induced by chronic exposure to the same
drug during adult life.
For instance, treatment with dopamine antagonists early in life
has been observed to result in alterations within the dopaminergic
system and related neural systems that are generally in an oppo-
site direction from those compensatory responses seen following
chronic treatment with these drugs later in life (Spear and Scalzo
1986). After withdrawal from chronic neuroleptic treatment in
adulthood, animals typically exhibit an enhanced response to
34
dopamine agonists (e.g., amphetamine and apomorphine) (Muller and
Seeman 1978; Spear et al. 1980) and attenuated responses to dopa-
mine antagonists (e.g., haloperidol) (Asper et al. 1973; Thornburg
and Moore 1975) and cholinergic agonists (e.g., arecoline)
(Dunstan and Jackson 1977; Gianutsos and La1 1977). These psycho-
pharmacological alterations presumably result, in part, from the
production of dopamine postsynaptic receptor supersensitivity,
which has been characterized (using 3H-haloperidol as a ligand) by
an increase in receptor number with no change in affinity (Burt et
al. 1977). Oopamine presynaptic autoreceptors in striatal and
mesolimbic dopamine regions also appear to be supersensitive fol-
lowing adult chronic treatment with neuroleptics (Roth 1979).
In contrast, chronic early haloperidol treatment has been reported
to produce an attenuated response to amphetamine (Spear et al.
1980) and apomorphine (Rosengarten and Friedhoff 1979) and accen-
tuated responses to haloperidol and arecoline (Spear et al. 1980;
Shalaby and Spear 1980)--psychopharmacological response profiles
opposite to those seen following chronic neuroleptic treatment in
adulthood. Following early chronic exposure to either direct
(haloperidol) or indirect (alpha-methyl-para-tyrosine) dopamine
antagon'sts (Rosengarten and Friedhoff 1979; Rosengarten et al.
1983), 3H-spiroperidol binding is decreased--again, an opposite
response from that seen after chronic adult neuroleptic exposure.
Similarly, whereas dopamine autoreceptors have been reported to be
supersensitive following chronic neuroleptic treatment in adult-
hood, they have been reported, conversely, to be hyposensitive
after chronic neuroleptic treatment throughout gestation and the
preweaning period (Shalaby and Spear 1980; Scalzo and Spear 1985).
Thus, neural modifications induced by chronic neuroleptic treat-
ment during development often appear to be opposite those induced
by such treatment in adulthood.
As shown in table 1, it appears that treatment during the prenatal
period is critical for producing these effects. For instance,
treatment with haloperidol during the prenatal period alone de-
creases 3H-spiroperidol binding and apomorphine-induced stereo-
typed behavior (Rosengarten and Friedhoff 1979), with the critical
period for these effects apparently occurring during gestational
days 15 to 18 (Rosengarten et al. 1983). Early postnatal treat-
ment, conversely, has been observed to produce an adult-typical
profile of increased receptor binding and apomorphine-induced
stereotyped behavior. Thus, it appears that, whereas postnatal
neuroleptic treatment alone produces compensatory responses within
the dopaminergic system that are often similar to those seen after
treatment in adulthood, prenatal treatment (or combined pre- and
postnatal treatment) at the time when these receptors are first
developing produces long-term effects opposite to those occurring
in response to chronic neuroleptic treatment in adulthood.
The outcome of chronic neuroleptic treatment early in life VS. in
adulthood also appears to differ in longevity. The neurochemical
and psychopharmacological alterations induced by chronic neuro-
leptic treatment in adulthood dissipate rapidly, within days or
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TABLE 1. Comparison of the psychopharmacological and neuro-
chemical alterations produced by chronic haloperidol
treatment during development or in adutthood
Following Early Chronic Treatment Following Adult
(Tested In Adulthood) Chronic Treatment
Combined Pre-
PrenataI and PostnataI PostnataI
Treatment Treatment Treatment
Amphetamine Attenuated Accentuated
responsiveness
Haloperidol
responsiveness
Accentuated Attenuated
Arecoline
responsiveness
Accentuated Attenuated
Dopamine
autoreceptor
sens i t i v i t y
Hyposensitive No difference Supersensitive
Apomorphlne-
induced
stereotypy
Attenuated No difference Accentuated Accentuated
Dopamine
receptor
binding
D e c r e a s e d Increased Increased
NOTE: "--" means that this combination of treatment and test has not been
assessed.
several weeks after termination of the drug treatment regimen
(Muller and Seeman 1978). In contrast, the effects of chronic
neuroleptic treatment early in life reviewed above are long-
lasting, appearing to be at least as evident when examining ani-
mals in adulthood rather than shortly after treatment termination.
These alterations may persist into older adulthood as well, given
that dopamine autoreceptor hyposensitivity induced by chronic
haloperidol treatment early in life is seen not only in young
adults (2 to 3 months old) but also in older adult rats (12 to 13
months old) (Scalzo and Spear 1985).
There are a number of interesting aspects about the receptor
alterations induced by early drug treatments. As the affinity of
receptors remains constant during normal development (Balazs and
Brooksbank 1981; Bruinink et al. 1983), so the affinity remains
constant following the early drug treatment, with the decrease in
DA receptor binding (following prenatal neuroleptic treatment)
being associated with a decrease in the number of binding sites
with no change in their affinity (Rosengarten and Friedhoff 1979).
Alterations in dopamine receptor binding can also be seen in the
opposite direction following early drug treatment, with chronic
exposure to the dopamine precursor L-DOPA during the end of the
second and the beginning of the third trimester inducing an in-
crease in DA receptor binding (Friedhoff and Miller 1983). Thus,
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treatment with either a dopamine agonist or antagonist at the time
when dopamine receptors are first developing seems to have a long-
term effect on the number of dopamine receptors present in adult-
hood, even though only a small proportion of the total number of
dopamine receptors eventually present in the adult are evident
during the prenatal period of drug exposure (Pardo et al. 1977;
Deskin et al. 1981). Given that in a number of neuronal systems,
including the dopaminergic system, receptors appear to develop
prior to afferent input to these receptors (Woodward et al. 1971;
Coyle and Campochiaro 1976; Coyle et al. 1984), it appears that
these drug-induced alterations in the "setting" of the number of
receptors eventually to be formed may occur at least partially
prior to the development of structured synaptic connections.
The lack of data makes it impossible to determine at present
whether it is only in the dopaminergic system that manipulating
neurotransmitter availability for associated receptors in their
nascent stage results in alterations in the setting of the popu-
lation number of those receptors. Indeed, evidence suggests that
this may not occur with the benzodiazepine receptor system at
least. Kellogg (1985) has reported that prenatal exposure to di-
azepam does not produce any marked alterations in the characteris-
tics of the benzodiatepine receptor binding site but alters other
neural systems. It is interesting to note, however, that opposite
responses following drug treatment during development and in
adulthood have been observed not only at the receptor level but
also behaviorally. As Kellogg expresses it:
In some instances, the effect on the offspring from
prenatal exposure to certain drugs has been similar to
the effects of maternal conditions for which the drugs
might be prescribed. (Kellogg 1985, p. 150)
In other words, developmental drug exposure may induce long-term
behavioral alterations-analogous to the behaviors for which the
drug is useful in treatment in adulthood.
IMPLICATIONS FOR THE SELECTION OF TEST METHODOLOGIES IN
NEUROBEHAVIORAL TERATOLOGICAL RESEARCH
As discussed above, there are a substantial number of ways in
which any given psychoactive substance could influence neuro-
behavioral functioning. Recognizing these potential mechanisms
what implications can be derived for the selection of appropriate
test methodologies in behavioral teratological and neuroterato-
logical research? In all instances examined, once the nervous
system has matured to a point where it is capable of responding to
acute exposure to a given drug, it appears that the drug acts
directly on the same neural systems via the same mechanisms of
action that it has in adulthood. Thus, to predict the potentia 1
neurobehavioral teratogenic effects of a drug whose central ef-
fects are known, one should consider the adult-typical mechanisms
of action of the drug and what roles those neural systems may play
in the developmental process. For instance, when assessing the
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neurobehavioral teratogenic effects of drugs that influence levels
of neurotransmitters/neuromodulators involved in regulating the
process of neuronal generation and differentiation, it would ap-
pear critical to examine neural measures sensitive to the action
of these regulatory or trophic substances and behavioral measures
previously linked to disruption of neural generation at the ages
when the treatment is administered (Rodier 1980).
Given that drug administration early in life often influences the
development of the neurotransmitter system(s) upon which the drug
exerts its central effects, it would also appear to be particu-
larly useful to focus examination on neurochemical measures of
that neurotransmitter system and on behavioral measures previously
shown to be sensitive to acute alterations in those neural systems
(Kellogg 1985; Geyer and Reiter 1985). Indeed, it has been argued
that a generalized behavioral test screen for use with any poten-
tial teratogenic compound may be of questionable appropriateness
when working with substances whose central effects in adult ani-
mals have been well characterized (Kellogg 1985).
It is much more difficult to predict the neurobehavioral conse-
quences of drugs whose mechanisms of action are unknown. In the
absence of any prior data on the potential behaviors and neural
systems that may be affected by the substance, it has been sug-
gested that initial testing should include general "apical" behav-
ioral tests which are rather global in nature and likely to
reflect alterations in any of a number of neural systems (e.g.,
locomotor activity and learning/performance tasks) (Geyer and
Reiter 1985). A recent workshop to discuss strategies for the
selection of test methods in behavioral teratology has identified
a number of categories of functional effects that should be exam-
ined in initial apical tests: (1) physical growth and maturation;
(2) reflexes; (3) motor development/activity; (4) sensory/
attentional; (5) affective; (6)cognitive (learning/memory/
performance); and (7) reproductive behavior (Geyer and Reiter
1985). Neural measures to be assessed would also have to be very
broad-based initially, or perhaps delayed until after sufficient
behavioral testing is conducted to provide suggestive evidence
regarding what potential neural systems might be affected. Al-
though the broad-based nature of the behavioral teratogenic tests
used has occasionally been criticized by those outside the field
as being atheoretical and essentially "fishing expeditions," in
the absence of any prior data on the potential behaviors and
neural systems that may be affected, this broad-based approach is
considered to be essential in initial work, to be followed ideally
by more specific tests as needed to characterize specific func-
tional alterations (Geyer and Reiter 1985). Even when prior
knowledge of the mechanism of action of the test substance can
provide some guidance for the choice of appropriate test metho-
dologies, numerous potential nonspecific effects of the drug
treatment make it possible, if not likely, that unpredicted con-
sequences may also occur--consequences that may be undetected if
only very specific tests are used. Apical tests may also provide
useful adjunct tests for such nonspecific effects in conjunction
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with more specific test methodologies directed toward examining
alterations induced by the known mechanisms of action of the test
substance.
There is one last important variable to be considered when select-
ing test procedures to be used in neurobehavioral teratology
experimentation: the consideration of testing age (Spear 1984).
Although most testing of neurobehavioral teratogenic effects has
been conducted in adult offspring, testing throughout the lifespan
would appear to be essential to determine the true neurobehavioral
teratogenic potential of a substance. For instance, alterations
induced by early drug exposure, although effectively masked in
adulthood, may become more evident with the decline in neural
function seen during the aging process, perhaps leading to pre-
mature senescence or death (Spyker 1975). As another possibility,
drug-induced neurobehavioral alterations could be considered to be
a special case of early brain damage, with perhaps substantial re-
covery occurring in some cases following insults that occur during
gestation (Riley et al. 1985). A focus on testing in infancy is
not only possible, in view of recent advances in developmental
psychobiology, but also perhaps critical. Given that the limited
data available on neurobehavioral teratogenic consequences in
humans are typically derived shortly after birth, correlations
between human and animal data might be expected to be closer when
analogously assessing the behavior of the test animal population
early in life. Examining the potential teratogenic effects of
test compounds in developing animals may additionally provide more
direct indices regarding the underlying primary direct alterations
induced by teratogens than testing animals in adulthood. As dis-
cussed previously, the direct neural effects of a teratogen may
lead not only to secondary disruptions in the development of other
neural substrates but also to alterations in the ability of the
young organism to interact and adapt appropriately to its immedi-
ate environment. Each of these teratogen-induced effects, alone
and in combination, may alter the prospectus for future develop-
ment, gradually leading to a concatenation of alterations in
neurobehavioral functioning as the animal matures that may make it
progressively difficult to determine the underlying primary alter-
ations induced by the neurobehavioral teratogen (Spear et al.
1985). Research using a developmental approach to examine system-
atically the neurobehavioral teratogenic effects of a variety of
drugs of use and abuse, using testing methodologies specifically
chosen on the basis of the known neural actions of the test com-
pound, has the potential to reveal a great deal about the proc-
esses of normal neural maturation and how they are altered by
chemical insults early in life.
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Alcohol and Brain Development
James R. West, Charles R. Goodlett, and Sandra J. Kelly
INTRODUCTION
There is a story (which may or may not be true) that Alice B.
Toklas, the long-time confidante of Gertrude Stein, leaned over
her dying friend and whispered, "Gertrude, what is the answer?
What is the answer?" After a moment, Gertrude wrinkled her brow,
raised her head slightly, and replied, "What was the question?"
There is considerable relevance in that vignette to the problems
in identifying teratogenic alterations in the central nervous
system (CNS) associated with the abuse of substances such as
alcohol. Experimental strategies for research directed toward a
suspected teratogen depend, in large part, on the types of ques-
tions which can be addressed, which in turn depend on the level of
progress in that area of research at that particular time. Formu-
lating the appropriate questions is fundamental to progress in
understanding neuroteratological effects of substances of abuse in
general and of alcohol in particular. In this paper, we illus-
trate a few of these issues by presenting some of the data from
our laboratory on changes in brain development resulting from
perinatal alcohol exposure. In doing so, we trace the evolution
of our questions and experimental approaches to fetal alcohol
effects using animal model systems (while taking some liberties
with the chronological order of these questions). As a conse-
quence, this paper takes a somewhat unusual approach in that we
focus as much on the choice of questions as on the data.
One of the most basic questions of neuroteratology, and one that
is generally the first asked, is whether a particular substance
can adversely affect the structural and functional development of
the brain. In the case of ethyl alcohol, the possible teratogenic
effects were suspected for centuries (Rosett 1976), but the fetal
alcohol syndrome (FAS), expressed as a characteristic pattern of
craniofacial abnormalities and varying degrees of CNS dysfunction,
was not formally defined in humans until 1973 (Jones-and Smith
1973; Jones et al. 1973). The status of alcohol as a teratogen
was obscured because many women who abused alcohol also abused
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other drugs and suffered from nutritional deficits. Thus, it was
not always possible to demonstrate whether the observed birth de-
fects were caused by the alcohol or were a function of other fac-
tors. Since it is unethical to give alcohol to pregnant women in
controlled studies, the task of answering most of the questions
pertaining to possible alcohol-induced birth defects fell to
animal research.
GOALS OF ANIMAL MODEL RESEARCH
The most serious fetal alcohol effects in surviving FAS infants
are varying degrees of mental retardation (Clarren 1986;
Streissguth 1986). Therefore, a significant amount of fetal
alcohol research in animals has focused on the CNS (West 1986).
An initial goal of this research was to document whether alcohol
could disrupt normal development. A number of well-controlled
animal studies over the last decade have demonstrated a variety of
neuromorphological (Colangelo and Jones 1982; Davies and Smith
1981; Hammer 1986; Phillips 1986; Pettigrew 1986; Samson 1986;
West and Pierce 1986), neurochemical (Druse 1986), hormonal
(Weinberg et al. 1986). and behavioral (Bond 1986; Riley et al.
1986) alterations associated with perinatal alcohol exposure.
For most substances, it is sufficient to demonstrate that they
have teratogenic properties. However, for substances of abuse,
such a demonstration is just the first goal of experimental re-
search, since, as in the case of alcohol, simply publicizing that
it is teratogenic is not enough to eliminate the health hazard.
Even the Surgeon General's (1981) recent advice to abstain from
alcohol during pregnancy has failed to prevent some pregnant women
from drinking heavily. Subsequently, the major goals of fetal
alcohol research have changed. Questions now should be formulated
that focus on more sophisticated problems, such as the mechanisms
that underlie the fetal damage and the factors that contribute to
the severity of such damage. Eventually, these and other ap-
proaches should lead us to address the prospects for the preven-
tion of FAS or therapy for offspring of mothers who drank during
pregnancy.
Now that alcohol has been shown to act as a teratogen and to dis-
rupt brain development, it has become important to consider more
specific questions concerning factors that affect the relative
risk of fetal alcohol effects. One of the questions most fre-
quently asked is, How much alcohol is harmful? This seemingly
simple question is actually extremely complicated and may be un-
answerable in such a simple form. In terms of the CNS, it is now
clear that the minimum amount of alcohol that is harmful to devel-
opment depends on several factors, including the blood-alcohol
levels achieved, the pattern of consumption (or exposure), the
period of development in which alcohol exposure occurs, and the
particular brain regions and types of cells under consideration.
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SELECTING AN ANIMAL MODEL
In order to evaluate the large number of animals necessary for
dose-response studies of the effects of alcohol, it was necessary
to find a CNS fetal alcohol effect that was easy to measure yet
was sensitive to the teratogenic effects on the brain, and at the
same time, was relevant to FAS in humans. Brain growth, as indi-
cated by brain weight/body weight ratios, is such a measure.
Since microcephaly (a smaller than normal head) is a primary
feature of FAS (Jones and Smith 1973; Streissguth et al. 1980),
microencephaly (a smaller than normal brain for body size) was
considered an appropriate measure to incorporate into our animal
model research. Samson and his associates (Diaz and Samson 1980;
Samson and Diaz 1982; Samson and Grant 1983) demonstrated the
effectiveness of using brain weight and the brain weight/body
weight ratio as a measure of alcohol's effects on brain develop-
ment during the early postnatal brain growth spurt in the rat, a
period of brain development roughly equivalent to the human third
trimester. Samson (1986) showed that, in the rat, microencephaly
resulted from alcohol exposure during the third trimester equiva-
lent in the absence of decreases in body weight, but prenatal
exposure (encompassing the first and second trimester equivalents)
produced decreases in body weight as well as brain weight. In the
third trimester equivalent model, microencephaly is an excellent
measure upon which to focus these dose-response studies.
In order to model the effects of exposure during the third trimes-
ter, it is necessary to expose the rat to the suspected teratogen
during the first 2 weeks after birth. Not surprisingly, there are
several problems related to nutrition and experimental control
associated with administering a drug such as alcohol to neonatal
rats (Samson and Diaz 1982; Abel and Riley 1986). In order to
control some of these problems, we used an artificial rearing
technique (West et al. 1984b; West et al. 1984c). Although it
isolates a pup from its mother and littermates, it allows precise
manipulation of the dose and rate of delivery of alcohol while
maintaining adequate nutritional intake and body growth. Also, in
addition to using control groups reared artificially without expo-
sure to alcohol, we standardly include normally reared rats to
evaluate the effects of the rearing procedure per se.
PATTERN OF ALCOHOL EXPOSURE
Using brain weight/body weight ratios as a measure of micro-
encephaly, we began our investigations of factors that contribute
to the severity of CNS fetal alcohol effects. One of the most
obvious factors is the amount of alcohol exposure. We were now
back to our original question: How much alcohol is harmful? Our
first dose-response analysis of alcohol exposure during part of
the early postnatal brain growth spurt (postnatal days 4 to 10)
used relatively continuous exposure to alcohol in four doses rang-
ing from 6.6 g/kg/day to 9.7 g/kg/day, with each dose divided into
12 fractions each day and delivered every 2 hours. Not surpris-
ingly, the extent of microencephaly was a function of dose, with
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the higher doses producing the greatest restriction of brain
weight/body weight (Pierce and West 1986a), corroborating the work
of others (Samson and Grant 1983). More importantly, there was
substantial variability at each dose, both in the brain weight/
body weight ratios at postnatal day 10 and in the blood-alcohol
concentrations (BACs) measured on day 6. The brain weight/body
weight ratios were more highly correlated with BAC than with dose
(Pierce and West 1986a).
Since BAC appeared to be important in the appearance of micro-
encephaly, we predicted that anything that operated to increase
the peak BAC would increase the amount of microencephaly. It is
impossible to dissociate BAC from dose, since BAC is a function of
the amount of alcohol given plus the rate of delivery. Webster
and his associates (1983) provided an interesting approach to this
problem. They found that two injections of alcohol (2.9 g/kg)
spaced 4 hours apart induced more malformations than if the injec-
tions were spaced 6 hours apart. The fact that the 4-hour inter-
injection interval produced higher peak BACs than injections
spaced 6 hours apart suggested that the peak BAC, rather than the
total amount of alcohol injected, was a crucial factor in those
teratogenic effects of alcohol. We hypothesized that manipulation
of the peak BAC would also be an important determinant of the
severity of alcohol-induced alterations in the CNS during later
periods of development.
These considerations suggest that the alcohol consumption pattern
of the pregnant woman, or, in animal studies, the method of expo-
sure of the animal to alcohol, can determine the peak BAC and
thereby the risk of fetal alcohol effects. Most animal models of
fetal alcohol exposure use forced consumption of alcohol via a
liquid diet by the dam during gestation, and these studies have
not been directly concerned with the pattern of alcohol consump-
tion and the resulting pattern of BACs. Since the dam primarily
controls the intake of alcohol in these models, experimental
manipulation of the pattern of alcohol exposure is difficult to
achieve. Artificial rearing allows careful and precise control
over the concentration and rate of delivery of the alcohol. Thus,
exposure of the pup to alcohol via artificial rearing during post-
natal days 4 to 10 provides an excellent method of testing the
effects of different patterns of exposure while maintaining a
constant daily amount of alcohol.
In testing the effect of manipulating the daily pattern of expo-
sure to alcohol, we used a dose of 6.6 g/kg/day, which did not
induce significant brain growth deficits when given uniformly in
fractions delivered every 2 hours from postnatal days 4 to 10
(Pierce and West 1986a). We reasoned that, if a given amount of
alcohol that was just below threshold for inducing microencephaly
(when given in a uniform daily pattern that did not produce high
BACs) were condensed into a shorter period each day (so that the
peak BACs were higher), this condensed treatment would restrict
brain growth if the peak BAC were, in fact, a key factor in pro-
ducing microencephaly. The uniform delivery of the 6.6 g/kg/day
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dose produced BACs that were low (80 mg/dl) and stable over 24
hours. When the same daily amount was condensed into just 12
hours of each day, the resulting BACs were cyclic, with peaks near
270 mg/dl. This condensed treatment significantly limited brain
growth (Pierce and West 1986b). Furthermore, when the same dose
was condensed even more (into just 8 hours of each day), the peak
BAC was even higher (near 400 mg/dl), and brain growth was even
more severely restricted (West et al., in press) (figure 1). In
further support of the hypothesis that peak BAC is a key factor in
the amount of alcohol necessary to produce microencephaly, we
found that the condensed alcohol exposure, but not the uniform
alcohol exposure, produced permanent effects on brain growth and
behavior (Kelly et al., in press). Taken together, these findings
strongly suggest that any condition that tends to produce high
BACs increases the risk that any dose of alcohol will affect brain
growth and behavior. In the human situation, women alcoholics
tend to binge rather than drink continuously (Madden and Jones
1972), and FAS children have been born to binge drinkers (Clarren
et al. 1978; Hermann et al. 1980). While women who drink during
pregnancy usually decrease the amount of alcohol they consume
during the third trimester, when they do drink during this period,
they often binge drink (Stephens 1985)--a situation perhaps simi-
lar to the condensed dose version of our third trimester model.
TEMPORAL VULNERABILITY
The second variable that we investigated that might affect the
threshold for CNS damage was temporal vulnerability. In this
case, the question was whether there is a particular period when
alcohol is especially harmful to the development of the brain. If
so, this would make the threshold for CNS damage variable across
time and would suggest that the state of brain development is an
important factor in the sensitivity of the brain to teratogenic
effects of alcohol.
The study of possible critical periods of a teratogen's effects on
the CNS is complicated because of the complexity of the brain it-
self and because it develops over an extremely long period. In
addition, although the brains of all mammals exhibit the same gen-
eral stages of development, the timing of those stages, relative
to birth, can be quite different (Dobbing and Sands 1979). The
period of most rapid brain growth, often called the brain growth
spurt, occurs during the third trimester and continues after birth
in humans (Dobbing and Sands 1973). In species (such as the rat)
that are less developed at birth than humans, the brain growth
spurt occurs after birth during the first 2 postnatal weeks. In
other words, in terms of brain development, the entire gestation
in the rat is equivalent to only the first and second trimesters
in humans. This difference in developmental timing is significant
if rats are used as a model system for studying CNS defects with
the intention of extrapolating the results to humans.
Another problem that complicates the timing issue is that, even
within a particular species, brain development is heterogeneous in
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FIGURE 1. Variations in the extent of restricted brain growth
(microoencephaly) in 10-day-old male rats induced by
the same daily amount of alcohol administered in
different patterns during postnatal days 4 to 10
(third trimester equivalent)
NOTE: The three groups of rats given alcohol received 6.6 g/kg/day. The uniform
alcohol (UA) exposure group received the alcohol distributed uniformly (in
12 fractions 2 hours apart) during each 24-hour period. The condensed
alcohol (CA-12 and CA-8) exposure groups received the alcohol condensed
into 12 and 6 hours, respectively, In each 24-hour period. The gastrostomy
control (GC) group was treated In the same manner as the UA group, except
that an isocaloric amount of maltose-dextrin was substltuted for the alco-
hol. The suckle control (SC) group was reared normally by dams. Note that
as the dally period of exposure became shorter, resulting in progressively
higher BACs, the amount of microencephaly became greater.
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that not all brain regions develop at the same time or at the same
rate. While the neurons in most nuclei are generated during the
second trimester equivalent, there is considerable variation in
the onset and completion of neurogenesis across different regions.
In addition, a few regions have populations of both large and
small cells that develop over extended and different periods. For
example, the hippocampus, cerebellum, and olfactory bulb each have
populations of large cells that are generated during the second
trimester equivalent, and populations of small cells that are
formed primarily during the third trimester equivalent.
The Hippocampus as a Model System
We examined several aspects of these interrelated questions of
differential vulnerability to alcohol due to differences in the
developmental timing of the alcohol exposure and regional or cell-
ular differences in the brain by focusing on the hippochmpal for-
mation. This strategy provided several advantages. The cellular
and synaptic organization of the hippocampus and dentate gyrus is
relatively simple, and the source and pattern of termination of
intrinsic and extrinsic connections are reasonably well known
(Isaacson and Pribram 1986). The development of the cells of the
hippocampal formation has also been well studied (Schlessinger et
al. 1975; Schlessinger et al. 1978; Bayer 198O), and, of the two
primary cellular components, the hippocampal pyramidal cells are
generated prenatally in the rat, while the dentate granule cells
are generated almost exclusively after birth. This fortuitous
circumstance allowed us, using the third trimester equivalent
model, to determine the effect of alcohol exposure on one popula-
tion of neurons that was postmitotic and another that was under-
going proliferation. Finally, the hippocampal formation has been
used extensively in rats to study neuroplasticity, particularly
the reactive synaptogenesis induced in mature rats by lesions of
major sources of afferents such as the entorhinal cortex. Thus,
the hippocampal formation provides a good system for examining
several aspects of teratogenic effects of early alcohol exposure
on neuronal development and plasticity in animal model research.
Effects of Alcohol on Developent of Mossy Fibers
Our earliest specific neuromorphological studies concerned the
. effects of alcohol on the development of the mossy fiber projec-
tion from the granule cells of the dentate gyrus to the pyramidal
cells in field CA3 of the hippocampus. Our first questions were:
Does prenatal alcohol exposure affect the normal development of
this CNS projection? Are there regions of the brain or different
cell populations that are especially vulnerable to alcohol, i.e.,
have a lower threshold for damage, during development? In our
earliest study, we administered a liquid diet containing either
35-percent ethanol-derived calories or an isocaloric amount of
maltose-dextrin to pregnant rats from day 1 to day 21 of gesta-
tion, i.e., the period of brain development equivalent to the
first and second trimesters in humans. At birth, all pups were
fostered to surrogate mothers and weaned at 21 days. After the
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rats reached adulthood, brain sections were processed with the
Timm stain, and the hippocampi were examined for alterations in
laminar staining. As shown in figure 2, the mossy fiber system--
the major output from the dentate gyrus to the hippocampus
proper--contained an aberrant distal infrapyramidal terminal field
FIGURE 2. Timm-stained horizontal sections through the mid-
temporal hippocampi of adult rats treated previously
with alcohol during different periods of development
KEY: (A) Treatment during gestational days 1 to 10 (first trimester equivalent).
(B) Treatment during gestational days 11 to 21 (second trimester equiva-
lent). (C) Treatment during gestational days 1 to 21 (first and second tri-
mester equivalents). (D) Treatment during postnatal days 1 to 10 (third
trimester equivalent).
NOTE: The letters a, b, and c denote subfields of hippocampal field CA3. Arrows
indicate the aberrant infrapyramidal mossy fibers. The control groups (not
treated with alcohol) were similar to the groups given alcohol In gesta-
tional days 1 to 10 (panel A) and gestational days 11 to 21 (panel B) and
are not presented In this figure.
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at midtemporal levels in the rats given alcohol throughout gesta-
tion (West et al. 1981; West and Hodges-Savola 1983). Other areas
of the hippocampal formation, especially the dentate gyrus, ap-
peared normal in the Timm-stained material. The presence of these
alcohol-induced aberrant mossy fibers was confirmed using the
anterograde transport of horseradish peroxidase (HRP) (West and
Pierce 1984). We also used the anterograde transport of HRP to
investigate whether the terminal fields of the major afferents to
the dentate gyrus were altered by the alcohol exposure. As with
the Timm-stained analysis, the position and size of the commis-
sural (Dewey and West 1985b) and perforant pathway (Dewey and West
1985c) projections to the dentate molecular layer were unchanged.
Thus, the axonal connections of the dentate granule cells were
altered by exposure to alcohol throughout gestation, but the in-
puts to the same cells in the dentate gyrus were apparently
unaffected.
We next asked whether the timing of the alcohol insult in relation
to the stage of development was important for producing the aber-
rant mossy fibers. A liquid diet containing 35-percent ethanol-
derived calories was given to pregnant rats during the first,
second, or combined first and second trimester equivalents. Other
(neonatal) rats were exposed to alcohol on postnatal days 1 to 10
using the artificial rearing procedure. When examined at adult-
hood, there was a differential effect on the mossy fiber terminal
field due to the timing of the alcohol in the development. The
mossy fiber terminal fields in animals exposed to alcohol during
either the first or second trimester equivalents did not differ
from controls. However, the mossy fiber patterns in rats that
were exposed to alcohol throughout gestation (first and second
trimester equivalents) were aberrant, similar to results reported
previously (West et al. 1981; West and Hodges-Savola 1983). More
importantly, the Timm-stained mossy fiber terminal zones in the
rats exposed to alcohol during the third trimester equivalent were
even more aberrant than those of the animals exposed to alcohol
throughout gestation (West and Hamre 1985) (figure 2).
Since the mossy fiber effects were more severe in the rats exposed
to alcohol during the third trimester equivalent than in any of
the prenatally exposed groups, even though the amount of alcohol
given was less, we initially concluded that the third trimester
may be a time when the hippocampus is especially sensitive to
alcohol. However, in addition to the differences in the develop-
mental timing of the alcohol between the groups, they also dif-
fered in the peak blood-alcohol levels; the pups of the third
trimester were exposed to higher BACs than the pups exposed in
utero. The more recent data from our laboratory indicate that the
peak BAC is more important than daily dose in producing CNS-
related fetal alcohol effects (Kelly et al., in press; Pierce and
West 1986a; Pierce and West 1986b) and suggest that it may have
been the higher peak blood-alcohol levels in the animals exposed
to alcohol during the third trimester equivalent, rather than dif-
ferences in temporal vulnerability, that were responsible for the
differential effects. This problem, which has yet to be resolved,
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illustrates a real difficulty in conducting well-controlled, un-
confounded comparisons of the effects of a particular teratogen in
different periods of development.
REGIONAL VULNERABILITY
The Timm stain and HRP analysis indicated that different neuronal
populations were selectively affected by the alcohol exposure.
Another aspect which would indicate differential vulnerability
would be cell loss in specific regions of the hippocampus. There
are two reasons for investigating the effects of alcohol exposure
on neuron number during development. First, comparing the effects
of early postnatal alcohol on pyramidal and granule cells in the
hippocampal formation would indicate whether neuron populations
are more vulnerable to the toxic effects of alcohol after they
have been formed (pyramidal cells) or during their period of
neurogenesis (granule cells). Second, since it had been hypothe-
sized that the extent of the aberrant infrapyramidal mossy fiber
terminal field was a function of the granule cell/pyramidal cell
ratio (Gaarskjaer 1978). selective changes in the number of gran-
ule and pyramidal cells following early postnatal alcohol exposure
would provide additional data related to our previous observations
on alterations of the mossy fiber projection.
Given these considerations, we exposed neonatal rats to 9.7
g/kg/day of alcohol in the formula, distributed uniformly over
each 24-hour period during postnatal days 4 to 10. Cell counts
performed on pups sacrificed on postnatal day 10 revealed that the
alcohol treatment resulted in a significant decrease in pyramidal
cells, but only in field CA4 (West et al. 1986). However, there
was a lo-percent increase in the number of granule cells in the
dentate gyrus, which indicates an increase in either neuron pro-
duction or migration. Together, these changes in neuronal number
suggest that an increased ratio of granule cells to pyramidal
cells might account for the aberrant mossy fiber terminal fields
observed in alcohol-exposed rats, since there may be an over-
abundance of mossy fiber axons relative to the available synaptic
space (West et al. 1981; West and Hodges-Savola 1983; West and
Pierce 1984; West and Hamre 1985). Furthermore, these cell count
data indicate possible differential susceptibility of different
cell types to alcohol. Taken with the results of others (Bauer-
Moffett and Altman 1977; Phillips and Cragg 1982), the data sug-
gest that differentiating neurons are more vulnerable to alcohol
than proliferating pools of neurons. Clearly, however, this needs
to be verified in different areas of the CNS.
From the analysis of both Timm-stained and HRP-labelled afferent
projections to the dentate gyrus, it appears that perinatal alco-
hol exposure affects organization of the terminal fields in the
hippocampus proper but not the dentate gyrus. However, as is the
case with all negative findings, interpretation of results should
be done cautiously; the alcohol may well have effects on a brain
region that are not detectable by the measures being used. In
fact, as illustrated below, this is exactly the case in the
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dentate gyrus when differences are exposed by other experimental
manipulations.
Perforant pathway lesions in normal adult rats, which remove most
of the input to the outer three-fourths of the dentate molecular
layer (Matthews et al. 1976), induce other afferents to the molec-
ular layer to sprout new terminals and reoccupy the deafferented
region in a stereotypical manner (Cotman and Nadler 1978). Using
a variety of neuroanatomical techniques, we found evidence that
the lesion-induced reorganization of both the septal (cholinergic)
and the commissural projections to the molecular layer were dif-
ferent in the animals exposed to alcohol throughout gestation from
the control animals (Dewey and West 1984; Dewey and West 1985a;
West et al. 1984a). Interestingly, the sprouting response of the
adult rats treated prenatally with alcohol resembled that which
occurs in normally reared rats when the entorhinal lesions are
made in preweanling rats rather than in adults (Nadler et al.
1977; Gall and Lynch 1981; West 1984). The enhanced neuro-
plasticity of the alcohol-treated rats may indicate that some
factors involved in lesion-induced reorganization never reached
the state of maturation normally found in adult rats. The ab-
normal sprouting responsiveness does indicate that the dentate
gyrus was, in fact, affected by the prenatal alcohol exposure.
Therefore, whether or not a region is affected by alcohol exposure
during development not only depends on where one looks in the
brain but also on how one looks.
CONCLUSION
Our approach to the analysis of the teratogenic effects of alcohol
has now evolved to a concentration on anatomical alterations of
the hippocampal formation. This has several advantages, not only
from a neuromorphological perspective but also for a much broader
range of studies of neuroscience and behavior. The large base of
knowledge concerning the electrophysiological, neurochemical, and
developmental characteristics of the hippocampal formation
(Isaacson 1982; Isaacson and Pribram 1986). plus the large amount
of literature on its involvement in behavioral processes (O'Keefe
and Nadel 1978; Olton et al. 1979; Seifert 1983) provide many
directions to correlate neuroanatomical effects of alcohol expo-
sure with these other properties. For example, we have already
shown that the condensed exposure to alcohol during the third
trimester equivalent produces deficits in development of spatial
navigation learning (Goodlett et al., in press), a task known to
reauire the normal maturation of hippocampal function (Dyck et al.
1985). Hablitz (1986) has also shown that prenatal alcohol expo-
sure disrupts the normal recurrent inhibition demonstrated in CA1
by paired-pulse stimulation of afferents in the stratum radiatum.
Thus, the opportunities exist to analyze the relationship of
neuroanatomical, neurophysiological, neurochemical, and behavioral
consequences of perinatal alcohol exposure with regard to hippo-
campal function.
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The experimental results described above illustrate a useful ap-
proach using an animal model system for the study of the terato-
genic effects of a substance of abuse. The research strategy
focused on questions that we felt would allow us to extrapolate
the answers to the human condition. Our findings have emphasized
the problems of direct attempts to estimate the minimum amount of
alcohol that is harmful to development of the CNS in humans. What
we have tried to do is to ask questions that concern the factors
that must be taken into account when the question of how much
alcohol is harmful is addressed. These factors are likely to be
relevant to the effects of alcohol on human development. From the
data discussed in this paper, it is clear that, before the ques-
tion of how much alcohol is harmful is resolved, the relevance of
several factors--the pattern of alcohol exposure, the period of
development in which the alcohol exposure occurs. the brain struc-
ture and cell types being examined, and the most sensitive param-
eters to measure--need to be determined. Hopefully, the answers
to these questions will eventually lead to an understanding of the
mechanism(s) of the teratogenic effects of alcohol on the CNS.
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Endogenous Opioids, Opioid
Receptors, and Neuronal
Development
Ian S. Zagon
INTRODUCTION
The quintessential question of developmental biology, how do sys-
tems composed of many different types of cells that form function-
al units arise from a single cell, is most keenly posed by the
nervous system in which cellular diversification and multicellular
organization reaches the pinnacle of complexity. In the rat
brain, for example, well over 100 million cells (Smith et al.
1976) are derived and become organized into networks that execute
all the sophisticated and subtle capabilities of the nervous sys-
tem, with most embryologic events taking place within a 5- to 6-
week timespan. Needless to say, in the human brain, the magnitude
is staggering. The human cerebellum, for instance, contains over
50 billion cells (Zagon et al. 1977). with all these elements
largely being derived and organized within a 2- to 3-year period.
Research efforts to delineate the major morphogenetic processes
(cellular proliferation, migration, differentiation, growth, and
death) have been revealing. One avenue of investigation, elucida-
tion of the role of endogenous opioid systems, i.e., endogenous
opioids and opioid receptors, has been particularly promising and
has provided new and exciting concepts in developmental biology
and neuroplasticity. The intention of this chapter is to outline
some of the historical background, principles, and evidence
regarding endogenous opioid and opioid receptor control of neuro-
development and to discuss briefly the implications of these
findings to normal and abnormal brain development.
HISTORICAL BACKGROUND, PRINCIPLES. AND EVIDENCE
The roots of the discovery that endogenous opioid systems regulate
neurobiological development (Zagon and McLaughlin 1983a; Zagon and
McLaughlin 1983b; Zagon and McLaughlin 1984a) lie not only in the
research interests of this laboratory in perinatal drug abuse
(Zagon 1985; Zagon et al. 1982; Zagon et al. 1984) but in the
revelation that opioid receptors (Simon et al. 1973; Pert and
Snyder 1973; Terenius 1973) and endogenous opioids (Hughes 1975)
are present in neural tissues. Intrigued by research findings
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that endogenous opioid systems exert a marked influence on the
growth of neural tumors (Zagon and McLaughlin 1983c). we raised
the question as to whether endogenous opioids and opioid receptors
played a role in neuro-ontogeny. We utilized opioid antagonists
to interfere with the interaction of endogenous opioids and opioid
receptors in the developing brain. The use of opioid antagonists
rather than opioid agonists was motivated by our knowledge that
the half-lives of endogenous opioid agonists are as little as a
few minutes and that interpretation of the results from these ex-
periments could be extremely complex, since it would be difficult
to distinguish between action and reaction following opioid ago-
nist administration. In contrast, the opioid antagonist paradigm
allows one to monitor precisely the duration of opioid receptor
blockade by measuring nociception, e.g., hot plate test, following
a challenge with opioid agonists such as morphine.
In the first series of experiments, naltrexone, a potent opioid
antagonist, was administered on a chronic basis to preweaning rats
(Zagon and McLaughlin 1983a). Preweanina develounent in the rat
(birth to day 21) is characterized by explosive body and brain
growth and serves as a good model to examine the influence of
various agents on developmental events. At 21 days, body, brain,
and cerebellar weights of rats receiving daily injections of nal-
trexone at a dosage (50 mg/kg) that blocked morphine-induced anal-
gesia 24 hours/day were 18 percent, 11 percent, and 5 percent
greater than control weights, respectively. In addition, morpho-
metric analysis of the cerebrum revealed a somatosensory cortex
that was 18 percent thicker than that of control animals. The
cerebellum of naltrexone-treated rats was 41 percent larger in
total area and contained 70 percent more glial cells and 30 per-
cent more internal granule neurons. Neurons derived prenatally,
such as Purkinje cells, were unaffected in terms of cell number by
opioid antagonist treatment. The results of these early experi-
ments provided evidence that endogenous opioids and opioid recep-
tors normally interact during brain development and suggest that
endogenous opioid systems may play an integral role in cell pro-
liferation, migration, and differentiation.
Further information about neurodevelopment and endogenous opioid
systems was revealed in experiments contrasting a dosage (50 mg/kg
naltrexone) of opioid antagonist that blocked the receptor for an
entire 24-hour injection period with a dosage (1 mg/kg naltrexone)
that blocked the opioid receptor for a short time each day, i.e.,
4 hours per injection period (Zagon and McLaughlin 1983b). When
drug injections began at birth, rats injected with 50 mg/kg nal-
trexone showed increases in body weight over controls by 3 days of
age, with significant increases in body weight recorded throughout
the preweaning period, i.e., days 3, 6, 10, 15, and 21. Rats in-
jected with 1 mg/kg naltrexone were subnormal in weight during the
preweaning period, with statistically reliable reductions noted on
days 6, 10, 15, and 21. Consonant with the data on body weights,
the effect of naltrexone on organ growth was dose related. The
wet weights of brain, heart, kidneys, liver, and skeletal muscle
were 11 to 32 percent more than controls for rats in the 50 mg/kg
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group but 5 to 24 percent below normal for animals given 1 mg/kg
naltrexone. Calculation of relative organ weights, i.e., organ to
body weight ratios, indicated that the changes in organ wet
weights of naltrexone-treated animals were generally proportional
to that of body weights with only two exceptions. In the 50 mg/kg
naltrexone group, brain weight was significantly less affected
than body weight, whereas the weight of skeletal muscle was
markedly more affected than body weight.
In these experiments, the timing of the appearance of certain
physical characteristics, i.e., hair covering, incisor eruption,
ear opening, eye opening, was evaluated. Animals in the 50 mg/kg
naltrexone group exhibited a significantly earlier appearance of
eye opening than controls, whereas the 1 mg/kg naltrexone group
showed a significant retardation in the proportion of animals with
ear and eye opening on the median day. Measurement as to the ini-
tial appearance of walking, a milestone in behavioral ontogeny,
showed that the 50 mg/kg naltrexone group was able to walk between
days 8 to 12, while the animals in the 1 mg/kg naltrexone group
walked between days 13 to 15; the range for control subjects was
10 to 13 days. Furthermore, at the age when only half (50 per-
cent) of the controls were able to walk, no rats in the 1 mg/kg
naltrexone group could walk, and all (100 percent) of the animals
in the 50 mg/kg naltrexone group could walk. These results indi-
cated that opioid antagonist administration could markedly alter
the course of somatic and neurobiological development, with the
direction of effects dependent on dosage. The dosages of 1 and 50
mg/kg naltrexone mediating these actions were remarkably low (0.05
to 2.5 percent, respectively, of the LD50). However, both dosages
were more than sufficient to antagonize morphine-induced analge-
sia. Therefore, complete opioid receptor blockade each day stimu-
lates development, whereas intermittent daily receptor blockade
inhibits growth.
Although opioid challenge experiments revealed that the 50 mg/kg
dosage blocked the opioid receptor for 24 hours/day, and a dosage
of 1 mg/kg naltrexone blocked the receptor for 4 to 6 hours/day,
the relationships among growth processes, drug dosages, and the
pharmacological properties of naltrexone, e.g., ability to block
the opioid receptor, required elucidation. A series of experi-
ments was designed to explore this question (Zagon and McLaughlin
1984a). In the first study, groups of neonatal rats received
daily injections of either 0.1, 1, 10, 20, 50, or 100 mg/kg nal-
trexone or sterile water, with body and brain weights sampled at
weaning. Daily injections of 0.1 to 50 mg/kg naltrexone had no
effect on infant viability during the preweaning period. However,
daily injections of 100 mg/kg naltrexone resulted in a 40-percent
mortality rate. The effect of naltrexone on body weight was
clearly dependent on dosage. Animals receiving 0.1, 1, or 10
mg/kg naltrexone weighed 11 to 13 percent less than 21-day-old
control rats, whereas animals receiving 20, 50, or 100 mg/kg nal-
trexone weighed 16 to 22 percent more than controls. Comparison
of the 0.1, 1, and 10 mg/kg naltrexone groups, as well as the 20,
50, and 100 mg/kg naltrexone groups, revealed no between-group
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differences within either set of dosages. The effects of naltrex-
one on brain weight were also dependent on dosage. Rats in the
0.1 and 1 mg/kg naltrexone groups had brains weighing markedly
less (5 percent) than those of control animals. The brain weights
of rats in the 10 mg/kg naltrexone group also were less than con-
trols, but the difference was not statistically significant.
Animals in the 20, 50, and 100 mg/kg naltrexone groups had brain
weights that were increased 6 to 13 percent from control values.
To examine whether the marked biphasic effect of naltrexone on
growth was related to the pharmacological action of opioid recep-
tor blockade induced by naltrexone, 21-day-old rats receiving 1,
10, 20, or 50 mg/kg naltrexone were challenged with morphine. The
results show that a dosage of 1 or 10 mg/kg naltrexone blocked the
antinociceptive effect of morphine for 4 to 6 hours and 6 to 12
hours, respectively. Dosages of 20 or 50 mg/kg naltrexone were
effective in blocking the opioid receptor for an entire 24-hour
injection period.
In order to investigate further whether body and brain development
were related to the pharmacological action of naltrexone in block-
ing the opioid receptor, as well as to explore whether low and
high dosages of naltrexone produced growth effects because of
interaction with different populations of receptors, a second set
of experiments was performed. Growth and nociceptive response
were monitored in rats given 3 mg/kg naltrexone three times daily,
a dose which blocked the opioid receptor for an entire 24-hour
period. Increases of 31 percent and 10 percent in body and brain
weights, respectively, were found compared to control levels.
However, once daily injections of 9 mg/kg naltrexone (the cumula-
tive dosage of three daily injections of 3 mg/kg), a dosage that
blocked the opioid receptor for 6 to 12 hours/day, resulted in
animals with a C-percent decrease in body weight and no statisti-
cal change in brain weight. These results clearly demonstrated
that the duration of opioid receptor blockade governs somatic and
neurobiological development.
In view of the changes in body and brain growth, along with the
provocative finding concerning the timetable for walking, we in-
vestigated the effects of interruption of endogenous opioid/opioid
receptor interaction by opioid antagonists on neurobehavioral
ontogeny (Zagon and McLaughlin 1985). The development of sponta-
neous motor and sensorimotor behaviors of preweaning rats, as well
as ambulation, emotionality, and nociception at weaning (day 21)
were studied in rats given chronic administration of 1 or 50 mg/kg
naltrexone from birth to day 21. The age at which a specific
spontaneous motor behavior or performance initially appeared and
the age at which 100 percent of the animals demonstrated a partic-
ular behavior were accelerated in animals given 50 mg/kg naltrex-
one but were delayed in rats injected with 1 mg/kg naltrexone. In
general, ambulation, emotionality, and nociceptive responses were
not affected by naltrexone treatment, although the frequency of
face washing in both naltrexone groups and activity cage perform-
ance in the 50 mg/kg naltrexone group deviated from control
levels. Observations of head-shake and wet-dog-shake behaviors in
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naltrexone-treated animals at 2 hours and 10 hours after drug
injection were similar to controls with the exception of an ab-
normal increase in the 1 mg/kg naltrexone group at 10 hours.
These results imply that endogenous opioid systems play a role in
regulating neurobehavioral development. Further study will be
needed to learn whether these changes are a consequence of the
somatic and morphological alterations known to occur with naltrex-
one administration, or if the timetable of behavioral ontogeny is
dictated by endogenous opioid/opioid receptor interaction.
A series of histological and morphometric studies was conducted to
establish more fully the role of endogenous opioid systems in reg-
ulating brain development (Z gon and McLaughlin 1986a; Zagon and
McLaughlin 1986b).
1986a), the developing cerebella of 21-day-old rats given a tempo-
In the irst study (Zagon and McLaughlin
rary (1 mg/kg naltrexone) or complete (50 mg/kg naltrexone) block-
ade of opioid receptors th oughout the first 3 weeks of postnatal
life were investigated. I general, 50 mg/kg naltrexone had a
stimulatory action on cerebellar development, whereas 1 mg/kg nal-
trexone had an inhibitory influence. Both sexes were affected
comparably. Limits to the ability of naltrexone to modulate cere-
bellar ontogeny were noted, with more latitude existing toward
growth enhancement than impairment. The temporal course of neuro-
genesis was not delayed in naltrexone-treated rats; abbreviation
of the timetable of neuro-ontogeny remains to be explored. Appar-
ently, the events that transpired over the preweaning period were
dramatically affected. The most notable effects in 1 mg/kg nal-
trexone rats were marked decreases in dimensions of cerebellar
area, the content of internal granule neurons, and cellular and
tissue differentiation. Characteristics of the 50 mg/kg naltrex-
one group included increases in dimensions of cerebellar area,
neural cell number, content, and size, and structural changes
consistent with acceleration in growth and differentiation. Nal-
trexone influenced both neurons and glia, but only neural cells
still being generated during the first 21 days after birth were
altered in regard to quantity.
In a companion study (Zagon and McLaughlin 1986b) on opioid antag-
onist modulation of cerebral and hippocampal development, the same
experimental paradigm was utilized. As with the cerebellum, 50
mg/kg naltrexone had a stimulatory effect on growth, whereas 1
mg/kg naltrexone had an inhibitory effect, with both males and fe-
males being affected comparably. Opioid antagonist action was
especially directed at cellular and tissue differentiation, with
marked changes in macroscopic dimensions of area and histotypic
organization observed in the cerebrum. A prominent effect on the
cerebrum of the 1 mg/kg naltrexone group was a substantial in-
crease in packing density of the neural cells, reflecting a re-
duced area for accommodating neural elements. Changes in the
hippocampus were largely restricted to the 1 mg/kg group. How-
ever, the number of granule cells was increased in the dentate
gyrus of the 50 mg/kg group, suggesting that opioid receptor
blockade affects cell types undergoing postnatal proliferation.
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As in the cerebellum, cellular elements derived prior to naltrex-
one treatment, e.g., pyramidal neurons, were capable of being
influenced in only their capacity to differentiate.
It is possible that the establishment of neuronal organization
and intricacy in the developing brain is dependent on endogenous
opioid/opioid receptor interactions. To address the role of en-
dogenous opioids in neuroplasticity, developing neurons in the
cerebral cortex, hippocampus, and cerebellum were structurally
examined in lo-day-old rats subjected to continuous opioid recep-
tor blockade, i.e., 50 mg/kg naltrexone (Hauser et al., submitted
for publication). The lengths of oblique dendrites of pyramidal
cells in the cerebral cortex and basilar dendrites of the hippo-
campus were increased 136 percent and 52 percent, respectively,
from controls, whereas the concentrations of spines in these cells
were increased 183 percent and 69 percent, respectively. Dendrit-
ic area and the number of spiny branches of cerebellar Purkinje
neurons were 43 percent greater than controls, and spine concen-
tration of granule cells in the dentate gyrus was increased 76
percent. Thus, endogenous opioid systems appear to play a pro-
found role in neuronal growth and the expression of dendritic
spines, suggesting that the developing nervous system is plastic
and modifiable by endogenous opioid/opioid receptor interactions.
In view of the enormous changes in growth induced by opioid antag-
onists, opioid-antagonist-associated alterations in the hormonal
milieu and nutrition should be discussed. The possibility that
endogenous opioid control of developmental expression is an in-
direct effect of hormonal changes, such as that of thyroid hor-
mones, pituitary hormones, and adrenal and testicular androgens,
is difficult to support. For example, none of these hormones has
been demonstrated to make a normal animal larger; they can only
bring a hormonally deficient animal to normal levels (Zamenhoff
(1971). Moreover, the developmental actions recorded with opioid
antagonists are not comparable to morphological studies previously
conducted. Furthermore, administration of opioid antagonists such
as naloxone and naltrexone to rats has been reported to cause no
alterations in levels of physiological growth hormone or insulin
secretions (Tannenbaum et al. 1979). Insofar as nutrition is con-
cerned, the possibility that opioid antagonists (perhaps mediated
by endogenous opioid systems) alter food consumption. and hence
growth, warrants consideration. Investigations of the effects of
acute injections of naltrexone on milk intake in preweaning rats
has been undertaken by Aroyewun and Barr (1982). Their results
show no differences in milk intake between lo-day-old experimental
animals receiving 10, 30, or 50 mg/kg naltrexone or saline-
injected rats. At 14 days of age, only the 50 mg/kg naltrexone
group differed from controls, with these animals consuming marked-
ly less than control pups. Thus, nutritional deficits should not
have been involved in the decreased body weights observed in rats
given 10 mg/kg or less of naltrexone. As for the 20 to 100 mg/kg
dosages of naltrexone, these animals weighed more than controls,
even though some dosages (50 mg/kg) may have led to reduced milk
consumption. Moreover, the stimulatory and inhibitory actions of
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naltrexone on growth were observed by 3 and 5 days of postnatal
life, respectively, a time well before any problems in milk
consumption were detectable by Aroyewun and Barr. To investigate
further the possibility that inadequate nutrition led to lower
body weight, a comparison of the brain weights of 1 mg/kg nal-
trexone animals to a group of control rats matched for body weight
was conducted. In spite of the brain-sparing effect classically
observed with nutritional deficits, we found that 1 mg/kg
naltrexone-treated pups at 21 days had significantly smaller
brains than those of control animals matched for weight. In other
words, the brains were not "spared" in the naltrexone group, sug-
gesting that the actions of naltrexone may not be nutritionally
related. As for the possibility that the stimulatory effect of
naltrexone was due to greater food consumption, overnutrition dur-
ing the preweaning period cannot increase growth beyond normal
limits (Wurtman and Miller 1976). Thus, alterations in nutrition
or hormones do not appear to be a primary locus of opioid-
antagonist-induced growth regulation.
The work using the opioid antagonist paradigm casts light on the
role of endogenous opioid systems in growth. It would appear that
endogenous opioids have a normal and important interaction with
opioid receptors during nerodevelopment. Abolishment of this
interfacing, either with a high dose of naltrexone or multiple
daily injections with a low dose, produces an animal with an
accelerated pattern of growth; cell proliferation, migration, dif-
ferentiation, and growth are affected. A temporary blockade of
opioid receptors each day seems to retard growth. Although more
work needs to be performed, it is known that administration of
opioid antagonists causes an increase in opioid receptors, a
supersensitivity to opioid agonists, and an increase in plasma
levels of endogenous opioids (Bardo et al. 1983; Recant et al.
1980). Thus, the growth inhibition observed with low dosages of
naltrexone administered once daily may be the result of inter-
action of basal OF elevated levels of endogenous opioids with an
increased number of receptors, producing an enhanced reaction dur-
ing the daily interval when opioid antagonist is no longer
present.
Evidence for direct involvement of endogenous opioids and opioid
receptors in growth comes from a number of other quarters. Exper-
iments examining the effects of exogenous opioids on neuroblastoma
cells in culture reveal that opioid agonists inhibit growth in a
dose-response, stereospecific, and naloxone-reversible manner
(Zagon and McLaughlin 1984b; McLaughlin and Zagon 1984). More-
over, endogenous opioids such as methionine enkephalin adminis-
tered to neuroblastoma cells in culture are also inhibitory to
growth in a naloxone-reversible fashion. The question of whether
endogenous opioid systems act directly under in vivo conditions
also should be considered. It is well known that opioid receptors
are associated with developing neural cells (Gibson and Vernadakis
1981; Spain et al. 1985) and that endogenous opioids are present
in growing nervous tissue (Maseda et al. 1983). For example, 3H-
methionine enkephalin and H-naloxone receptor binding have been
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detected in the developing cerebellum (Tsang and Ng 1980; Tsang et
al. 1982a; Tsang et al. 1982b), with the highest levels recorded
within the first few days of life, declining to low levels shortly
thereafter. ß-endorphin and enkephalin levels in the cerebellum
were also found to reach their highest levels in the first post-
partum week and to decline subsequently to low levels (Maseda et
al. 1983; Tsang et al. 1982b). Recently, the distribution of
enkephalin in the cerebellum was examined by immunocytochemistry
(Zagon et al. 1985). Methionine and leucine enkephalin were found
to be concentrated in the external aerminal cells of the 10-day-
old rat cerebellum and localized throughout the cortical
cytoplasm. Enkephalin was not detected by immunocytochemistry in
differentiated neural cells originating from this iayer, e.g.;
internal granule neurons. Further work in our laboratory has now
detected enkephalin immnunoreactivity within the developing germi-
nal cells using immunoelectron microscopic procedures. This
activity was not recorded in the cell nucleus but was apparent
throughout the cortical cytoplasm, often being associated with
mitochondria (Prouty et al., unpublished observations).
Thus, the results of studies using the opioid antagonist paradigm,
as well as investigations of endogenous opioids and opioid recep-
tors in developing systems, reveal that the endogenous opioids
appear to regulate neurodevelopment by an inhibitory mechanism.
The endogenous opioids seem to be extremely active in modulating
growth, since blockade of endogenous opioid/opioid receptor inter-
action results in altered growth within a short period of time.
A number of major questions need to be addressed at this juncture.
Two of the most pressing are: What peptides and receptors are
involved in neurodevelopment? How do neuropeptides and receptors
interact at the cellular and molecular levels to affect their reg-
ulation of growth? Some information does exist as to the type of
opioid receptor that may be involved in neuro-ontogeny. Studies
using ß-funaltrexamine (B-FNA), a highly selective and irreversi-
ble µ opioid receptor antagonist, have been conducted in pre-
weaning rats (Zagon and McLaughlin 1986c). Animals given B-FNA
did not differ from controls in body weight, brain and cerebellar
weight, macroscopic dimension of the brain, area of the cerebel-
lum, or organ weight. The dosage of ß-FNA employed (5 mg/kg)
blocked morphine-induced analgesia (2 mg/kg morphine sulfate) for
each injection period (48 hours). In contrast to B-FNA treatment,
rats given naltrexone (50 mg/kg) in a regimen which completely
blocked the opioid receptor throughout ontogeny exhibited marked
increases in somatic and neurobiological growth. These results
suggest that, in and of themselves, µ receptors selectively antag-
onized by B-FNA do not play an important part in regulating devel-
opment. Further studies with specific opioid agonists and
antagonists in this regard will be valuable.
CONCLUSIONS AND IMPLICATIONS
In view of the evidence briefly presented in this chapter, endoge-
nous opioid systems are extremely important in regulating the
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development of the nervous system. These findings hold great
promise in terms of understanding normal and abnormal development
and for the design of experiments to probe growth. One of the
critical issues in this regard is whether dysfunction of the en-
dogenous opioid systems, be it problems in opioid receptors and/or
endogenous opioids, is involved in problems of development of the
nervous system in children. More information about endogenous
opioids and opioid receptors may contribute to the potential for
therapeutic intervention in growth-related abnormalities, espe-
cially those targeting neural development. Knowledge about endog-
enous opioids and opioid receptors in regard to neurobiological
development may also hold keys to unraveling the mechanisms in-
volved in perinatal opioid exposure. It has been estimated that
up to 230,000 children have already been perinatally exposed to
opioids such as heroin, methadone, and morphine (Zagon et al.
1984; Zagon 1985). These children often display growth impairment
along with a constellation of neurobehavioral irregularities, in-
cluding abnormalities in motor skills, learnfng, and interpersonal
relationships. Little is known about the etiology and patho-
genesis of the perinatal opioid syndrome. It is feasible that
exogenous opioids are inhibiting development by the same mechanism
used by endogenous opioids to control growth normally, and more
research into this area could prove to be an important source of
clinical prevention and treatment.
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Endocrine Consequences of
Perinatal Methadone Exposure
Cynthia Kuhn, Lisa Bero, Diane Ignar, Scott Lurie, and
Elizabeth Field
INTRODUCTION
The response of the developing nervous system to chronic perturba-
tion, either pharmacologic or behavioral, is a vital area in the
understanding of neural adaptation in general. Although the im-
mature nervous system is generally viewed as more vulnerable to
insult, it simultaneously shows the potential to recover from dam-
age that would be devastating to adults. The ability of young
patients to recover from central nervous system (CNS) insults is a
well-known proof of this precept. The adverse consequences of ex-
posing the developing nervous system to alcohol, cocaine, or other
CNS-active drugs provide a marked contrast, in producing notable
and permanent disruption of CNS function. Because our understand-
ing of neural development is so poor, it is very difficult to pre-
dict the outcome of exposing the developing nervous system to
chronic pharmacologic challenge. The goal of research in this
area is to determine which processes are relatively at risk and
which are relatively protected in the immature organism compared
to the adult. The experimental model used in this study of the
problem is an examination of the effect of chronic opiate adminis-
tration on endogenous opioid control of developing neuroendocrine
function, and its perturbation by chronic exposure to opioids.
This project has almost become a case study in the difficulties
and rewards of understanding the capacity of the immature nervous
system to adapt to a chronic pharmacologic stimulus.
BACKGROUND
Review of the Literature
This work was stimulated by the significant literature suggesting
that offspring of women who use opiate analgesics throughout
pregnancy are addicted and undergo withdrawal at birth. These
children exhibit low birth weight and delays of somatic and neuro-
behavioral development (Zagon et al, 1982; Zagon and McLaughlin
1984; Sonderegger and Zimmerman 1979; Hans et al. 1984). The
recent explosion of information about endogenous opioids and their
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potential role in regulation of developmental events has provided
potential physiological mechanisms to explain these clinical find-
ings and has stimulated interest in the field.
It is possible that disrupted endocrine function might contribute
to the disturbances of somatic and behavioral development follow-
ing perinatal opiate addiction, since endogenous opioid systems
play a role in neuroendocrine regulation in adult animals. Anec-
dotal reports of altered hormone levels in addicted infants and in
animals exposed to opiates during development include transient
elevations of thyroxine and prolactin (PRL) at birth, as well as
changes in thyroid, glucocorticoid, and ovarian responsivity to
challenge later in life (Glass 1982; Rosenfeld et al. 1981;
Jhaveri et al. 1980; Litto et al. 1983; Sonderegger and Zimmerman
1978; Bakke et al. 1973). These changes could result from morpho-
logic damage to specific populations of neurons during development
(a classical teratogenic effect); alternatively, they might simply
reflect adaptations in the neural networks involved in opioid-
induced changes in hormone secretion which are somewhat different
from the adaptations which occur in adults following similar
treatments. This distinction is central to all problems in devel-
opmental neurotoxicology and is particularly important if the dis-
rupting agent, like the opiates, has marked effects on the adult
nervous system which resemble, at least in part, those caused in
the immature brain. The experimental model developed in these
studies has proven particularly useful in addressing this ques-
tion, and the results support the notion that at least some of the
endocrine consequences of perinatal opiate exposure represent the
latter process.
Studies of developmental effects of perinatal opiate exposure
often involve chronic administration of opiates during gestational
and/or postnatal development in treatment regimens that have been
designed more to resemble clinical exposure of developing humans
than to address specific mechanistic questions. As a result,
there is considerable phehomenologic literature reporting changes
in opiate sensitivity in adult animals following neonatal exposure
(mainly persistent tolerance although occasionally enhanced
activity of opiates after perinatal exposure (Kirby et al. 1982;
Zimmerman et al. 1974; Thompson and Zagon 1981; Zagon and
McLaughlin 1980; Hovious and Peters 1984)), but there has been
little systematic comparison between the responses of neonatal and
adult animals to similar chronic treatment regimens. Furthermore,
there are few studies in which potential biological concomitants,
such as changing receptor numbers, have been measured following
chronic developmental administration of opioid agonists or antago-
nists, and these few studies have yielded inconsistent results:
Some investigators report increased receptor number and others,
decreased receptor number (Bardo et al. 1983; Bardo et al. 1982;
Tsang and Ng 1980; Handelman and Quirion 1983).
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MODEL FOR STUDY OF PERINATAL OPIATE EFFECTS
One major source for such disagreement has been the diversity of
treatment paradigms, behavioral end points, and biochemical
assessments. Also, many of these studies were conducted a number
of years ago, before the multiplicity of endogenous opioid systems
had been defined. Therefore, determinations of whole brain opiate
receptor numbers were made from averaged results of disparate
endogenous opioid systems with different ontogenetic development
and different responses to pharmacologic challenge. Assessing
opiate action in immature animals presents an additional problem
in these studies. Many opioid effects, including analgesia, con-
trol of respiration, and locomotor effects, cannot be measured
conveniently in immature animals or act through neural pathways
that mature after a major part of the treatment paradigm is com-
pleted (and animals are already tolerant to the effects of admin-
istered opiates). This problem of behavioral evaluation is
implicit in all studies of developing nervous system function.
A strategy that is very useful in circumventing this difficulty is
to use neuroendocrine function, specifically, secretion of anteri-
or pituitary hormones, as a model behavior. Hormone secretion can
be measured in animals too young for more sophisticated behavioral
assessments, i.e., during the first postnatal week. For studying
endogenous opioid systems, this strategy is particularly useful,
because opioid effects on hormone secretion are mediated mainly by
fairly well-defined neural networks. Furthermore, opioid control
of hormone secretion matures early in comparison to other neural
controls. For example, morphine causes profound stimulation of
growth hormone (GH) secretion as early as postnatal day 5 in the
rat, while other pharmacologic stimuli, such as pentobarbital and
the -adrenergic agonist clonidine, are not effective until wean-
ing or later (Kuhn and Schanberg 1981). Similarly early ontogeny
of opioid effects has been described in the fetal sheep, an ele-
gant model of neuroendocrine ontogeny which has been studied in
detail (Gluckman et al. 1980).
In this study, we have been investigating systematically the pat-
tern of endocrine responses to various acute and chronic opioid
manipulations. These responses include studies of both basal hor-
mone levels and hormone secretion following pharmacologic chal-
lenge. We have used the rat for these studies, because many
aspects of opioid regulation of neuroendocrine function, as well
as perinatal opioid addiction, resemble phenomena observed in
humans. However, this model, like any other, has several draw-
backs, including the possible role of nutritional and physiologic
variables in endocrine function, and all effects of perinatal
opiate manipulations must be interpreted with these considerations
in mind. In many of our chronic studies, methadone has been used
for the direct clinical relevance of the finding. However, there
were only minor differences among the endocrine responses elicited
by different opiate alkaloids.
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MULTIPLE ENDOCRINE RESPONSES TO OPIATES IN ADULTS
In adult rats, the endocrine effects of opiate agonists have been
well characterized (figure 1): Opiates increase serum levels of
GH, PRL, adrenocorticotropic hormone (ACTH). and corticosterone
(CS), and decrease thyroid-stimulating hormone (TSH) secretion
FIGURE 1. Model of opioid effects on anterior pituitary
hormone secretion
(Millan and Herz 1985; Howlett and Rees 1986; Meites et al. 1979).
Variable decreases in luteinizing hormone (LH) secretion are re-
ported in these studies, depending upon the age and sex of the
animal. The most sensitive indicator of opioid involvement in
regulation of LH secretion is the pronounced elevation of LH ob-
served following administration of the opioid antagonist naloxone.
Similar results follow the administration of the opiate agonist
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methadone (figure 2). The development of tolerance to these dif-
ferent endocrine effects of opiates in adults have been studied in
the past but only using a single treatment paradigm and a single
FIGURE 2. Effect of methadone (2.5 mg/kg) on serum hormone levels
in adult male rats
KEY: * Indicates statistically different from time-matched control, p<.05 or
better.
NOTE: Animals were treated with methadone and killed at various times after
treatment, and hormone levels were then determined. Results are expressed
as man ± SEM. Saline-injected controls were killed at each time point.
As control values did not differ from each other, values were pooled and
shown at t=0. However, appropriate time-matched controls were used for
statistical evaluation. N=6-8 in each group.
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endocrine measure (Cicero et al. 1975; Paroli and Melchiorri 1961;
Kokka et al. 1973; Muraki and Tokunaga 1978; Deyo et al. 1980;
Eisenberg and Sparber 1979; Miodustewski et al. 1982). Therefore,
it is difficult to compare the development of tolerance at differ-
ent sites. The comparison of multiple endocrine responses has
proved extremely useful in understanding opiate tolerance in adult
and developing animals.
When adult rats were treated with methadone chronically and the
pattern of endocrine response to a challenge dose of methadone was
assessed, the results demonstrated clearly that tolerance develop-
ment is quite specific for different endocrine systems. For
example, the development of tolerance to opiate-induced changes in
CS is observed following a low-dose treatment regimen (methadone
5 mg/kg/day for 20 days) (figure 3). Following treatment with
increasing dose regimens of methadone, changes in LH, TSH, PRL,
and GH follow in sequence, although the effects of methadone
tolerance on GH and PRL secretion develop slowly and occur only
with extremely high dose regimens. This specificity offers an
opportunity for studying differential tolerance development in
various endogenous opioid neurons using a single model system.
For example, recent delineation of the roles of opiate
receptors has offered an avenue for understanding these patterns
of response in both adult and developing animals. Another impor-
tant criterion of tolerance development in endocrine systems is
the specificity for the effects of opioids. For example, CS
responses to opiates are eliminated following even short treatment
regimens that do not influence responses to agents which act on
different neural regulation of CS secretion, such as CS responses
to the acetylcholinesterase inhibitor physostigmine or the dopa-
mine ß hydroxylase inhibitor diethyldithiocarbamate (DDC) (figure
4). These findings suggest that tolerance does not develop
through adaptation at the anterior pituitary or the end organ, an
important observation if endocrine function is to be used as a
model of neuronal tolerance.
In neonatal rats, endocrine responses to opioids resemble qualita-
tively those observed in adults. As early as postnatal day 5,
methadone or morphine increase GH, PRL, and CS and decrease TSH
secretion (Kuhn and Bartolome 1983), and a profound opioid inhibi-
tion of LH secretion is indicated in female rats by the large
increases in LH secretion which follow naloxone administration
(Cicero et al. 1986). Administration of endogenous opioids, in-
eluding ß-endorphin, various enkephalin derivatives, and dynor-
phin, elicits changes in endocrine function identical to those
caused by administration of methadone. For example, ß-endorphin
administration to a 5-day-old rat pup increases GH, PRL, and CS
and decreases TSH secretion significantly (figure 5).
However, several characteristics of the endocrine response in
neonates differ significantly from the response observed in
adults, and these differences represent a common and important
occurrence that influences interpretation of chronic studies.
FIGURE 3. Endocrine response to a challenge dose of methadone
following chronic treatment of adult male rats
KEY: C/S (black bar) = chronic saline, acute saline; C/M (stippled bar) = chronic
saline, acute methadone; M/S (striped bar) = chronic methadone, acute
saline; M/M (clear bar) = chronic methadone, acute methadone; * indicates
significantly different from C/S control, p<.O5 or batter; + indicates sta-
tistically different from M/S control, p<.05 or better.
NOTE: Animals were treated with saline or methadone (5 mg/kg/day) for 20 days and
given a challenge dose of methadone at the end of the treatment regimen (or
2 reeks later on day 45), killed, and their hormone levels determined.
Results are expressed as mean ± SEM. N=6-8 In each group.
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FIGURE 4. Effect of increasing morphine injections (5 mg/kg,
b . i . d . , increasing by 5 mg/kg/injection over 5 days)
on CS response to saline, morphine, physostigmine, or
DDC
KEY: * Indicates statistically different from chronic saline control, p<.O5 or
better; † indicates statistically different from chronic morphine control,
p<.05.
NOTE: Animals were treated chronically, withdrawn for 36 hours, then treated with
saline, morphine (10 mg/kg), physostigmine (0.5 mg/kg), or DDC (100 mg/kg).
Al I drug pretreatments were given 45 minutes before killing, except DDC
which was given 4 hours before killing. Results are expressed as mean
± SEM. N=8-10 in each group.
First, the responses last significantly longer, in part because of
the slowed elimination of opiates from neonatal rats (figure 6)
(Shah and Donald 1978). This phenomenon obviously must influence
the choice of treatment regimen in the pup, as administration of
identical doses to pups and adults can result in relatively higher
drug exposure for the pups. However, many endocrine responses
are smaller, in part because pituitary stores and responsiveness
to releasing factors as well as hormonal feedback effects on
secretion tend to be somewhat blunted during the early postnatal
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FIGURE 5. Endocrine response to ß-endorphin in neonatal rats
KEY: * Indicates statistically different from saline-Injected control, p<.05 or
better.
NOTE: Five-day-old rat pups were Injected intracerebroventricularly with saline
or ß-endorphln (0.1 µg) and killed at various times after injectlon. After
the animals were killed, hormone levels were determined. Results are ex-
pressed as percent control ± SEM. N=6-8 In each group.
period in rats for GH, PRL, and TSH (Fisher et al. 1977; Goodyer
1981). Furthermore, the number of opioid receptors is much lower,
thereby limiting the maximal possible response attainable
(Wohltmann et al. 1982; Tsang et al. 1982a; Tsang et al. 1982b;
Kent et al. 1982; Patey et al. 1982; Tsang and Ng 1982). There-
fore, pups tend to be somewhat less responsive despite the pres-
ence of greater drug levels.
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FIGURE 6. Effect of methadone (2.5 mg/kg) on serum hormone levels
at different postnatal ages
KEY: * Indicates statistically different (p<.05 or better) than time-matched
control.
NOTE: Ten-day-old, twenty-day-old, and sixty-day-old (adult) animals were treated
with saline or methadone and killed at various times after drug injection;
then serum hormone levels were measured. Results are expressed as de-
scribed in figure 2. N=8 or more In each group.
POSTNATAL ACUTE OPIATE CHALLENGE
Next, we focused on the neuroendocrine response of rat pups to an
acute opiate challenge following chronic postnatal treatment.
This treatment paradigm does not span several other critical peri-
ods of neuroendocrine development, including the prenatal periods
of opioid neuron formation and endocrine gland differentiation.
However, it does allow us to determine whether tolerance develops
during chronic administration in pups that demonstrate a neuro-
endocrine response. Rat pups were treated from postnatal day 1
until weaning (day 20) with methadone (5 mg/kg/day in two daily
doses). This particular treatment regimen was chosen for several
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reasons. First, the suckling period in the rat resembles, from
the standpoint of neuroendocrine ontogeny, the last trimester of
human gestation, during which most fetal growth and rapid ontogeny
of neural control of hormone secretion occur. Therefore, disrup-
tion of neuroendocrine function would be most likely to produce
the effects on offspring growth and development during this time
period. Second, this treatment period does not involve maternal
administration, and so is not complicated by effects on maternal
physiology or by withdrawal at birth. The results of this study
showed that postnatal administration of large doses of methadone
had relatively little effect on basal levels of growth-regulating
hormones. A transient decrease in serum thyroxine was observed
during the early phase of treatment, and there was a transient
decrease in CS as weaning was approached. Instead, endocrine
effects of postnatal methadone administration were characterized
by marked endocrine responses to each injection and by persistent
and selective changes in neuroendocrine responsivity to opiate
challenge (figure 7). For example, PRL and TSH responses to
opioid challenge were abnormal on day 45, long after withdrawal,
while GH and CS responses were normal (Kuhn and Bartolome 1984).
In contrast, when adult rats are treated with a similar regimen,
PRL responses to a challenge dose of opiate are not affected by
even a more intensive dosage regimen, but CS responses remain
abnormal for a long period of time after drug withdrawal (figures
8 and 9).
These results exemplify two opposite responses of the developing
nervous system to insult. The persistent abnormality in PRL se-
cretion typifies the effects expected following drug administra-
tion during development, i.e., the more prolonged disruption of a
system following developmental exposure than after treatment
during adulthood. However, in the same animals, CS secretion
actually recovered faster in pups than it did when animals were
treated chronically in adulthood: CS secretion actually was more
perturbed when animals were treated in adulthood. This finding
demonstrates the ability of the immature nervous system to repair
damage through adaptations which are not possible in adult
animals.
NEURAL PATHWAY MEDIATION OF OPIATE EFFECTS
At this point we made a critical decision to define more carefully
the specific neural pathways mediating the PRL and CS responses
which were different after chronic opioid treatment during devel-
opment. We examined the effect of changing neurotransmitter medi-
ation of opioid regulation of hormone secretion during ontogeny,
and also on the ontogeny of different opioid receptor subtype
systems. The results showed that the variable responses of devel-
oping animals to chronic morphine challenge might be explained by
the changing neurotransmitter control of opiate-induced hormone
secretion.
In adult rats, morphine-induced PRL secretion requires an intact
serotonergic innervation of the hypothalamus from the dorsal raphe
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FIGURE 7. Endocrine response to a challenge dose of methadone
following chronic postnatal treatment
KEY: C/S (clear bar) = chronic saline. acute saline; C/M (black bar) = chronic
saline, acute methadone; M/S (stippled bar) = chronic methadone, acute
saline; M/M (striped bar) = chronic methadone, acute methadone; * indicates
significantly different from C/S control, p<.05 or better; + Indicates sta-
tistically dltterent from M/S control, p<.05 or better.
NOTE: Animals were treated with saline or methadone (5 mg/kg/day) for postnatal
days 1 to 20 and given a challenge dose of methadone at the end of the
treatment regimen (or 2 weeks later on day 45), killed, and their hormone
levels were determined. Results are expressed as mean ± SEM. N=6-8 in
each group.
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FIGURE 8. Comparison of PRL response to acute challenge at the
end (day 20) and 2 weeks after withdrawal (day 45)
following postnatal or adult treatment with methadone
(5 mg/kg/day)
KEY: * Indicates statistically different from C/S control, p<.05 or batter;
+ Indicates statlstlcally different from M/S control, p<.O5 or better.
NOTE: Animals were treated as described In figure 3. Results are expressed as
mean ± SEM.
nucleus (Demarest and Moore 1981; Spampinato et al. 1979). How-
ever, other studies showed that functional serotonergic innerva-
tion of those hypothalamic neurons involved in regulating PRL
secretion does not mature until the beginning of the third post-
natal week (Becu and Libertun 1982; Cocchi et al. 1977). We
considered the possibility that two different endogenous opioid
systems were involved in regulation of PRL secretion: one a
serotonin-independent system which matured early and the other a
serotonin-dependent system which matured later and predominated
over the earlier maturing system. To test this possibility, we
investigated the ability of various pharmacologic treatments to
impair morphine-induced PRL secretion in neonatal and adult rats.
The results showed that blockade of serotonergic function by
the antagonist cyproheptadine, or by chemical lesioning with
5,7 dihydroxytryptamine (DHT), eliminates morphine-induced PRL
elevations in adult but not neonatal rats (figures 10 and 11). On
the other hand, serotonergic mediation of opiate-induced analgesia
can be demonstrated in neonatal rats. These findings suggest that
specific opioid systems that mature early are particularly at risk
for disruption by perinatal addiction, and, conversely, that
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FIGURE 9. Comparison of CS response to aaute challenge at the end
(day 20) and 2 weeks after withdrawal (day 45) fol-
lowing postnatal or adult treatment with methadone
NOTE: Animals were treated and results analyzed as described in figure 8.
systems like the serotonergic-opioid system regulating PRL secre-
tion might be relatively resistant to treatments which precede
establishment of functional transmission in the system.
ONTOGENY OF OPIATE RECEPTOR SUBTYPE-SPECIFIC RESPONSES AND
CHANGING NEURAL PATHWAY MEDIATION OF OPIATE EFFECTS
The recent discovery of the presence of the three different endog-
enous opioid systems and their role in neuroendocrine ontogeny
provides a specific neural mechanism to explain many acute and
chronic opioid effects which were poorly understood, including the
apparently disparate mechanisms involved in control of PRL secre-
tion. The three different endogenous opioid systems are thought
to have unique endocrine functions (Bero and Kuhn 1986; Spiegel et
al. 1982; Koenig and Krulich 1984; Krulich et al. 1986a; Krulich
et al. 1986b). The endorphin neurons with cell bodies in the
arcuate nucleus are thought to utilize ß-endorphin as the major
neurotransmitter and to mediate opioid effects on PRL, LH, and
possibly ACTH through actions on µ receptors. Enkephalin neurons
are widespread through the hypothalamus and are thought to act
through (and possibly µ) opioid receptors, which have been
implicated in control of LH and GH secretion. Finally, the endog-
enous opioid dynorphin is contained in cell bodies within the
magnocellular nucleus and elsewhere in the hypothalamus, and is
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FIGURE 10. Effect of 5,7 dihydroxytryptamine (5,7 DHT) treatment
on PRL response to morphine in adult and neonatal
rate
KEY: * Indicates p<.05 or better relative to saline/saline control; + indicates
p<.05 or bettor relative to morphine.
MOTE: Rats were pretreated with saline (solid bars) or 5.7 DHT (100 µg free base
with desipramine. 20 mg/kg) (striped bars). Four days later, the animals
were injected with morphine or saline 30 minutes before sacrifice. Results
are expressed as mean ± SEM. N=6-8 In each group.
thought to modulate PRL, LH, and ACTH secretion through actions on
receptors. The differential ontogeny of these different opioid
neuronal systems and their receptors provides a conceptual frame-
work for understanding the specific developmental effects reported
in a paper by Eisenberg (1985). Both receptor-mediated
changes in PRL secretion are found in adult rats (Koenig and
Krulich 1984). Therefore, we postulated that the serotonin-
dependent and -independent systems may reflect actions of differ-
ent opioid receptors with a differential ontogeny. To evaluate
this possibility, we developed pharmacologic challenges for spe-
cific opioid receptor subtype systems and found that, in rat pups,
as reported previously in adult rats (Koenig and Krulich 1984;
Krulich et al. 1986a; Krulich et al. 1986b). PRL secretion
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FIGURE 11. Effect of cyproheptadine on PRL response to morphine
in adult and neonatal rate
KEY: * Indicates statistically different from saline-injected control;
+ indicates statistically different from morphine treatment, p<.05.
NOTE: Rats were pretreated with saline (solid bars) or cyproheptadine (10 mg/kg)
(striped bars), followed 45 minutes later by saline or morphine. Animals
were killed 30 minutes after the second injectIon. Results are expressed
as mean ± SEM. N=6-8 In each group.
increases in response to small and probably receptor subtype-
selective doses of the agonist (U50,488) and the µ agonist
morphine (5 mg/kg).
By combining neurotransmitter antagonist treatments with these
opioid receptor subtype-specific agonists, we have shown that the
serotonin-dependent and -independent processes are mediated by
opiate receptor subtypes which appear to have a differential
ontogeny. In adults, PRL secretion stimulated by a µ receptor-
selective dose of morphine is blocked by the serotonin antagonist
cyproheptadine, while the PRL response to a small dose of the
opioid agonist U50,488 is not affected (figure 12). In neonatal
rats, PRL responses to agonists are larger and appear earlier
than responses to µ agonists. Furthermore, responses to U50,488
and morphine are blocked by cyproheptadine in adult but not neo-
natal rats (figures 13 and 14). These findings then suggest an
explanation for the tolerance development observed during chronic
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FIGURE 12. Effect of cyproheptadine on tail flick latency in
10-day-old rate
KEY: Open bars = tall flick latency on day 1; striped bars = tall flick latency
on day 2; * indicates p<.05 relative to day 1; + indicates p<.05 relative to
morphine on day 2.
NOTE: Vehicle or cyproheptadine was injected 45 minutes before saline or mor-
phine. Analgesia was assessed 30 minutes later by the tall immersion
method. The results are expressed as latency to withdraw tall from warm
water. N=10 for each treatment group.
treatment of pups but not adults. The treatment paradigm in the
neonatal experiment may have resulted in the selective stimulation
of the receptors which were already functionally stimulating PRL
secretion, while sparing the v-mediated, serotonin-dependent sys-
tem which is not functional until the beginning of the third post-
natal week. The tolerance evident during challenge on day 21
probably reflected, for the most part, the tolerance development
at a single opioid receptor subtype that mediates the
serotonin-independent mechanism for stimulating PRL secretion.
The immediate question raised by these studies is whether the PRL
results reflect a generalized phenomenon of more marked adaptation
at than at µ opioid receptors, or simply the greater exposure of
the early maturing response.
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FIGURE 13. Lack of inhibition by cyproheptadine of morphine or
U50,488 effects on PRL secretion in adult rate
KEY: * Indicates p<.05 relative to saline-injected control; † indicates p<.O5
relative to morphine treatment.
NOTE: Animals were pretreated with vehicle (open bar) or cyproheptadine (10
mg/kg) (striped bar), followed by saline, morphine (1 mg/kg), or U50,488
(0.5 mg/kg). Animals were killed 30 minutes after the second injection,
and PRL was determined. Results are expressed as mean ± SEM. N=6-8 In
each group.
SUMMARY
In summary, we have shown that marked acute responses as well as
persistent changes in hypothalamopituitary responsivity to opiate
challenge result from perinatal opioid addiction. We have also
shown that different endocrine systems and opioid receptor sub-
types develop at different rates, and that the responses of these
systems depend upon the relative timing of the treatment regimen
and the functional development of the particular opioid system in-
volved. It should be emphasized that these studies have investi-
gated only a single developmental window. The additional critical
question of how opioid neuron function is affected by treatment
during the period of active neuronal differentiation has not yet
been answered. However, these studies do demonstrate the utility
of this neuroendocrine model in assessing opioid function follow-
ing chronic treatment regimens. By using neuroendocrine function
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FIGURE 14. Effect of cypoheptadine on morphine or U50,488
effects on PRL secretion in 10-day-old rats
NOTE: Animals were treated and results expressed as described in figure 13.
as an end point, multiple systems can be studied simultaneously in
the same animal. This has a particular advantage in studying the
effects of chronic drug exposure on the developing nervous system,
because hormone secretion is an easily quantifiable and early
maturing functional index which can be used to identify vulnerable
(and resistant) systems. Endogenous opioid systems appear to be
particularly important in neuroendocrine regulation during the
early phase of development, when other neural controls have not
yet matured. Our preliminary results suggest that specific opioid
systems that mature early may be especially important in the spe-
cific neuroendocrine effects of perinatal opiate addiction.
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Cellular Mechanisms of
Noradrenergic Enhancement of
Long-Term Synaptic Potentiation
in Hippocampus
Daniel Johnston, William F. Hopkins, and Richard Gray
INTRODUCTION
The action of norepinephrine (NE) in the functioning of the cen-
tral nervous system (CNS) is not known. However, the diffuse pro-
jections of noradrenergic fibers throughout the cerebral cortex
(Moore and Bloom 1979) have led to the belief that this system
plays some neuromodulatory role (Kety 1970; Woodward et al. 1979;
Foote et al. 1983). Evidence has been presented to suggest that
NE is involved in the plasticity of the developing nervous system
(Pettigrew and Kasamatsu 1978; Bear and Singer 1986), in control-
ling the behavioral states of an animal (Kety 1970; Aston-Jones
and Bloom 1981a; Aston-Jones and Bloom 1981b), and in learning and
memory (Crow 1968; Ogren et al. 1980; Mason 1981). The control of
behavioral states may be particularly relevant to this symposium,
because if drugs of abuse have receptors on locus coeruleus
neurons or their axon terminals, it would be expected that they
would modify the output of the noradrenergic system and possibly
the behavioral state of the organism.
NE-containing fibers have also been shown to innervate the hippo-
campus diffusely. The areas most densely innervated are the hilar
region of the dentate gyrus and stratum lucidum of CA3 (Moore and
Bloom 1979). Several years ago, we began an investigation of the
noradrenergic effects on mossy fiber synaptic transmission. Mossy
fibers are the axons from dentate granule cells, and they form
synapses onto CA3 pyramidal cells. These synapses are excitatory
and have many unique characteristics. For example, the synaptic
endings are unusually large--approximately 5 µm in diameter
(Amaral 1979). They contain a high concentration of zinc (Haug
1967) (the function of which is unknown), and they terminate on
the proximal portion of the apical dendrites of the pyramidal
neurons (Johnston and Brown 1983). This latter characteristic has
enabled the use of voltage-clamp techniques for the study of the
biophysical properties of this synapse (Brown and Johnston 1983;
Johnston and Brown 1983).
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The close anatomical location of the mossy fiber synapses to the
somata of the CA3 neurons was shown to be correlated with a very
small electrotonic distance (Johnston and Brown 1983). Thus, a
voltage clamp applied to the somata of the CA3 neurons can provide
a reasonable voltage clamp of the mossy fiber subsynaptic mem-
brane. Because of this unique situation, Brown and Johnston
(1983) were able to determine many of the biophysical parameters
of this synapse, including its conductance, reversal potential,
and kinetics. The mossy fiber synapse thus serves as one of the
best characterized (at a biophysical level) excitatory synapses in
the mammalian CNS.
Long-term synaptic potentiation (LTP) was first described by Bliss
and Lomo (1973). They showed that brief tetanic stimuli given to
excitatory synaptic pathways resulted in a long-term enhancement
of synaptic efficacy. Considerable interest has been focused on
the mechanisms and properties of LTP at synapses in the hippo-
campus and elsewhere (Bliss and Dolphin 1982: Swanson et al.
1982). Because of the unusual properties of the mossy fiber syn-
apses. we were oarticularlv interested in the features of LTP at
these-synapses. In parallel with our studies of LTP, we developed
a new preparation in which patch-clamp techniques could be applied
to adult cortical neurons (Gray and Johnston 1985). These methods
enabled us to investigate possible membrane mechanisms associated
with LTP.
In this review, we will describe studies in which we found that
NE, through ß-adrenergic receptors, enhances the magnitude, dura-
tion, and probability of induction of LTP at mossy fiber synapses
(Hopkins and Johnston 1984; Hopkins and Johnston, in press).
Using patch-clamp techniques on hippocampal granule cells, we also
found that ß-adrenergic receptors enhance the activity of voltage-
dependent calcium channels (Gray and Johnston, in press). The
results from these two areas of investigation have led to our
current hypothesis that NE enhances LTP through increased calcium
influx into presynaptic elements or postsynaptic elements, or
both.
METHODS
Methods for extra- and intracellular recordings from rat hippo-
campal slices have been described in detail elsewhere (Brown and
Johnston 1983; Johnston and Brown 1983; Hopkins and Johnston
1984). All drugs were bath-applied, and ascorbate (20 µM) was
routinely added to both control and catecholamine-containing solu-
tions. For extracellular recordings, micropipettes of 1 to 10
were filled with 2 M sodium chloride and placed under visual guid-
ance in stratum pyramidale and stratum lucidum of the CA3 sub-
field. Mossy fibers were stimulated with stainless steel bipolar
electrodes positioned in the hilus close to stratum granulosum in
the dentate gyrus (see figure 1). Field potentials were evoked
with brief, low-intensity (0.05 msec, 5-100 µA), constant-current
pulses and were averaged on-line by a laboratory computer. Low-
intensity stimuli were used to reduce the probability of ohserving
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epileptiform activity, which is sometimes evoked when multiple
high-frequency trains are used.
The techniques for patch-clamping acutely exposed neurons from
adult hfppocampal slices have also been described elsewhere (Gray
and Johnston 1985; Gray and Johnston, submitted for publication).
Slices were treated with proteolytic enzymes for 15 to 20 minutes
and then shaken gently to split the slices along the cell body
regions, exposing the neural somata. The exposed neurons were
then patch-clamped in the whole-cell or cell-attached configura-
tion, using conventional techniques (Hamill et al. 1981). The
compositions of the pipette and bath solutions were chosen to
block all potassium and sodium currents, and drugs were applied by
pressure-ejection through a single- or double-barrelled puffer
pipette placed near the soma of the clamped cell.
RESULTS
The initial set of experiments was designed to determine whether
bath-applied NE affected synaptic efficacy. One method of examin-
ing this question is to compare the input-output characteristics
and responses in normal saline with those obtained in the presence
of NE. The input-output curve in our experiments represents the
amplitude of the population excitatory postsynaptic potential
(pEPSP) as a function of the stimulus current intensity used to
activate the mossy fibers. This population response is measured
extracellularly and results from the synchronous activation of a
number of mossy fiber synapses. Figure 2 illustrates the findings
of a typical experiment. With the mossy fibers stimulated at a
frequency of 0.2 Hz, the addition of 10 µM NE to the bath had
little or no effect on the amplitude of the pEPSP. In other
experiments, NE sometimes produced a small rightward shift in the
input-output curve. However, we never observed a leftward shift.
A leftward shift would be indicative of an increase in synaptic
efficacy; a rightward shift would represent a decrease in synaptic
efficacy. We concluded from these results that, under conditions
of low-frequency stimulation, NE did not augment the efficacy of
mossy fiber synapses.
When NE was present during high-frequency stimulation, the results
were auite different. Fiaure 3 shows the results of one of the
types'of experiments used-to test for NE's effects on LTP. Slices
were chosen in which we could obtain a control episode of LTP
whose amplitude decreased over approximately 60 minutes. NE was
then added to the bath, and another high-frequency stimulus train
was given to induce a second episode of LTP. With NE present in
the bath only immediately before and during the high-frequency
train, the magnitude and duration of LTP were increased. The
third episode of LTP was in normal saline and yielded magnitude
and duration values similar to those of control. In other
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FIGURE 1. Schematic diagram of the hippocampal slice preparation
KEY: MF=mossy fibers, AD=area dentata. V=voltage recording amplifier.
NOTE: A bipolar stimulating electrode was placed adjacent to the hilar side of
stratum granulosum of the dentate gyrus, and recording electrodes were
positioned In stratum pyramidale and stratum lucidum of CA3 to record the
extracellular population spike and EPSP, respectively.
SOURCE: Hopkins and Johnston (submitted).
experiments (data not shown), NE also increased the probability of
inducing LTP when low-intensity stimulus trains were given to the
mossy fibers. A number of pharmacological experiments were per-
formed, the results of which suggested that the NE enhancement of
LTP is probably mediated by ß-adrenergic receptors through an
increase in cyclic adenosine monophosphate (CAMP) (Hopkins and
Johnston 1984).
These results led to the hypothesis that NE increases the magni-
tude, duration, and probability of induction of LTP through ß-
adrenergic receptors and CAMP. The effects of NE on mossy fiber
synapses also appeared to be dependent on the frequency of stimu-
lation. At low stimulus frequencies, NE either had no effect or
tended to depress synaptic transmission, whereas when NE was pres-
ent during a high-frequency stimulus train, there was an enhance-
ment of synaptic efficacy.
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FIGURE 2. Input-output curves for the pEPSP vs. stimulus current
intensity before, during, and after bath application
of 10 µM NE
NOTE: The inset depicts examples of pEPSPs evoked by a series of different
stimulus current intensities.
SOURCE: Hopkins and Johnston (submitted).
The obvious question that arises from these investigations is, By
what cellular mechanism(s) does NE modulate LTP? To address this
question, we felt it necessary to develop a new preparation In
which patch-clamp techniques could be applied to adult cortical
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FIGURE 3. Effects of brief bath apptication of NE (10 µM) on LTP
NOTE: In this experiment, NE was present 20 minutes before and during tetanic
stimulation but was washed out immediately after the conditioning train.
Arrows indicate time of conditioning train (100 Hz, 2 Sec, 50 µA) for each
episode.
SOURCE: Hopkins and Johnston (submitted).
neurons. This preparation is shown schematically in figure 4. As
described earlier, slices from adult guinea pigs were treated with
proteolytic enzymes and agitated gently until the slices split
apart along the cell body region, exposing pyramidal cells and
granule cells at the edge of the slice. We have used this prepa-
ration to study ligand- and voltage-gated ion channels from
cell-attached, excised-patch, or whole-cell configurations (Gra
and Johnston 1985; Gray and Johnston, submitted for publication).
Although the mechanisms underlying LTP in hippocampus (or else-
where) are unknown, one finding that appears to be consistent in
many laboratories is that LTP is critically sensitive to calcium
(Dunwiddie and Lynch 1979; Turner et al. 1982); thus, calcium
influx into at least the postsynaptic neuron is a prerequisite for
LTP (Lynch et al. 1983). A plausible working hypothesis directing
our initial experiments was that the modulation of LTP by NE could
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FIGURE 4. Schematic drawing of a hippocampal slice before (above)
and after (below) it was split along cell body re-
gions to expose pyramidal neurons and dentate granule
c e l l s
NOTE: The slice was split along the major cell body layers (pyramidal CA1 and
area dentata (AD)), exposing the somata and proximal processes.
SOURCE: Gray and Johnston (1985). Reprinted by permission from J Neurophysiol
54:134-142, Copyright 1985, the American Physiological Society.
be mediated through a modulation of calcium currents, It is dif-
ficult to obtain voltage-clamp recordings of calcium currents
using traditional microelectrode techniques because calcium cur-
rents are relatively small and hard to measure in the presence of
potassium currents. Potassium currents are usually much larger
than calcium currents, and it is difficult to block them complete-
ly by drugs applied to the external bath. Using a whole-cell
recording technique, however, the cell can be internally dialyzed
with ionic substitutions and drugs that block potassium channels,
allowing a much better separation of calcium currents from
101
potassium currents. In our experiments, we replaced internal
potassium with cesium ions, which are impermeable through potassi-
um channels, and added two drugs (tetraethylammnonium (TEA) and
3,4,diaminopyridine (DAP)) known to block several different
potassium channels to both the inside and outside solutions.
Tetrodotoxin (TTX) was also added to the bath to block voltage-
dependent sodium conductances. These manipulations allowed us to
record relatively pure voltage-dependent calcium currents without
contamination from currents flowing through potassium or sodium
channels.
Figure 5A shows results of an experiment in which we measured the
peak amplitude of the calcium current before and after the appli-
cation of NE to the external surface of a hippocampal granule
cell. A small, but significant, increase in the peak inward
FIGURE 5. Application of norepinephrine or 8-bromo-cAMP increased
the peak inward calcium current
NOTE: (A) Plot of peak Inward current vs. time after formation of whole-cell
clamp. Above. a 500-ms puff of 10 µM NE was applied at the time indicated
by the downward arrow. Sample traces before (*) and after (+) drug appli-
cation are shown below. The charge carrier in this experiment was calcium.
Holding potential, -60 mV; command potential, 0 mV. (B) Identical experi-
ment, except that a 5OO-ms puff of 8-bromo-cAMP was applied at the arrow,
above. Sample traces before (*) and after (+) drug application are shown
below.
SOURCE: Gray and Johnston (in press). Reprinted by permission from Nature,
Copyright 1967, Macmillan Magazines Limited.
calcium current occurred with 10 µM NE. In other experiments
(data not shown), we found that the ß-adrenergic receptor iso-
proterenol had effects similar to those with NE. leading to the
hypothesis that the enhanced calcium current is mediated through
activation of ß-adrenergic receptors. Because the activation of
ß-adrenergic receptors has been shown to increase the levels of
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cAMP in hippocampus (Bloom 1975; Segal et al. 1981), we investi-
gated whether CAMP would mimic the action of NE. Figure 5B shows
the results of an experiment using the membrane-permeable analog
8-bromo-cAMP. We found that it also produced a very significant
enhancement of the peak calcium current.
To explore further the enhancement of voltage-dependent calcium
currents by CAMP, we recorded the activity of single calcium chan-
nels from cell-attached patches. Figure 6 illustrates the results
of two experiments. Figure 6A is from an experiment in which cal-
cium channel activity was measured in response to step depolariza-
tions during control (1) and after application of 8-bromo-cAMP to
the surface membrane of the cell (2). We measured the fractional
open time by determining the length of time during a command that
the current exceeded a preset threshold level. The graph on the
upper right (3) shows that when 8-bromo-cAMP was applied, the mean
fractional open time increased from about 0.2 to about 0.3.
Figure 6B is from another experiment in which a patch contained
multiple calcium channels. A similar experiment was performed in
which we measured channel activity during commands and averaged
all of the commands under control conditions (1) and after appli-
cation of 8-bromo-cAMP (2). The ensemble average currents are
shown in the lower right panel (3) before and after the addition
of 8-bromo-cAMP. A small, but significant, increase in the aver-
age channel activity, similar to the results obtained with the
whole-cell recording techniques, was produced by 8-bromo-cAMP.
DISCUSSION
In summary, these results indicate that NE enhances the magnitude,
duration, and probability of induction of LTP at mossy fiber exci-
tatory synapses. Furthermore, we found that NE increased voltage-
dependent calcium conductance. The obvious conclusion from these
investigations is that the augmented LTP results from increased
calcium influx. The action of NE in increasing calcium currents
is in contrast to its effects on neurons from peripheral ganglia,
in which it appears to decrease calcium currents (Dunlap and
Fischbach 1978; Dunlap and Fischbach 1981). However, NE has been
shown to increase calcium conductance in ventricular heart cells
through ß-adrenergic receptors (Cachelin et al. 1983; Reuter 1983;
Bean et al. 1984). The increase in voltage-dependent calcium
current, which we observed in hippocampal neurons, could lead to
significant changes in synaptic transmission if NE enhancement of
the calcium current occurred presynaptically. Moreover, results
from other laboratories strongly suggest that calcium influx into
the postsynaptic neuron is a requirement for the mechanisms of LTP
(Lynch et al. 1983). If NE increased calcium currents post-
synaptically, an enhanced LTP might result. It is not known whe-
ther LTP is modulated by NE elsewhere in the brain; however, if
the NE enhancement of calcium conductance mechanisms occurs else-
where, NE could be expected to modulate numerous neuronal proc-
esses that are linked to calcium influx into pre- or postsynaptic
elements.
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FIGURE 6. Application of 8-bromo-cAMP increased the activity of calcium channels
NOTE: Single-channel activity from cell-attached patches on granule cells.
1 µM TTX; and 10 mM HEPES.
Patch pipettes contained 96 mM BaCl2; 100 µM 3,4-DAP;
The pH was adjusted to 7.35 with TEA-OH. The exposed cells were bathed In normal extracellular
saline. (A1) Consecutive traces of channel activity in control saline In response to step commands from -60 to +70 mV, with
respect to the unknown resting potential. (A2) Channel activity in the same patch 10 s after a 500-ms pressure pulse was
applied to a puffer pipette that was located near the cell body and contained normal extracellular saline plus 5 mM 8-bromo-
cAMP. (A3) Plot of the fraction of time during the command when the current level was more negative than a threshold level
(-O.25 pA) before and after application of 8-bromo-cAMP. The threshold was set at -3 times the standard deviation of the
baseline noise calculated from traces In which no channel activity was visible. (B1) Control channel activity In a different
patch (different granule cell from that in A) in response to a command from
potential. The patch contained many channels.
-40 to +60 mV with respect to the unknown resting
8-bromo-cAMP.
(B2) Channel activity in the same patch after a 5OO-ms application of 5 mM
(B3) Ensemble averages of 56 traces before and 56 traces after drug application. All current traces shown were
filtered at 2 kHz (-3 dB, Bessel response). All calibration bars are 1 pA x 10 ms.
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Neuronal Adaptation in the
Hippocampus Induced by
Long-Term Ethanol Exposure
Don W. Walker and Bruce E. Hunter
INTRODUCTION
Chronic and excessive use of alcohol is widely acknowledged to
result in brain damage and associated functional deficits. The
evidence supporting this statement has emerged from research
investigating cognitive, morphological, electrophysiological, and
biochemical abnormalities in chronic alcoholic patients (Begleiter
and Platz 1972; Cala and Mastaglia 1981; Freund 1973; Parsons
1977; Porjesz and Begleiter 1981; Ron 1977; Thomson and Ron 1982).
Ethanol is a unique drug in that it contains calories (7 kcal/g)
which can replace nutrient calories, resulting in the potential
for malnutrition. In fact, alcoholic brain damage has tradition-
ally been attributed to malnutrition, especially thiamine defi-
ciency, rather than to the neurotoxic effects of ethanol per se
(Dreyfus 1974; Victor et al. 1971). It seems likely, however,
that ethanol can directly exert neurotoxic effects because brain
damage and cognitive impairment are observed in alcoholics with no
history or evidence of malnutrition, head trauma, or exposure to
other toxic agents or drugs (Brewer and Perrett 1971; Epstein et
al. 1977; Freund 1973; Lynch 1960; Smith et al. 1973). Although
the relative contribution of ethanol exposure per se is obviously
difficult to address experimentally in human studies, controlled
animal experiments from a number of laboratories have provided
strong evidence for a direct neurotoxic effect of ethanol, though
the mechanism of this toxicity is unknown (cf. Walker et al. 1981;
Walker et al. 1982).
For the purposes of this discussion, chronic ethanol treatment
(CET) will be considered as the duration of continuous ethanol
exposure likely to result in lasting (or permanent) structural and
functional alteration of neurons, which, in our experience, re-
quires a minimum of 3 months of treatment. Ethanol exposure for
only a few days, by contrast, while inducing tolerance and/or
physical dependence, produces a disturbance of neuronal function
thought to last for only a few days. Although neuronal damage
associated with chronic or prolonged ethanol exposure can occur at
levels of ethanol intake insufficient to produce evidence of
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physical dependence (Walker and Freund 1971; Walker et al. 1980b),
it is obvious that both ethanol neurotoxicity and the development
of physical dependence could occur simultaneously. In studying
the neuronal alterations associated with prolonged ethanol treat-
ment, it is thus difficult to separate the neurotoxic changes from
the more transient changes associated with the ethanol withdrawal
reaction unless a sufficiently long posttreatment ethanol-free
period is given prior to data collection, or data are collected at
several time points following the ethanol treatment.
Collectively, research from our laboratory and others has provided
convincing evidence of ethanol neurotoxicity despite more than
adequate nutrient intake:
(1)
(2)
(3)
Behavioral. In rodents, CET produces deficient learning of
several behavioral tasks including shuttle box avoidance
(Freund 1979; Freund and Walker 1971; Irle and Markowitsch
1983; Sotzing and Brown 1976; Triet et al. 1980; Walker and
Freund 1971), temporal discrimination (Denoble and Begleiter
1979; MacDonall and Marcucella 1978; Smith et al. 1979;
Walker and Freund 1973), complex maze learning (Bond and
DiGiusto 1976; Fehr et al. 1976), temporal alternation
(Walker and Hunter 1978), and spontaneous alternation
(Beracochea and Jaffard 1985; Walker et al. 1981).
Anatomical. CET induces morphological abnormalities in the
rodent hippocampus and cerebellum, including neuronal de-
generation and loss (Irle and Markowitsch 1983; Kunz et al.
1976; Lescaudron and Verna 1985; Phillips and Cragg 1983;
Roulet et al. 1985; Tavares and Paula-Barbosa 1982; Walker et
al. 1980a; Walker et al. 1980b; Walker et al. 1981; Walker et
al. 1982) and altered dendritic structure and spine density
(Goldstein et al. 1983; King et al. 1985b; Kunz et al. 1976;
McMullen et al. 1984; Pentney 1982; Popova 1983; Riley and
Walker 1978; Tavares et al. 1983a; Tavares et al. 1983b;
Walker et al. 1981).
Neurophysiological. CET induces complex changes in the func-
tion of hippocampal neurons, including reduced intrinsic
inhibition (Abraham et al. 1981; Durand and Carlen 1984a;
Rogers and Hunter 1985), deficient development of long-term
potentiation in area CA1 (Durand and Carlen 1984b) and the
dentate gyrus (Abraham et al. 1984), and altered distribution
of afferent synaptic connections in CA1 and the dentate gyrus
(Abraham and Hunter 1982; Abraham et al. 1982).
Our recent research has focused on the use of the rat hippocampus.
as a model system to investigate the dynamic characteristics,
selectivity, and potential mechanisms of the effect of CET on neu-
ronal structure, connectivity, and function. The hippocampus was
chosen for a number of reasons, including: (1) The short-term
memory deficit observed following chronic alcohol consumption in
the rat (Beracochea and Jaffard 1985; Walker and Hunter 1978) is
strikingly similar to that seen in chronic alcoholic patients
(Butters and Cermak 1975), patients with hippocampal lesions
(Milner 1959; Milner et al. 1968). and rats with hippocampal
lesions (Walker and Means 1973). (2) The vast available infor-
mation on the normal anatomy, electrophysiology, and pharmacology
of the hippocampus provides a significant data base. (3) The
relatively simple and highly laminated structure of the hippo-
campus facilitates quantitative morphological and physiological
measurement, thereby enhancing detection of possibly subtle
alterations induced by CET. (4) The hippocampus is apparently
sensitive to CET, since a number of laboratories have reported
structural and physiological alterations in the hippocampus after
CET.
Because the hippocampus is the brain structure serving as the
model system for the work discussed below, a brief description of
the basic anatomical features that facilitate quantitative analy-
sis will be provided.
Figure 1 is a schematic transverse section illustrating the orga-
nization, major divisions, and principal cell types of the hippo-
campus. The hippocampal complex is divided into two regions: the
hippocampus (Ammon's horn or cornu ammonis (CA)) and the dentate
gyrus (DG). Figure 1 shows the relationship of these regions in
cross section. The intrinsic synaptic organization of the hippo-
campus is marked by several salient characteristics. (1) There is
an intrinsic trisynaptic series of excitatory connections begin-
ning with a projection from the entorhinal cortex to the DG, the .
DG to CA3, and finally CA3 to CA1 (Gottlieb and Cowan 1973;
Guthrie and Elliott 1980; Hjorth-Simonsen 1973; Hunter et al.
1986; Laurberg 1979; Swanson et al. 1978). (2) There is a laminar
arrangement of morphological elements in the hippocampus. The CA
and DG are basically trilayered; in each, a relatively tightly
packed principal cell layer is bordered on either side by layered
neuropil which is cell poor (figure 1). (3) The specific afferent
terminations of the hippocampus are also laminated, so that each
class terminates upon relatively specific portions of the den-
drites of pyramidal (CA) and granule (DG) cells. (4) The remark-
able lamellar organization of the hippocampus is such that a slice
transverse to the longitudinal axis of the hippocampus only 300 to
500 µm thick preserves the basic trisynaptic series of intrinsic
connections.
Previous research has shown that CET produces a 10- to 30-percent
loss of both pyramidal and dentate gyrus granule cells in the ro-
dent hippocampus, depending on the duration of exposure and other
variables (Irle and Markowitsch 1983; Kunz et al. 1976; Lescaudron
and Verna 1985; Phillips and Cragg 1983; Walker et al. 1980b;
Walker et al. 1981). Because of the intrinsic and commissural
monosynaptic connections of the hippocampus (Fricke and Cowan
1978; Laurberg 1979), this neuronal loss necessarily results in
partial deafferentation of surviving hippocampal and dentate gyrus
neurons. Furthermore, because deafferentation in the hippocampus
is known to stimulate synaptic reorganization, including sprouting
of remaining afferents (Cotman and Nadler 1978), CET is likely to
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FIGURE 1. A schematic transverse section through the hippocampal
formation illustrating the divisions, organization,
and principal cell types
produce a complex sequence of changes including destructive cell
loss, deafferentation, and synaptic reorganization. The surviving
neurons will likely obtain some new targets for their projections
and/or receive additional afferents to replace those which were
lost. It is likely that destructive and compensatory changes
occur simultaneously during CET and that further reorganizational
or regenerative changes may occur following CET. As a result,
some quantitative Golgi studies have found decreased dendritic
branching and decreased density of dendritic spines on hippocampal
cells surviving CET (Goldstein et al. 1983; McMullen et al. 1984;
Riley and Walker 1978), whereas others report normal (Lee et al.
1981; Lescaudron and Verna 1985) or increased (Kunz et al. 1976)
dendritic spine density on surviving CA1 pyramidal cells. The
variability in the reported effects of CET on dendritic spine den-
sity in the hippocampus is not surprising, because it is apparent
that each of the above results could be expected if destructive
and compensatory changes are occurring simultaneously during CET.
In other words, some cells destined to die may exhibit dendritic
dying back and loss of synapses preceding death. Other cells not
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damaged by CET may become hyperinnervated by gaining afferents
that have lost contacts with dead or dying cells.
With these considerations in mind, we have concentrated our recent
efforts on characterizing the CA1 pyramidal cells and DG granule
cells that survive CET. The following questions have been
pursued:
(1) Are there changes in the spatial extent, pattern, and/or den-
sity of specific afferents of surviving hippocampal neurons
following CET?
(2) Are there changes in the synaptic function of surviving
hippocampal neurons following CET?
(3) Do hippocampal neurons damaged or altered by CET recover
during abstinence?
(4) What is the effect of CET on the capacity of surviving hippo-
campal neurons for reactive synaptogenesis?
In order to study these questions, we have standardized our CET
parameters both to facilitate comparison across experiments and to
allow comparison with our previous work. Ethanol was administered
to mature, male Long-Evans rats via a nutritionally controlled
liquid diet (Walker and Freund 1971) for 20 weeks (group E). Con-
trol groups (group S) were individually pair-fed an identical diet
with sucrose substituted isocalorically for ethanol or were given
free access to pelleted laboratory food. Except where noted
(e.g., recovery series), an ethanol-free period of 8 weeks was
imposed before experimentation began in order to control for the
possible residual effects of ethanol withdrawal. The average
daily ethanol consumption under these conditions is 12 to 15 g/kg,
resulting in a blood-ethanol concentration of 100 to 200 mg/kg.
All morphological data are collected in coded material, and all
electrophysiological experiments are performed on coded animals.
The codes are not broken until all data collection is completed.
SYNAPTIC CONNECTIVITY AND FUNCTION OF HIPPOCANPAL NEURONS
SURVIVING CET
In order to fully characterize alterations in the afferent synap-
tic distribution and/or synaptic function of CA1 pyramidal cells
and DG granule cells that survive prolonged ethanol exposure, we
have combined the use of both electrophysiological and anatomical
techniques.
Electrophysiological Analysis of Afferent Synaptic Distribution in
the Hippocampal Formation After CET
Electrical stimulation in the stratum radiatum (SR) of CA1 or in
the angular bundle (fibers from the entorhinal cortex) produces
positive-negative dipole fields in CA1 and the dentate gyros (DG),
respectively. In the synaptic field, one sees a negative field
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potential called the extracellular excitatory postsynaptic poten-
tial (EPSP), which reflects summated excitatory synaptic activity
(Lomo 1971). As the recording electrode is moved toward the cell
layer, the amplitude of the EPSP progressively decreases, until it
eventually inverts to a positive potential. If the stimulus cur-
rent applied to the afferent fibers is increased, a negative
potential develops superimposed on the positive EPSP, which re-
flects summated single-unit activity (Andersen et al. 1971) and is
termed the population spike (PS). Such laminar analysis is used
to study afferent distribution but lacks precision because of vol-
ume conduction of the large field potentials. We combined field
potential and current source density (CSD) analysis in order to
investigate the effect of CET on synaptic distribution in the
hippocampus, since CSD analysis defines more precisely the distri-
bution of synaptic currents. The theory of CSD analysis and the
specific computational formulae have been presented in detail pre-
viously (Freeman and Nicholson 1975; Nicholson and Freeman 1975).
The CSD is mathematically derived from extracellular field poten-
tials by calculation of the second spatial derivative. Negative
(inward) current flows reflect the location of a current sink,
whereas positive (outward) current flows reflect the locus of a
current source.
We first investigated the effects of CET on the distribution of
Schaffer collateral-commissural (SCH/COM) afferents within the SR
of rat hippocampal CA1 (Abraham et al. 1982). Stimulation of the
SCH/COM afferents elicited short-latency, ne ative field poten-
tials throughout the synaptic terminal zone (stratum radiatum).
CSD analysis in normal animals revealed that the synaptic currents
generated in the SR concentrate into bimodal yet overlapping com-
ponents, peaking 71.3 µm and 228.3 µm from the pyramidal cell
layer. CET produced: (1) a 13.2-percent shrinkage of the overall
extent of current sinks in the SR; (2) a 37.4-percent reduction in
the spatial extent of the sink proximal to the cell layer; and (3)
an increase in the amplitude and area of the more distal sink.
This contraction of proximal afferents and expansion of distal
afferents was present even though the CSD profiles were adjusted
to control for individual differences in the width of the major
lamina of CA1. We tentatively proposed the proximal and distal
sinks to reflect a separation of the COM and SCH afferents,
respectively. CET thus appeared to have selectively produced per-
sistent damage to the COM-CA1 pathway. This selective deafferen-
tation combined with other, unspecified factors may have provided
the stimulus for reorganization of SCH afferents (Abraham et al.
1982; Goldowitz et al. 1979).
We next investigated the persistent effect of CET on the distribu-
tion of entorhinal afferents to the stratum moleculare of the den-
tate gyrus (Abraham and Hunter 1982). Electrical stimulation of
the angular bundle elicited a short-latency, negative field poten-
tial covering the outer two-thirds of the molecular layer. CSD
analysis revealed that CET produced: (1) a significant shrinkage
of the spatial extent of the current sink in the stratum molecu-
lare; (2) a significant reduction in the distance from the peak
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inward synaptic current to the granule cell layer; and (3) no
change in the distance from the proximal inversion point to the
granule cell layer. Taken together, these results indicate a loss
of entorhinal afferents in the outer molecular layer. Coupled
with available anatomical evidence, these results suggest that CET
produces a preferential loss of the lateral entorhinal afferents
to the dentate gyrus.
Anatomical Analysis of Afferent Synaptic Distribution in the
Hippocampal Formation After CET
The foregoing results suggest that CET produces a specific reduc-
tion in COM afferents to CA1 and lateral entorhinal afferents to
the DG. However, we do not yet know whether such results reflect
a reduction in these specific afferent fiber populations, altera-
tions in synaptic efficacy, or changes in the structure of target
neurons. Therefore, we have begun the study of specific hippo-
campal afferents using morphological techniques. We have used
acetylcholinesterase (AChE) (Geneser-Jensen and Blackstad 1971;
Lynch et al. 1972) and Timm's sulfide-silver (Haug 1973; Zimmer
and Haug 1978) histochemical stains and quantitative auto-
radiography (Fricke and Cowan 1978; Gottlieb and Cowan 1973) to
assess alterations in the spatial extent and density of specific
hippocampal afferents after CET. Quantitative analysis of this
material is accomplished with a Computerized Image Analysis System
linked to a microscope (King et al. 1985a; Reep et al. 1984).
The pattern of Timm's (Haug 1973; Zimmer and Haug 1978) and AChE
(Geneser-Jensen and Blackstad 1971; Lynch et al. 1972) staining
has been shown to correlate with the extent of a number of hippo-
campal afferents. In the molecular layer of the DG, for example,
Timm's staining reveals three specific laminar bands that reflect
the lateral entorhinal, medial entorhinal, and commissural/
associational (C/A) afferents to the DG granule cells. The spa-
tial extent (width) and the optical density of the Timm's stain
bands were measured in the molecular layer of both blades of the
right DG. CET did not significantly affect the widths of any of
the bands in either blade. However, the stain density was signif-
icantly reduced by CET in each of the terminal fields of the
buried blade, suggesting a reduced terminal density of lateral
entorhinal and C/A afferents to the surviving granule cells.
These results emphasize the importance of the quantitative analy-
sis of stain intensity in these studies, since terminal density
may be reduced by CET without a concomitant reduction in the spa-
tial extent of the terminal field. Since the density of Timm's
staining has not yet been quantitatively related to afferent
terminal density, these results await confirmation by ongoing
quantitative autoradiographic analysis of the effect of CET on the
density of afferent terminals from the entorhinal cortex to the
DG.
We have also completed analysis of the effect of CET on the pat-
tern and density of AChE staining in the DG molecular layer
contralateral to an entorhinal cortex lesion (the effect of CET on
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the partially deafferented lesioned side will be discussed later).
The DG molecular layer contralateral to an entorhinal cortex
lesion is typically used as a within-subjects control against
which alterations in the ipsilateral, partially deafferented DG
molecular layer are assessed. As shown in table 1, CET produced
significant reductions in the widths of the C/A clear zone (9
percent), the outer molecular layer (5 percent), and the total
molecular layer (6 percent) in the contralateral buried blade. No
significant effects of CET on AChE stain bands were observed in
the exposed blade. In addition, CET produced significant increas-
es in the density of AChE staining in both the C/A zone and the
outer molecular layer of the buried blade and, to a lesser extent,
of the exposed blade (table 2). Taken together, these results
suggest that CET may have resulted in a reduction in the spatial
extent and density of C/A and entorhinal afferents to the DG
molecular layer, resulting in a compensatory expansion of choli-
nergic afferents. However, since these data were collected from
animals receiving both prior CET and unilateral entorhinal cortex
lesions, it is possible that the effects of CET on the contra-
lateral molecular layer could be at least partially attributable
to an interaction between CET and the entorhinal lesion. Con-
sequently, we plan to examine the effect of CET on the pattern and
density of AChE staining in rats not receiving entorhinal cortex
lesions. We are also conducting autoradiographic studies to test
more directly the hypothesis that CET produces a preferential loss
of afferents from the lateral entorhinal cortex.
TABLE 1. The effect of 10 weeks of ethanol treatment on the
widths of AChE stain bands in the molecular layer of
the DG contralateral to an entorhinal cortex lesion
Stain Band
Group SG C/A OML ML
Contralateral Buried Blade
Ethanol (n=lO)
Sucrose (n=lO)
44.7 (1.3) *46.6 (1.1) *158.6 (4.6) *205.2 (3.1)
43.9 (1.9) 51.1 (1.0) 167.3 (4.3) 218.4 (2.9)
Contralateral Exposed Blade
Ethanol (n=10) 42.1 (1.3) 46.1 (1.7) 183.1 (2.5) 229.2 (2.1)
Sucrose (n=1O) 36.2 (1.5) 45.9 (1.7) 191.4 (5.6) 237.3 (3.5)
"p<.05
KEY: SG (supragranular band); C/A (commissural-associational); OML (outer
molecular layer); ML (molecular layer).
NOTE: Values are the group mean (± S.E.M.) width in microns derived from indi-
vidual means of 100 measurements per animal 110 measurements In each of 10
equally spaced horizontal sections through the hippocampus).
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TABLE 2. The effect of 20 weeks of ethanol treatment on the density of AChE staining in the DG
contralateral to an entorhinal cortex lesion
Stain Band
Group SG C/A OML1 OML2 OML3 OML4 OML5 OML
Ethanol (n=1O)
Sucrose (n=1O)
74 (3)
79 (3)
*125 (2)
140 (3)
Ethanol (n=1O)
Sucrose (n=1O)
89 (4) *140 (4)
99 (5) 151 (3)
Contralateral Buried Blade
*111 (2) *102 (3) *108 (4) *130 (5) *129 (5) *116 (4)
129 (5) 121 (5) 124 (6) 145 (6) 144 (7) 133 (6)
Contralateral Exposed Blade
*121 (5) 131 (5) 124 (6) 140
134 (4) 141 (5) 135 (5) 143
141 (6) 131 (5)
140 (5) 139 (5)
*p<.05
KEY: SG (supragranular band); C/A (commissural-associational); OML (outer molecular layer).
NOTE: Values are the group mean (± S.E.M.) optical density (gray level) derived from Individual means of 100 measurements per blade
for each animal 110 measurements in each of 10 equally spaced horizontal sections through the hippocampus). Lower values
represent more dense staining, since gray levels of pixels can vary from 0 (black) to 255 (white). The outer molecular layer
was divided into five equal portions for measurement (OML 1-5).
The Effect of CET on Synaptic Function in the Hippocampus:
Electrophysiological Studies
Whereas the experiments described above provide us with important
information in regard to the nature, extent, and specificity of
the alteration and possible reorganization of hippocampal cir-
cuitry induced by CET, functional disturbances could be produced
which are either undetectable by standard morphological methods or
compensated for by adaptive mechanisms in a specific afferent
system. In order to directly assess the functional alterations
produced by CET, we are evaluating the synaptic strength (through
input/output (I/O) functions) and synaptic plasticity (capacity
for potentiation) in specific hippocampal afferents by means of
extracellular field potential analysis.
We first studied the functional consequences of CET on the SCH/COM
input to the SR of CA1 (Abraham et al. 1981). Eight weeks after
CET, there was no significant alteration in the basic response
strength to single shocks to the SCH/COM path (EPSP and PS meas-
ures) as assessed by varying the stimulus current (I/O curves);
similarly, no changes were observed in the magnitude or duration
of long-term potentiation (Alger and Teyler 1976) produced by 5-,
10-, or 1OO-Hz stimulus trains. However, CET significantly en-
hanced paired-pulse potentiation of PS amplitude without altering
EPSP potentiation. Facilitation of the PS relative to control was
also observed during brief trains of stimuli at 5 and 10 Hz (fre-
quency potentiation). This latter pattern of results is similar
to that found for a variety of treatments that reduce inhibition
in the hippocampus (Lee et al. 1980). We therefore proposed that
CET may produce a lasting disruption of intrinsic inhibitory
neurotransmission in CA1 (Abraham et al. 1981).
We have recently evaluated the effects of CET on the response of
DG granule cells to perforant path (from the entorhinal cortex)
input (Abraham et al. 1984). CET did not influence the response
strength or potentiation of basic synaptic responses (EPSP) but
did decrease the PS. This effect could be seen in 4 ways: (1) in
the asymptotic portions of the I/O curves, (2) in paired-pulse
potentiation, (3) in the response to low-frequency stimulation
(1 or 5 HZ), and (4) during the development of long-term potentia-
tion. These results are consistent with previous anatomical evi-
dence of granule cell loss after CET (Walker et al. 1980b), but
they also suggest additional alterations such as a decrease in the
effectiveness of the EPSP-spike coupling mechanism, an increased
number or efficacy of synapses per surviving cell, or an increase
in the spike threshold of DG granule cells surviving CET. Because
these results in the DG are opposite (particularly for the paired-
pulse series) to those we observed in CA1 (Abraham et al. 1981),
it is obvious that CET does not uniformly influence all subfields
of the hippocampus. This suggests that the degree of destructive
and/or compensatory synaptic reorganization following damage by
CET may differ depending on the specific subfield or afferent
system studied.
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When these studies were completed, we believed that CET reduced
synaptic inhibition in CA1 by acting upon recurrent inhibitory
processes (Abraham et al. 1981). Because considerable evidence
has since accumulated to suggest the presence of feedforward as
well as recurrent inhibition in CA1 (Buzaki 1984), we decided to
reexamine these findings. We also decided to conduct these new
studies using the in vitro hippocampal slice to avoid the use of
anesthesia, because we thought it was possible that our previous
in vivo results could have been complicated by an interaction of
prior CET with urethane anesthesia (Abraham et al. 1981; Abraham
et al. 1984). We used paired-pulse stimulation techniques, be-
cause they provide a sensitive way of separating feedforward and
feedback inhibition. Antidromic conditioning stimuli provide a
pure activation of recurrent inhibitory circuitry, whereas ortho-
dromic conditioning stimuli should activate both feedforward and
recurrent inhibitory processes (Rogers and Hunter 1985). Paired-
pulse stimulation was delivered to CA1 in either orthodromic/
orthodromic (O/O) or antidromic/orthodromic (A/O) pairs with
interpulse intervals (IPI) ranging from 20 msec to 3 sec. CET
reduces the inhibition of the PS test pulse response with A/O
stimulation in a manner dependent upon current intensity. These
results strongly support the conclusion that CET produces a per-
sistent reduction of CA1 recurrent inhibitory processes--a conclu-
sion also supported by intracellular recording in the hippocampal
slice (Durand and Carlen 1984a). CET also enhanced the potentia-
tion of the PS test response across a wide range of IPIs in
response to O/O stimulation. That this was observed with condi-
tioning pulses subthreshold for eliciting a PS (where activation
of recurrent inhibition would be minimal) indicates that CET also
reduces feedforward inhibitory processes. Taken together, this
apparent reduction in both feedforward and recurrent inhibition
indicates that CET produces an enduring disruption in the proper-
ties of inhibitory interneurons in the CA1 region.
Our most recent electrophysiological studies have sought to
address the mechanism(s) underlying the action of CET on inhibi-
tion in CA1 (Hunter et al. 1986). We have examined, in the in
vitro hippocampal slice, PS responses evoked by stimulation in the
stratum radiatum (SR) or the stratum oriens (SO) in response to
microiontophoresis of -aminobutyric acid (GABA) or bicuculline
methiodide (BMI), a specific GABAa antagonist (Hunter et al.
1986). The sensitivity to GABA was evaluated by iontophoresis at
10 equidistant points parallel to the dendritic axis of pyramidal
cells from the alveus to the hippocampal fissure. Because BMI had
a prolonged duration of action, analysis was limited to four sam-
pling points. We utilized drug concentrations, ejection duration,
and backing currents derived from prior experiments which have
utilized this procedure (Andersen et al. 1982; Andersen et al.
1980). When GABA was iontophoretically administered 6 msec prior
to stimulation, CET produced an increase in the inhibitory re-
sponse to GABA application in the stratum pyramidale (SP) and the
SR with SR stimulation, as well as to application in the SP with
SO stimulation. This increase in the inhibitory effect of GABA
could also explain the apparent reduction in GABA facilitation
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produced by application in the SO with SR stimulation and in the
SR and SO with SO stimulation. BMI, a GABAa receptor antagonist,
produced a profound increase in PS amplitude in response to SR and
SO stimulation which peaked at approximately 1 minute following
application and was greatest in magnitude with application sites
near the SP. CET produced a significant increase in the excita-
tory response to BMI most pronounced with application in the SO
and proximal SR. Though it is clear that this inhibition is medi-
ated by GABA, the actions of GABA on CA1 pyramidal cells is quite
complex, being mediated not only by GABAa and GABAb receptors
different parts of the
but
utilizing different ionic mechanisms in
cell as well (Alger and Nicoll 1982a; Alger and Nicoll 1982b;
Andersen et al. 1980; Newberry and Nicoll 1984a; Newberry and
Nicoll 1984b). Nevertheless, our results suggest that CET pro-
duces an enduring reduction in GABA release together with a com-
pensatory up-regulation of GABAa receptor sensitivity or number.
Our current working hypothesis is that this reduction of GABA
release involves a CET-induced loss of GABAergic interneurons.
However, enduring alterations in synaptic terminal excitability or
GABA release cannot be ruled out, Further, potential CET-induced
changes in depolarizing dendritic GABA receptors (Alger and Nicoll
1982b) and GABA receptors remain to be clarified. Indeed,
Scheetz et al.  (1986) reported that 3 months of CET reduced by 19
percent the number of GABAergic interneurons in the DG of a strain
of ethanol-sensitive mice but did not change the number of these
interneurons in a strain of ethanol-resistant mice. These find-
ings also underscore the potential role of genetics in the suscep-
tibility of the brain to the neurotoxic action of ethanol.
STUDIES OF POSSIBLE RECOVERY FROM ETHANOL-INDUCED DAMAGE IN
SURVIVING HIPPOCAMPAL NEURONS
The extent and nature of possible reversibility of alcoholic brain
damage is of considerable importance. Recent findings suggest
that abstinent chronic alcoholics may recover significantly from
both cerebral atrophy (Artmann et al. 1981; Carlen et al. 1984;
Carlen et al. 1978; Ron et al. 1982) and cognitive deficits,
though recovery of cognitive performance is significantly de-
creased by even moderate posttreatment alcohol consumption
(Eckardt et al. 1980; Guthrie and Elliott 1980). Recent animal
studies have supported the conclusion that recovery from CET-
induced neuronal damage during ethanol abstinence can occur at
both the morphological (King et al. 1985b; McMullen et al. 1984;
Popova 1983) and functional (Durand and Carlen 1984b) levels.
We measured the density of dendritic spines on CA1 pyramidal and
DG granule cells as one index of morphological recovery (King et
al. 1985b). At the end of a 20-week CET period, half of the
animals were sacrificed, and half were given a 20-week abstinence
period before they were sacrificed. Brains were processed with a
modified rapid Golgi method (Scheibel and Scheibel 1978) to stain
dendritic spines, and spine density (spines/µm) was measured on
the dendritic tree in the stratum oriens and stratum radiatum for
CA1 pyramidal cells and in the stratum moleculare for DG granule
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cells. CET without abstinence (group A0 vs. group S0) reduced the
spine density of CA1 pyramidal cells and, surprisingly, increased
the spine density of DG granule cells (table 3). After 20 weeks
of abstinence (group A20 vs. group S20), the spine density had
returned toward normal for both pyramidal cells and granule cells
(table 3). There were no differences in spine density between the
two control groups (SO vs. S20) at any measurement location on
either cell type. These results indicate an initial remodelling
of spine density during CET that returns to normal during 20 weeks
of ethanol abstinence. Kunz et al. (1976) previously reported
that ethanol exposure for only 8 weeks produced an increased spine
density in surviving CA1 pyramidal cells. This observation,
coupled with our present results, suggests that the initial re-
sponse of CA1 pyramidal cells to CET may be to increase spine
density, which reverses to a decreased density during continued
exposure and reverses again, toward normal, with abstinence.
Whether granule cells respond to CET with an initial decrease
followed by a compensatory increase in spines only after longer
exposure remains to be determined.
TABLE 3. The effect of 20 weeks of CET and 20 weeks of ethanol
abstinence on the density of dendritic spines per
linear micron of dendrites of CA1 pyramidal cells and
DG granule cells
CA1 Pyramidal Cells DG Granule Cells
Treatment
Group Stratum Oriens Stratum Radiatum Stratum Moleculare
Alcohol
A0 (n=11) 1.779 (.079) 1.868 (.056) **1.753 (.053)
A20 (n=8) *2.010 (.045) *2.181 (.046) 1.659 (.088)
Sucrose
SO (n=6) 1.892 (.079) 2.001 (.113) 1.571 (.058)
S20 (n=8) 1.873 (.115) 2.011 (.074) 1.538 (.145)
*p<.05 as compared to group AO.
**p<.O5 as compared to group SO.
NOTE: Groups A0 end SO (alcohol or sucrose) were killed after 20 weeks of treat-
ment without an abstinence period. Groups A20 and S20 were killed 20 weeks
after the end of the 20-week treatment period. Values are the mean
(± S.E.M.) spines/µm.
Our recent Golgi results in the rat described above are at vari-
ance with our previous observations in the C57BL mouse of a
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substantial spine loss from both CA1 pyramidal cell basal den-
drites and DG granule cell dendrites after CET (Riley and Walker
1978). Our rat data are, however, in agreement with the recent
report that dendritic spine density in CA1 is normal when assessed
3 or 6 months after CET (Lescaudron and Verna 1985). There are a
number of possible explanations for the different results in mice
and rats. The most likely include: (1) The mouse may simply be
more sensitive to the toxic central nervous system (CNS) effects
of CET than rats, particularly since the ethanol intake (g/kg) and
resulting blood-ethanol levels are about doubled in the mouse
relative to the rat. (2) The mouse hippocampus may possess less
capacity for compensatory synaptic reorganization following neu-
ronal injury. (3) Recent electron microscopic observations found
that the dendritic spine heads of CA1 pyramidal cells in the mouse
following CET were reduced in size relative to controls (Phillips
and Cragg 1983). Many of the spine heads in the alcohol group
were too small to be visible with the light microscope at standard
magnification. Since our spine counts in the mouse study (Riley
and Walker 1978) were made at a magnification of 1000X, it is pos-
sible that some of the spines in the alcohol group were not seen.
Since our recent Golgi data in the rat were collected at a magni-
fication of 2250X, this was not a problem, as demonstrated by the
increase in spine density in granule cells after CET in the group
without subsequent abstinence. The increase in spine density in
granule cells is a possible anatomical substrate for the finding
that CET reduced the PS amplitude in the DG elicited by stimula-
tion of the entorhinal afferents, despite no change in the popula-
tion EPSP (Abraham et al. 1984). That is, if the decreased number
of surviving granule cells are innervated by an increased number
of entorhinal synaptic terminals, fewer cells would be fired per
unit EPSP, thereby reducing the PS amplitude although the EPSP
amplitude remains unchanged.
THE EFFECT OF CET UN REACTIVE SYNAPTOGENESIS IN SURVIVING
HIPPOCAMPAL NEURONS
The possibility that ethanol intake may limit morphological recov-
ery from brain damage is suggested by reports that reversibility
of cognitive performance and cerebral atrophy (Carlen et al. 1984;
Eckardt et al. 1980) is significantly decreased by even moderate
posttreatment alcohol consumption. We therefore conducted experi-
ments to examine two hypotheses: (1) that prior CET results in a
residual attenuation in the capacity for synaptic reorganization
in response to brain injury; and (2) that CET during the period
following brain injury suppresses synaptic reorganization. We
tested these hypotheses by determining the effects of CET on the
extent of reactive synaptogenesis of commissural/associational
(C/A) and cholinergic afferents to DG granule cells following par-
tial deafferentation induced by a unilateral lesion of the ento-
rhinal cortex. We chose this model because it has been widely
used to investigate reactive synaptogenesis (Cotman and Nadler
1978; Lynch and Cotman 1975). Unilateral ablation of the ento-
rhinal cortex in adult rats removes 86 percent of the synapses
from the distal 70 percent of the ipsilateral DG granule cell
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dendrites (Matthews et al. 1976a). The synaptic reorganization
and synaptogenesis subsequent to the denervation restores the par-
tially deafferented terminal zone to its normal synaptic density
(Matthews et al. 1976b). These new synapses originate primarily
from the septal area, the commissural and associational hippo-
campal pyramidal cells, and the contralateral entorhinal cortex.
The C/A fiber system expands outward by 10 to 20 µm, and the
cholinergic septal fibers and fibers from the contralateral ento-
rhinal cortex proliferate in the remainder of the denervated zone
(Cotman and Nadler 1978). We have used histochemical staining for
AChE to monitor these changes, because the expansion of the choli-
nergic septal input can be directly seen with this stain, and the
expansion of the C/A system can also be measured because it ap-
pears as a "clear zone" devoid of any AChE stain (Nadler et al.
1980).
The first experiment of this series (King et al., in preparation;
Walker et al. 1984) was designed to test the hypothesis that prior
CET may result in a lasting attenuation in the capacity for re-
active synaptogenesis in the DG. Two groups of rats were main-
tained on ethanol- or sucrose-containing liquid diets for 20
weeks. An 8-week abstinence period preceded partial denervation
of the DG by unilateral electrolytic lesion of the entorhinal
cortex. Horizontal sections were cut 40 days postlesion and proc-
essed for AChE staining. The width and optical density of affer-
ent terminal fields were measured in the DG (King et al. 1985a).
Unilateral lesion of the entorhinal cortex resulted in shrinkage
of the ipsilateral outer molecular layer (OML) of both the buried
(30 percent) and exposed (36 percent) blades of the DG. The
shrinkage was almost identical in both CET and control groups,
indicating that the lesion produced equivalent deafferentation.
Despite equal lesion-induced removal of entorhinal terminals from
the OML, the resulting expansion in the width of the C/A terminal
field was reduced 50 percent in the buried blade and 33 percent in
the exposed blade by prior CET. In addition, the condensation of
AChE staining density in the OML ipsilateral to the lesion was
reduced by prior CET, indicating that reactive synaptogenesis of
cholinergic afferents to the DG granule cells was also residually
suppressed by CET. These results indicate that prior CET produces
a residual alteration in the capacity for synaptic reorganization
that lasts at least 8 weeks after CET is discontinued. Using the
same model, West et al. (1982) reported that 2 weeks of CET be-
fore, and 9 days of CET after a unilateral entorhinal cortex
lesion almost totally blocked the expansion of the C/A fibers into
the deafferented zone. These results suggest that postlesion
ethanol exposure is even more effective than prelesion exposure in
suppressing reactive synaptogenesis.
We have recently completed a study to further investigate the
hypothesis that CET following brain damage suppresses synaptic re-
organization (Orona et al., in preparation). In this experiment,
the same model was used to study reactive synaptogenesis. except
CET or control diets were administered for a 40-day period follow-
ing a unilateral lesion of the entorhinal cortex in rats not
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previously exposed to ethanol. The lesion-induced expansion of
the ipsilateral C/A zone was reduced by greater than 50 percent as
compared to controls. There was also less "clearing" of AChE
staining density in the C/A zone and greater AChE condensation in
the outer molecular layer. These results indicate that ethanol
suppresses reactive synaptogenesis of C/A afferents following re-
moval of the ipsilateral entorhinal afferents. CET may have also
suppressed the expansion of the crossed entorhinal afferents aris-
ing from the contralateral entorhinal cortex, thus allowing the
cholinergic afferents to expand more than normal.
Taken together, the results described above support the conclusion
that both a prior history of ethanol exposure and ethanol exposure
after brain damage limit the capacity of surviving neurons for
recovery. These results have important implications for the
treatment of brain-damaged alcoholics as well as nonalcoholic
brain-damaged patients. Although the mechanism by which CET re-
duces reactive synaptogenesis is unknown, one possibility is an
ethanol-induced elevation of glucocorticoids. Elevated gluco-
corticoid levels are known to inhibit both morphological and
functional recovery following partial deafferentation (Dekosky et
al. 1984), and ethanol exposure (both acute (Knych and Prohaska
1981) and chronic (Kakihana and Moore 1976; Tabakoff et al. 1978))
is known to increase the level of circulating glucocorticoids.
Ethanol is also known to inhibit protein synthesis (Tewari et al.
1978). Since protein synthesis is undoubtedly required for re-
active synaptogenesis, its inhibition by ethanol could limit the
capacity for morphological reorganization.
CONCLUSIONS AND CAUTIONS
The foregoing results provide definitive evidence that prolonged
ethanol exposure results in altered neuronal structure, connectiv-
ity, and function in the rodent hippocampus. Depending on the
duration of ethanol exposure, the magnitude of exposure (blood-
ethanol level maintained), and the genetic susceptibility of the
species and strain, CET produces a loss of CA1 pyramidal and DG
granule cells ranging from 10 to 30 percent (Irle and Markowitsch
1983; Kunz et al. 1976; Lescaudron and Verna 1985; Phillips and
Cragg 1983; Roulet et al. 1985; Walker et al. 1980a; Walker et al.
1980b; Walker et al. 1981; Walker et al. 1982). The neurons sur-
viving CET are also abnormal. Morphological studies indicate that
surviving neurons possess fewer or rearranged synaptic contacts
(Abraham and Hunter 1982; Abraham et al. 1982; Goldstein et al.
1983; King et al. 1985b; Kunz et al. 1976; McMullen et al. 1984;
Riley and Walker 1978; Walker et al. 1981) (tables 1-3). Electro-
physiological studies indicate that local inhibitory processes in
area CA1 are deficient after CET (Abraham et al. 1981; Durand and
Carlen 1984a; Rogers and Hunter 1985), perhaps due to loss of
GABAergic interneurons (Scheetz et al. 1986). The capacity for
long-term potentiation in CA1 (Durand and Carlen 1984b) and the DG
(Abraham et al. 1984) is also reduced by CET. The available evi-
dence also indicates that neurons surviving CET are capable of
some degree of morphological (King et al. 1985b; McMullen et al.
123
1984; Popova 1983) and functional (Durand and Carlen 1984b) recov-
ery during abstinence from ethanol , although this recovery is pos-
sibly limited by the suppression of reactive synaptogenesis by
ethanol (King et al., in preparation; Orona et al., in prepara-
tion; Walker et al. 1984; West et al. 1982). Despite this recent
accumulation of evidence demonstrating the neurotoxic effect of
ethanol, many questions remain unanswered. The most important is
the issue of why some cells are lost, and others are not. Neurons
appear to be differentially susceptible to the toxic effects of
CET both between and within cell types. For example, DG granule
cells and CA1 pyramidal cells are apparently affected in an oppo-
site manner both morphologically (King et al. 1985b) (table 3) and
functionally (Abraham et al. 1981; Abraham et al. 1984). Further
research into the mechanisms of this differential susceptibility
of neurons to CET will therefore provide important clues to help
determine how ethanol exerts its deleterious action on the brain.
Finally, we would like to discuss some of the issues that bear on
the interpretation of data in these kinds of experiments. Because
it is evident that both destructive and compensatory processes
occur simultaneously during CET, caution must be used in attribut-
ing an observed morphological or functional alteration as repre-
senting solely a destructive or a compensatory mechanism. or in
interpreting a negative result as evidence of the absence of an
effect. During CET, for example, hippocampal cells are killed or
damaged, resulting in a partial deafferentation of other neurons,
which leads in turn to reactive synaptogenesis in undamaged affer-
ents. The end result may be that the total number of synapses
innervating a specific neuronal population may not differ from
controls, but the afferent synapses on the surviving cells will
have been rearranged and therefore differ qualitatively. Simply
counting the number of synapses in a particular region without
determining their origin may thus lead to the erroneous conclusion
that CET did not have an effect.
Another important issue is the interpretation of quantitative cell
count or synaptic density data after CET. A loss of cells or syn-
apses can be masked by a change in total area or volume of a cell
population or a synaptic field. In a previous study, for example,
we found that DG granule cell packing density (nucleoli per unit
area in a grid) was not significantly altered by CET, but the
total area of the granule cell layer was reduced by about 20 per-
cent as a result of a significant overall decrease in cell number
(Walker et al. 1980b). The same phenomenon has been observed in
the cerebellum (Tavares and Paula-Barbosa 1982; Walker et al.
1981). Finally, the importance of conducting parallel anatomical
and functional analyses of the effects of CET should be empha-
sized. In the spinal cord, for example, axonal sprouting can lead
to the development of abnormal function (McCouch et al. 1958).
Compensatory synaptic reorganization during or following CET thus
may or may not promote functional recovery. Even in the absence
of morphological recovery or compensation, surviving afferent
connections could exhibit changes in synaptic efficacy or potency
which would not be detected morphologically.
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It is apparent that, despite the accumulation of substantial
information during the last few years regarding the effects of
prolonged ethanol exposure on neurons, a great many questions re-
main to be answered. Clearly, the results obtained to date reveal
that the toxic effects of ethanol are dynamic and much more com-
plicated than suspected. Similarly complex dynamics may be ex-
pected to result from the toxic effects of other drugs.
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Amphetamine Changes Neostriatal
Morphology
Philip M. Groves, Lawrence J. Ryan, and Jean C. Linder
INTRODUCTION
The mammalian neostriatum, consisting of the caudate nucleus and
putamen, is known to be a principal site of dysfunction in
Huntington's and Parkinson's diseases. On the basis of this and
substantial other evidence, the neostriatum is believed to play an
important role in both motor and cognitive functions of the human
brain (Groves 1983). It has also been repeatedly established that
the neostriatum is an important site of action of many psycho-
active drugs, including amphetamine, cocaine, and opiates.
It is now clear that amphetamine acts on one of the major inputs
to the neostriatum (the dopaminergic system arising from the sub-
stantia nigra, pars compacta) to release dopamine onto post-
synaptic targets. Amphetamine also alters the firing rate of the
presynaptic dopamine neurons and releases dopamine from their
dendrites, leading to the phenomenon of self-inhibition (Groves et
al. 1975). Dopamine released within the neostriatum also has a
prominent site of action at autoreceptors located on dopaminergic
neuron terminals. Here it can regulate the amount of dopamine
released by each nerve impulse and alter biophysical properties of
the synaptic endings, for example, the electrical excitability of
the terminals (Tepper et al. 1985).
Over 95 percent of neurons within the neostriatum belong to a
single morphological class: the neostriatal medium spiny neuron.
This cell type is distinguished by its highly stereotyped morphol-
ogy and medium size. Three to five primary dendrites usually
radiate from the soma in a stellate pattern to form a spherical
dendritic field approximately 500 microns across. The dendritic
branching is distorted at the boundaries of histochemically de-
fined subregions (the striosomes and matrix (Graybiel and Ragsdale
1983)), so that neostriatal cells are confined to one anatomical
compartment (Penny et al. 1984). The cell body and proximal den-
dritic trunks are smooth, but at 20 microns from the soma, the
dendrites abruptly become heavily invested with dendritic spines,
ranging in density from one to four spines per micron of dendritic
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length (Wilson and Groves 1980). Each spine receives one or more
synaptic inputs arising from the cerebral cortex, midline thala-
mus, and substantia nigra. In addition, neostriatal inputs arise
from several other telencephalic and brain stem afferent systems,
including the basolateral amygdala and the raphe nuclei. Each
spine consists of a typically spherical head approximately 0.1-0.9
microns in diameter connected to the parent dendrite by a shaft
approximately 0.4-3.8 microns in length (Wilson et al. 1983).
Synapses from the major excitatory inputs of the thalamus and
cerebral cortex form asymmetrical (Gray's type I) synapses onto
the heads of the dendritic spines. Less commonly, a symmetrical
(Gray's type II) synapse is made onto the spine shaft. Despite
the use of a wide variety of anatomical approaches, including
anterograde degeneration, autoradiography (Hattori et al. 1973),
5-hydroxydopamine labelling (Groves 1980; Arluison et al. 1978a),
radiolabelled dopamine uptake (Arluison et al. 1978b), and immuno-
cytochemical identification of tyrosine hydroxylase immuno-
reactivity (Freund et al. 1984; Pickel et al. 1981), a definitive
identification of the synapses made in the neostriatum by dopami-
nergic projections arising from the brain stem has yet to be made.
ALTERATIONS INDUCED BY REPEATED AMPHETAMINE ADMINISTRATION
Repeated administration of amphetamine leads to a number of long-
lasting behavioral, physiological, and biochemical changes, indi-
cating the inherent plasticity of the neostriatum and its dopamine
input. For example, the locomotor and stereotyped behaviors
induced by acute amphetamine administration show a progressive
augmentation with repeated administration of the drug (Segal and
Schuckit 1983). This sensitization may parallel the progressive
augmentation of the psychotomimetic properties of this drug in
human amphetamine abusers. Similar behavioral effects have been
demonstrated with repeated administration of cocaine.
Repeated administration of amphetamine has also been demonstrated
to produce substantial biochemical and morphological alterations
in the neostriatum. For example, following the repeated adminis-
tration of amphetamine over several days, there is a substantial
and persistent decline in neostriatal dopamine content in a vari-
ety of experimental animals (Ellison et al. 1978; Seiden et al.
1975/76; Wagner et al. 1980a). Indeed, even following a single
high dose of the drug in rats pretreated with iprindole to retard
the degradation of amphetamine, neostriatal dopamine content may
be reduced for up to 1 year (Fuller and Hemrick-Luecke 1980).
Such long-lasting changes have also been demonstrated with chroni-
cally administered dopamine antagonists; in humans, dopamine-
antagonist-induced motor disturbances may persist for 5 years or
longer (Marsden 1982). Other examples of biochemical plasticity
following chronic amphetamine administration include a decreased
number of dopamine uptake sites (Wagner et al. 1980b) and a
decline in neostriatal tyrosine hydroxylase activity (Hotchkiss
and Gibb 1980).
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Dramatic morphological changes accompany these biochemical
sequelae of chronic amphetamine administration. Individual
dopaminergic axons in the neostriatum, revealed by histo-
fluorescence, appear to be swollen and distorted, and background
fluorescence appears to be reduced, suggesting a reduction in
dopamine content (Ellison et al. 1978; Jonsson and Nwanze 1982;
Lorez 1981; Nwanze and Jonsson 1981). This reduction probably
reflects degeneration of dopamine axonal terminals, since silver
stains (such as the Fink-Heimer method), used to reveal de-
generating axons and their terminals, show significant axonal
degeneration in the neostriatum following chronic amphetamine
administration (Ricaurte et al. 1982; Ricaurte et al. 1984a;
Ricaurte et al. 1984b; Wahnschaffee and Esslen 1985). This damage
appears to be rather specific, because degeneration was not ob-
served in several other brain regions, including the dopaminergic
substantia nigra and ventral tegmental area, the noradrenergic
locus coeruleus, and the serotonergic raphe nuclei. In immature
guinea pigs, chronic administration of amphetamine has also been
reported to lead to axonal degeneration in circumscribed regions
of the frontal neocortex (Wahnschaffee and Esslen 1985). Striatal
dopaminergic axons seem particularly vulnerable to drug-induced
damage, because axonal degeneration also occurs with administra-
tion of the neurotoxic contaminant (1-methyl-4-phenyl-1,2.3,6-
tetrahydropyridine, commonly known as MPTP) found in certain
synthetic street preparations of abused drugs. Ingestion of this
compound leads to dopamine cell loss in the substantia nigra and
to development of a Parkinsonian syndrome in humans and several
other species (Markey et al. 1986).
Thus, it has become clear that amphetamine can be neurotoxic when
administered repeatedly at high doses. Gross degenerative changes
are, in one sense, easily observable plastic changes that may be
taken to suggest that more subtle morphological alterations can
occur at lower doses and with less frequent administration.
Furthermore, since these neurodegenerative changes have been
demonstrated in albino rats, other animals, more sensitive to the
neurotoxic actions of amphetamine, may show different patterns and
types of changes. The importance of multispecies comparisons and
use of pigmented experimental animals for studying neuro-
degenerative changes has recently been highlighted by the fact
that the neurotoxic actions of MPTP could not be demonstrated in
albino rats (Markey et al. 1986).
STUDIES OF THE EFFECTS OF CHRONIC AMPHETAMINE ADMINISTRATION
Approaches/Procedures
Our studies of amphetamine-induced plastic changes have entailed
analysis of both gross degenerative changes and more subtle
anatomical alterations. Some of our results illustrate the poten-
tial of the neostriatum to alter its morphology in response to
repeated drug insult. Such morphological changes are presumed to
alter neostriatal cognitive and motor functions. Our studies have
used several anatomical approaches, including tyrosine hydroxylase
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and leu-enkephalin immunocytochemistry, Fink-Heimer degeneration,
and electron microscopy, to analyze the neurotoxic effects of
chronically administered amphetamine on the brains of pigmented
Long-Evans black-hooded rats. We view these studies as complemen-
tary to our continuing studies of more subtle morphological and
functional alterations induced by chronically administered amphet-
amine on the structure and function of presynaptic endings and
postsynaptic targets of the dopaminergic projections into the
neostriatum.
d-Amphetamine sulfate was continuously administered to rats for
periods of 1 to 3 days via indwelling subcutaneous minipumps
(Alzet minipumps, model 2ML1). For some electron microscopic
studies and Fink-Heimer staining, animals were sacrificed and
perfused immediately at the end of drug administration. For the
immtunocytochemical and other Fink-Heimer staining experiments,
animals survived for 1 day prior to perfusion. Standard anatom-
ical procedures were followed throughout.
Results
Our experiments confirm the general outline of neurotoxic ampheta-
mine effects identified by Schuster, Seiden, and their colleagues
(Ricaurte et al. 1982; Ricaurte et al. 1984a; Ricaurte et al.
1984b) and demonstrate several other important effects. For exam-
ple, in pigmented animals, the degenerative sequelae are more ex-
tensive, involving large regions of motor and somatosensorytortex
as well as the neostriatum. Within the neostriatum, extensive
degeneration, involving most of this structure, is seen with Fink-
Heimer labelling (the most posterior regions usually show the
least degeneration). In figure 1, the deposition of silver
grains, indicative of axonal degeneration, is clearly seen in the
neostriatum of a Long-Evans rat treated with approximately
60 mg/kg/day of d-amphetamine sulfate for 3 days. The effect is
dose related; doses ranging from 15.9 to 67.6 mg/kg/day show
progressively greater and more extensive degeneration. Behavioral
effects were also dose related; the lowest doses of the drug
produced increased locomotion, hyperresponsiveness, and moderate
weight loss, and the highest doses led to intense and continuous
stereotyped grooming, orofacial stereotypy, severe weight loss,
and insomnia.
These dramatic degenerative and behavioral consequences of chronic
amphetamine administration are thought to result from the release
and accumulation of dopamine. The neostriatal degeneration ob-
served as a result of the chronic amphetamine regimen probably
reflects damage to dopaminergic afferent axons, because previous
studies using histofluorescence have revealed numerous swollen
fluorescent axons (Ellison et al. 1978; Lorez 1981; Nwanze and
Jonsson 1981), and, in our tissue, we have found many abnormally
swollen and distended axons labelled immunocytochemically for
tyrosine hydroxylase. Swollen profiles such as those shown in
figure 2 were not found in sham-operated control rats.
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FIGURE 1. Neostriatal axonal terminal degeneration
NOTE: (A) Axonal degeneration, as shown by dense silver grain deposits. is seen
throughout this section of neostriatum from a Long-Evans rat that received
60 mg/kg/day d-amphetamine sulfate for 3 days. (B) No degeneration is seen
In a sham-operated control rat.
The distortion of dopamine axons was specific to the neostriatum.
In the globus pallidus, which also possesses a dense network of
tyrosine-hydroxylase-immunoreactive axons, neither swollen and
distorted immunolabelled axons nor Fink-Heimer-labelled degenera-
tion was found. In the electron microscope, neostriatal tissue
had numerous profiles showing classical signs of degeneration.
The profile shown in figure 3, for instance, is electron dense
(dark) and shows scalloped and shrunken margins. Many vesicle-
containing profiles appeared distended and filled with debris.
These perhaps correspond to the swollen axons seen in the light
microscope.
Labelling, either for Fink-Heimer axonal degeneration or for
tyrosine hydroxylase immunoreactivity, failed to reveal axonal or
somatic degeneration or damage in other regions of the basal gang-
lia, including the substantia nigra, globus pallidus. and sub-
thalamus, nor was damage observed in any cortical region receiving
a dopaminergic projection. Damage was not observed in the nor-
adrenergic nucleus locus coeruleus nor in some targets of the
locus coeruleus, including the hippocampus, cerebellum, and thala-
mus. In the thalamus, the midline nuclei, which project into the
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FIGURE 2. Neostriatal axonal distortions
NOTE: Large swollen and distorted axons are seen labelled for tyrosine hydroxy-
lase immunoreactivity in the neostriatum of a rat treated for 3 days with
50 mg/kg/day d-amphetamine. Normal axons at arrows.
neostriatum, and the ventral nuclei, which receive output from the
basal ganglia and motor cortex, were examined with particular
care. No damage was observed in these regions following any
regimen of chronic amphetamine administration.
In pigmented Long-Evans rats, extensive degeneration was observed
in frontal cortex. This damage was densest in regions of primary
motor cortex and supplementary motor cortex, with lighter terminal
degeneration in sensorimotor cortex, though only circumscribed
parts of these regions were involved. Furthermore, animals that
showed greater behavioral effects and greatest weight loss showed
the most extensive neocortical damage. Figure 4 illustrates the
prominent yet circumscribed nature of the damage to motor cortex.
The densest degeneration within motor cortex appears to be in
intermediate layers, though Fink-Heimer labelling is seen through-
out the depth of the cortex. Whether or not the degeneration
represents monoaminergic elements is a topic of current investiga-
tion. It seems unlikely, though, that dopaminergic terminals are
involved, because these regions are not known to receive a dopami-
nergic innervation.
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FIGURE 3. Ultrastructure of neostriatal degeneration
NOTE: The figure shows an electron micrograph of a typical dark, degenerating
profile In the neostriatum of a rat treated with 50 mg/kg/day of d-
amphetamine. The profile is debris filled, with scalloped. distorted
edges.
Neocortical degeneration was not observed in two albino Sprague-
Dawley rats in which degeneration was observed in the neostriatum,
nor has extensive neocortical damage been reported in earlier
studies of repeated amphetamine administration in other albino
rats (Ricaurte et al. 1982; Ricaurte et al. 1984a; Ricaurte et al.
1984b). The only previous report of dense cortical degeneration
was in pigmented guinea pigs, but, since immature animals were
used in those experiments Wahnschaffee and Esslen 1985). the
authors suggested that cortical damage resulted from a greater
vulnerability of the immature nervous system to amphetamine than
is seen in adults. We suggest that the presence of pigmentation
may also be an important variable.
More subtle alterations in neostriatal morphology may also be
produced by chronic amphetamine administration. The neostriatum
possesses several distinct anatomical compartments defined by
histochemical and connectional criteria (Graybiel and Ragsdale
1983; Gerfen 1985). One compartment, termed the striosomes,
stains heavily for substance-P, leu-enkephalin, opiate receptors,
and, in immature rat brains, for tyrosine hydroxylase. Medium
spiny neurons within the striosomal compartment appear to project
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FIGURE 4. Dense degeneration in a circumscribed region of primary
motor cortex following 3 days of continous ampheta-
mine administration
into the dopaminergic substantia nigra, pars compacta (Gerfen
1985). The larger matrix compartment, in contrast, characteris-
tically labels more heavily for acetylcholinesterase and somato-
statin, and projects into the substantia nigra, pars reticulata
(Gerfen 1985). The existence of two distinct compartments opens
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the possibility of an anatomical basis for differential plastic
and functional actions of chronic amphetamine. In this regard, we
have observed that chronic amphetamine administration induces an
uncharacteristically patchy distribution of tyrosine hydroxylase
immunoreactivity in the adult animal, which normally has a rela-
tively homogeneous distribution of tyrosine hydroxylase immuno-
reactivity in the neostriatum. These amphetamine-induced patches
correspond to leu-enkephalin-labelled patches seen in adjacent
sections and so probably correspond to striosomes.
POSSIBLE DENDRITIC SPINE ALTERATIONS RESULTING FROM CHRONIC
AMPHETAMINE ADMINISTRATION
In addition to these large, systemwide changes, it is conceivable
that the dendritic spines of the common spiny neuron, where the
three major inputs to the neostriatum synapse, represent a site
for drug-induced plasticity. Indeed, changes in the morphology of
the dendritic spines of granule cells of the dentate gyrus have
been suggested to accompany potentiation of synaptic transmission
following high-frequency stimulation (Fifkova and Van Harreveld
1977). Alterations in the dendritic spine have also been theo-
rized to play an important role in learning and memory (Crick
1982). It is conceivable that the behavioral augmentation seen
following repeated amphetamine administration results from similar
changes at the dendritic spine, thus altering the synaptic effi-
cacy of the major afferent systems of the neostriatum. Such
changes in synaptic efficacy could be accompanied by changes in
the morphology of the spine, including the size and shape of the
synaptic contact. Such alterations are currently being examined
and quantified in animals given repeated administrations of
amphetamine as well as the dopamine antagonist haloperidol.
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Delta-9-Tetrahydrocannabinol-
Dependent Alterations in Brain
Structure
Philip W. Landfield
INTRODUCTION
Although chronic exposure to marijuana or cannabinoids has been
found to induce lasting behavioral changes (Nahas and Paton 1979;
Stiglick and Kalant 1982), little is known about the nature of the
neural consequences of such long-term exposure. In particular, it
is not known whether long-term use induces structural changes in
the brain (which presumably are only gradually reversible, if at
all) and, if SO, whether such anatomical changes are associated
with functional alterations. It is clear that cannabinoids
strongly affect central neural function (cf. Turkanis and Karler
1983; Campbell et al. 1986). but there have been essentially no
major systematic studies of the long-term effects on brain struc-
ture of chronic marijuana exposure, or of exposure to delta-g-
tetrahydrocannabinol (THC), the primary active constituent of
marijuana. One research project on this question (Harper et al.
1977; Heath et al. 1979) reported ultrastructural brain changes in
monkeys exposed to marijuana and THC, but the groups included only
2 to 3 animals. Furthermore, some experimental (but not control)
animals bore implanted depth electrodes, and several of the ultra-
structural changes reportedly induced by THC, e.g., clumped vesi-
cles and large intercellular spaces, are characteristic of poor
tissue fixation.
Thus, apart from the studies conducted at this laboratory, which
are described below (see Landfield et al. (1987) for a more de-
tailed description), and one other ongoing project with rats
(e.g., Scallet et al. 1986). almost nothing is known about the
effects of chronic THC exposure on mammalian brain structure.
Clearly, there are important sociomedical reasons for conducting
studies to determine whether chronic THC exposure induces changes
in brain anatomy. Moreover, assessing the effects of THC might be
valuable in the analysis of basic neurobiological processes, since
a substance able to alter brain structure in adult mammals would
be of considerable interest in this regard. Consequently, we have
143
undertaken extensive, long-term studies in rats, using quantita-
tive light and electron microscopic approaches, to assess the
effects of chronic THC exposure on brain anatomy. The present
chapter summarizes the rationale and results to date of these
studies, and also considers possible interactions of THC with
endogenous adrenal steroid systems. As discussed below, the
increasing evidence that such interactions occur, in conjunction
with evidence that corticosteroids are able to modulate brain
structure in adult mammals, provides some of the stronger indi-
cations of a possible effect of chronic THC on brain structure.
INTERACTIONS OF THC AND GLUCOCORTICOID SYSTEMS
Corticosteroid Effects on Hippocampal Correlates of Aging
The mechanisms of aging in general, and brain aging in particular,
are not well understood, but there is growing evidence that neuro-
endocrine factors play at least a partial role in the vertebrate
aging processes (cf. Adelman and Roth 1982; Finch 1976; Finch and
Landfield 1985; Simpkins and Estes 1983). We have previously pro-
posed that glucocorticoids accelerate the process of brain aging
(Landfield 1978; Landfield et al. 1978; Landfield et al. 1981a),
because some pathological effects of corticoids in nonneural sys-
tems are overtly similar to changes seen with normal aging (cf.
review in Wexler 1976), and because the hippocampus, which is one
of the brain structures most affected by aging (Brody 1973;
Wisniewski and Terry 1973), contains the highest density of spe-
cific corticosteroid receptors of any brain structure (McEwen et
al. 1975). The hypothesis that hormones modulate brain aging led
to several directly testable predictions, including: (1) that the
activity of the adrenal system should correlate quantitatively
with measures of brain aging, and (2) that experimental manipula-
tion of adrenal steroids should modify the rate of appearance of
hippocampal correlates of aging. Further, if adrenal steroids
normally influence a component of brain aging (cf. Landfield
1978). then prolonged adrenalectomy should be able to retard this
process.
Testing each of these predictions, however, required the use of
reliable and sensitive indices of brain aging, which were not then
readily available. We therefore conducted an extensive series of
morphometric analyses of age-related changes in a well-defined
region of the rat hippocampus (field CA1), at both light and elec-
tron microscopic levels (Applegate et al. 1984; Landfield et al.
1981b; Lindsey et al. 1979). Using this model system and these
measures, we tested the above predictions and found substantial
evidence consistent with the hypothesis (e.g., Landfield et al.
1978). In particular, we found that adrenalectomy could retard
the development of several light microscopic morphologic indices
of hippocampal aging (Landfield et al. 1979; Landfield et al.
1981a), supporting the view that normal levels of corticosteroids
participate in brain aging. Other studies have found that ele-
vated corticosterone accelerates the decrease in neuronal density
seen with aging (Sapolsky et al. 1985).
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Although the evidence that corticosteroids influence brain aging
appears reasonably sound and consistent, there is still very
little known about the mechanisms of these effects. Changing
corticosteroid levels alters many other hormonal systems, includ-
ing ACTH and related neuropeptides. These peptides can exert a
direct (stimulantlike) action on some measures of brain physiol-
ogy, chemistry, and behavior (Gispen et al. 1977; Pfaff et al.
1971; Renaud and Padjen 1978). To test the possibility that pro-
longed adrenalectomy might have retarded brain aging correlates by
elevating ACTH and, consequently, increasing neural activation, we
conducted long-term studies of the effects of daily administration
of an ACTH analog, ORG 2766, and of an established neural stimu-
lant, pentylenetetrazol. These agents retarded some brain aging
correlates, as did prolonged adrenalectomy (Landfield et al.
1981a). Therefore, although the pattern of effects differed some-
what from that of adrenalectomy, the data raise the possibility
that more than one hormonal system may influence brain aging.
Nevertheless, it has been found recently that specific
corticosteroid-receptor-bearing neurons appear to be preferen-
tially lost from the hippocampus during aging or following chronic
administration of corticosterone (Sapolsky et al. 1985), which
lends considerable support to the view that corticosteroids act on
brain aging by a specific corticoid-receptor-mediated effect.
Effects of THC on Corticosteroids
It has been known for some years that THC or marijuana extract can
induce alterations in a variety of endocrine systems, including an
increased activity of the adrenal-pituitary axis (Dewey et al.
1970; Drew and Slagel 1973; Maier and Maitre 1975; Rosenkrantz et
al. 1975; see reviews in Braude and Ludford 1984). The latter
increase has been seen frequently in rats, and we also found an
increase of ACTH and corticosterone under our chronic treatment
conditions (see below). This increase, however, has not been
observed consistently in the few human or monkey studies that have
examined this question (e.g., Kolodny et al. 1974). On the other
hand, the adrenal-pituitary axis is extremely labile and difficult
to assess, and thymus involution, which could imply increased
corticoid activity, has been reported in monkeys given 15 days of
THC treatment (Thompson et al. 1974). More complete studies are
needed, e.g., on the 24-hour diurnal rhythm of cortisol, to obtain
a clear-cut answer to the question of human adrenal-pituitary axis
responses to THC.
Potential Corticoidlike Mechanism of the THC Effect on Brain
Evidence that THC increases adrenal-pituitary axis activity, in
conjunction with evidence that glucocorticoids accelerate some
aspects of brain aging, clearly raises the possibility that any
effects of THC on brain structure might be mediated in part by an
elevation of steroid activity. However, it is not necessary to
postulate that the THC influence on brain is mediated by endoge-
nous corticoids in order to consider the possibility that THC acts
on brain via steroidlike mechanisms. Because THC and some of its
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metabolites have chemical structures similar to those of some
naturally occurring adrenal steroids (e.g., Harris et al. 1976;
Szara 1973), it seems conceivable that THC could act on the brain
directly, perhaps by mimicking glucocorticoids and binding to
glucocorticoid receptors in the hippocampus. Other investigators
have raised the possibility that THC may bind to estrogen
receptors (Rawitch et al. 1977; Solomon et al. 1976) or induce
estrogenlike effects in the brain (Foy et al. 1982). However, not
all workers have found data consistent with this effect (Okey and
Bondy 1978).
Clearly, it is not yet established that THC acts on the brain
through glucocorticoidlike mechanisms. However, if this route of
action eventually proves to be the basis of the THC effect, then,
regardless of whether THC acts on hippocampal morphology directly
(by mimicking glucocorticoids) or indirectly (by elevating endoge-
nous adrenal steroids), the outcome of THC actions might be to
accelerate the development of a steroid-dependent aginglike
pathology in the brain. Young animals may be able to adapt some-
what to putative THC-induced aginglike effects, but, as adaptive
capacity declines with age, the degree of brain pathology seen
during aging might be substantially greater in animals previously
exposed to THC than in nonexposed animals. Thus, chronic use of
marijuana in youth could have implications for the quality of
later life that have not yet been recognized.
Based on these considerations, the studies described below were
aimed at defining the nature and possible underlying mechanisms of
the effects on brain structure of chronic THC exposure. The stud-
ies were conducted in the rat hippocampus, in which morphology has
been found to be affected by corticoid exposure, with treatment
periods sufficient to induce gradual, possibly aginglike effects
on the brain (e.g., approximately 30 percent of the lifespan: 8
months). Systematic, quantitative analyses of brain morphology
were performed, and direct measures of the chronic treatment
effects on adrenal-pituitary system hormones were carried out.
LONG-TERM STUDIES
Subjects and THC Administration
Male, Fischer 344 rats, 3 to 4 months old at the start of the
study, were housed doubly in an animal facility containing an HEPA
(high-efficiency particulate; absolute) filter/laminar air flow
system which filtered all particles larger than 0.3 from from the
air. The air filter removed airborne bacteria, and no infections
developed in the colony. Administration of agents was carried out
by an investigator wearing a clean lab coat and surgical mask and
gloves, using sterile needles.
The basic protocols used for preparation of THC are similar to
those described by Smiley et al. (1976). Briefly, the THC was
suspended in a solution of detergent (Pluronic F68; Wyandotte
Chemical Company) and ethanol. The ethanol was subsequently
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evaporated, saline was added to make up the appropriate concentra-
tions, and the solutions were sonicated.
Pathology and Blood Chemistry Studies
Animals were injected subcutaneously (SC) 5 times weekly with
saline alone, the Pluronic F68 vehicle alone, or 8 mg/kg THC in
Pluronic, for a period of 4 months. Blood samples were obtained
from each animal after 2 months and after 4 months of treatment
(by tail sampling while the animals were held in a restraining
cage). On each sampling occasion, blood was collected at both 2
minutes and 12 minutes after the animal was first handled and
placed in the restraining apparatus.
The animals were sacrificed after the 4-month test, and a complete
blood chemistry test (SMAC) was performed on plasma. The saline
and Pluronic-vehicle-alone groups did not differ from each other
on any variable. However, the THC group exhibited significant
elevations in glucose, cholesterol, and perhaps creatinine and
uric acid. Other investigators also have found THC-induced alter-
ations in glucose and cholesterol levels (e.g., Rosenkrantz et al.
1975). In addition, plasma from THC animals showed significant
decreases in total protein and albumin. Interestingly, several of
these changes are similar to those found in normally aging rats
(Landfield, unpublished results).
In the endocrine assays, THC-treated rats exhibited significant
elevations in plasma ACTH and corticosterone. In particular, ACTH
was dramatically increased after 12 minutes of restraint stress.
Thus, these results confirm earlier reports of chronic THC-induced
increases in adrenal activity and also provide direct evidence
that the effect is due to elevated ACTH. The negative feedback
control of ACTH by corticosterone has been postulated to be dis-
rupted by THC (Drew and Slagel 1973), an effect which would be
consistent with the steroidlike structure of THC (Szara 1973).
Similar elevations of stress-induced levels of ACTH and corticos-
terone are seen during aging (e.g., Landfield et al. 1978; Lewis
and Wexler 1974; Sapolsky et al. 1983).
Long-Term Morphometric and Behavioral Study
Similar long-term studies were conducted in other groups of young
rats, to investigate the possible morphological and behavioral
effects of chronic THC on the brain. These groups included a
Pluronic-vehicle-alone group (n=12), a low-dose THC (4 mg/kg)
group (n=12), and a high-dose (10 mg/kg) THC group (n=l2). The
high dose was reduced to 8 mg/kg approximately 1 month after the
start of these studies, because the animals appeared to react as
if the treatment were aversive.
Both the low and high doses of THC caused slight reductions in
body weight during chronic treatment. This reduction apparently
was due to decreased food and water intake, although the latter
effects were mild. We tested these variables on four occasions
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during the 8-month protocol. Water intake was found to be signif-
icantly reduced in THC animals, but the reduction of food intake
was not quite statistically significant. Of interest from the
point of view of a possible endocrinelike effect of THC, is the
fact that chronic treatment of rats with glucocorticoids induces
very similar, but more severe effects on body weight and food
intake (Stevenson and Franklin 1970).
Behavioral studies. On two occasions during the 8-month treatment
regimen, animals were examined for open field behavior, and at two
other times, they were tested for learning in a simple, one-trial,
active-avoidance paradigm. On the first test, animals were given
four retention/training trials at one trial per day (spaced
trials), and, on the second test, they were given three trials on
one day, each separated by 1 minute (massed trials).
Fourteen days following cessation of THC treatments, all animals
were assessed for acquisition and retention of maze-reversal
learning, which is affected both by hippocampal damage and aging.
Animals were trained for 1 week to consistently choose one arm of
a T-maze (to avoid footshock). The safe side was then reversed,
and the animals were trained to select the opposite side on three
successive acquisition trials (acquisition data were analyzed only
for the second and third trials, since the first trial was always
incorrect). They were then tested for retention of the reversal
24 hours later, on three retention trials. Animals were then
reversed again using the same trial sequence.
The high dose of THC exerted moderate effects on open field activ-
ity and active-avoidance training, but only on the first trial of
each paradigm. That is, after the first retention trial of the
spaced active-avoidance trials, THC animals matched the perform-
ance of the controls. In addition, THC animals were no different
from controls on any of the trials of the subsequent massed
active-avoidance test at the end of 8 months. Moreover, THC ani-
mals only differed from controls on the first test of open field
activity (although habituation affected scores of the controls
after the first session). Similarly, no differences in choice or
latency were found among groups in performance of the T-maze
reversal 2 weeks after the end of the THC treatments.
These very moderate effects of chronic THC on behavioral perform-
ance suggest that 8 mg/kg SC was not an effective high dose for
rats, at least under chronic conditions in which metabolism, e.g.,
clearance, and behavioral processes may be able to adapt. How-
ever, it is also highly possible that the tasks used to test the
animals were too simple or were not appropriate for detecting
effects of THC.
Neuroanatomical methods. Following the behavioral tests, animals
were deeply anesthetized and perfused intracardially with an
aldehyde solution. The brains were then prepared and trimmed for
light and electron microscopy by methods outlined below.
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All quantitative morphometric analyses were conducted blind, using
coded slides and micrographs, and all statistical analyses were
performed by determining the mean value for each animal, and
averaging these individual mean values to obtain the group mean.
Thus, the statistical populations were equal to number of animals,
for all statistical tests (analyses of variance).
Tissue preparation and sampling. The ultrastructural analyses
conducted in this study were among the larger quantitative elec-
tron microscopic (EM) analyses in the field, and involved counting
and measuring well over 5,000 synapses, performing point-counting
analyses on nearly 1,000 micrographs, and measuring areas for hun-
dreds of glial inclusions and glial profiles. However, the tissue
sampled by our procedures still represented only a tiny fraction
of total hippocampal neuropil. Thus, it was essential to use
highly systematic and consistent procedures in preparing, section-
ing, and analyzing the tissues. After fixation, we dissected out
the hippocampus and cut transverse, 250-µm-thick slices from the
middle of the septotemporal axis of the structure. Based on cell
layer patterns visualized under a dissecting microscope, and on
the septotemporal location, a consistently similar slice was
selected from each animal for analysis. This slice was then de-
hydrated, stained, and embedded in Araldite according to standard
EM procedures. The embedded tissue was trimmed on a plane perpen-
dicular to the medial-lateral axis of the slice and parallel to
the CA1 apical dendrites, on a line through CA1 and the dentate
gyrus (using consistent landmarks of the pyramidal and granule
cell layers). Semithin (1 µm) and thin sections (60 nm; silver-
gray interference color, stained with uranyl acetate and lead
citrate) were then cut from the block.
Electron micrographs were obtained from the apical dendritic re-
gion of CA1 (stratum radiatum), midway between the pyramidal cell
somal layer (stratum pyramidale) and the fibers of the perforant
path (stratum moleculare). This is the main terminal field for
the Schaffer collateral-commissural pathway (e.g., Swanson et al.
1978). A series of 20 micrographs per subject was shot in a
planned sequence across this region, at an initial magnification
of 12,500 X. The micrographs were photographically enlarged to
32,000 X for analysis. Another five micrographs were shot of the
five largest glial cell processes on the sections. Criteria for
acceptable fixation quality were normal, unswollen mitochondria,
sharp membranes with little intercellular space, well-dispersed
synaptic vesicles within the synaptic terminals, and normal-
appearing myelin. Tissues not meeting these criteria were
excluded from the analysis.
Light microscopy. The nucleoli of pyramidal cells were counted
across the stratum pyramidale on at least five semithin sections
per animal. Only neurons that were clearly within the pyramidal
somal layer were counted. The width of this cell layer on each
section was measured with a calibrated eyepiece, and data were
expressed as neurons/100 µm stratum pyramidale length.
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Nucleolar diameters and length of stratum radiatum, i.e., length
of apical dendrites, also were measured for each animal, in order
to ensure (1) that nucleolar diameter was not changed by the
treatment (since larger diameter structures are more likely to be
counted) (cf. Weibel 1979), and (2) that changes in overall struc-
ture size (which can affect neuronal density) had not occurred.
Electron microscopy. Synaptic active zones were defined as dark
paramembranous densities associated with at least two synaptic
vesicles. The total number of "edge synapses," i.e., synapses at
the edge of a micrograph, was divided by 2 before being included
in the count, to avoid overestimation of synaptic density (since
edge synapses theoretically appear in more than one micrograph).
Each active zone length was measured, using a digitizing pad and
morphometric software and hardware (Bioquant), and was simultane-
ously coded for the type of terminal with which it was associated.
Terminals were categorized as simple axospinous, perforated, axo-
dendritic, or multiple spine (cf. Peters et al. 1976). Multiple
spine synapses are characterized by two spines in contact with one
terminal. Mean active zone length was calculated separately for
each category for each animal.
The number of synapses per unit volume [Nv] can be estimated from
the number of synapses per area [Na] of micrograph, using stereo-
logical correction factors. That is, if synapses are signifi-
cantly larger than a fraction of the section thickness, they will
theoretically often be present in two or more sections, and will,
therefore, be overestimated. To correct for this, the average
length of synapses in micrographs (d) is incorporated with section
thickness (t) into the denominator of the formula for converting
Na to NV (Weibel 1979):
Since each individual synaptic category was analyzed separately
(which substantially reduces variability in trace length), the co-
efficients of variation for individual categories were well below
20 percent (cf. Weibel 1979). and the separate synaptic categories
were, therefore, treated as monodispersed populations in our
analyses. The total Nv was determined by adding the NV's of the
individual categories together.
Estimates of relative volume for each element of the neuropil were
determined using a 10 x 12 grid overlay on each micrograph. The
area immediately under each intersection of the grid was examined
and categorized for the element of neuropil it contained. Neuro-
pi1 elements were classified as terminal, axon, dendritic spine,
dendritic shaft, glial process, or unknown.
The volume fraction of each element in the neuropil was determined
for each subject from the fraction of test points [Pp] that were
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classified as a given element of neuropil. That is. the fraction
of test points [Pp] that cover a given element on a two-
dimensional representation is an unbiased estimator of the frac-
tional volume  [Vv] of that element (Weibel 1979), expressed as:
Mean volumes (v) for terminal and spine elements were readily cal-
culated by combining the above measures, i.e., dividing the volume
fractions [Vv] by the appropriate NV for each element:
Neuroanatomical Results
A significant decrease in hippocampal pyramidal cell density was
found in the high-dose THC animals. The effect could be seen
readily in some high-dose animals even without quantitative analy-
sis. In several other high-dose animals, however, neuronal counts
were within the range of the control group. Studies in which
plasma hormones and THC are correlated with brain anatomic changes
in the same animals may help to clarify the bases of these indi-
vidual differences.
Quantitative EM analyses revealed no major changes in synaptic
ultrastructure in THC-treated animals, despite the decrease in
neuronal density. However, a tendency for mean lengths to be
larger was seen in several categories for the high-dose group. In
addition, a nearly significant tendency toward more multiple spine
synapses was seen in high-dose THC-treated animals.
It has previously been found that multiple spines are more preva-
lent in the hippocampus during the synaptic reinnervation that
follows a lesion (McWilliams and Lynch 1984; Steward and Vinsant
1983), perhaps reflecting remodelling or axon-sprouting phenomena.
Conceivably, such compensatory activity could obscure changes
caused by a gradual and mild loss of neurons induced by THC. Sub-
sequent studies with higher doses of THC might accentuate or clar-
ify this effect, and could therefore yield important clues to the
nature of synaptic plasticity in the adult brain.
Although THC treatment did not substantially affect synaptic
density, it did alter EM measures of astrocyte reactivity. Dark,
membranous inclusions were present frequently in hippocampal
astrocyte cytoplasm in THC animals, and a greater fraction of the
cytoplasm of astrocytes was occupied by such inclusions in THC-
treated animals. Similar inclusions, vacuoles. and globules
increase substantially during normal aging (Landfield et al.
1981b; Vaughan and Peters 1974; Wisniewski and Terry 1973) or
following experimentally induced brain lesions (e.g., Cook and
Wisniewski 1973; Mugnaini et al. 1976).
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CONCLUSIONS AND FUTURE QUESTIONS
The results of the long-term studies indicate that chronic expo-
sure of young-mature subjects (of a mammalian species) to moderate
doses of delta-9-THC is associated with reduced neuronal density
and increased glial reactivity in the hippocampus. The higher
dose level (8 mg/kg) was compatible with near-normal function on
an active-avoidance task and near-normal food/water intake, and
therefore does not seem to induce extreme sedation or toxicity,
Despite the decline in neuronal density, synaptic density was not
found to be decreased by THC, although a nonsignificant trend
toward an increase in multiple spine contacts, i.e., two spines
per terminal, was observed. This observation may reflect synaptic
remodelling, sprouting, or compensation for terminal loss.
It is not clear why we did not observe an overall decline in
hippocampal synaptic density in THC-treated rats, similar to that
described in a recent abstract by Scallet et al. (1986). Further
studies may pinpoint the methodological or rat strain factors that
account for these differences.
Many aspects of blood chemistry were normal in our THC-treated
rats, although cholesterol, glucose, and possibly uric acid and
creatinine were elevated, while plasma protein and albumin were
decreased. Some of these effects also have been observed in other
studies (e.g., Rosenkrantz et al. 1975). In addition, "stress"
hormones such as ACTH and corticosterone were elevated in our THC-
treated rats. Interestingly, many of these same blood chemistry
and hormonal changes have been found in aged rats, as noted above.
The glial and neuronal density changes are extremely similar to
those which we have previously found to occur during normal aging
in rats. We have shown that these changes can be retarded or pre-
vented by chronic adrenalectomy (Landfield et al. 1979; Landfield
et al. 1981a). Therefore, of particular interest in this regard
was the observation that the THC treatment resulted in an eleva-
tion of plasma ACTH and corticosterone.
One hypothesis that might account for these findings is that THC
may bind to steroid receptors, mimicking the effect of gluco-
corticoids (e.g., Rawitch et al. 1977; Solomon et al. 1976; Szara
1973), thereby accelerating brain aging. An alternative possibil-
ity is that THC might increase ACTH release, possibly by interfer-
ing with negative feedback inhibition in the adrenal-pituitary
axis (Drew and Slagel 1973), or by more direct effects, thereby
elevating endogenous corticosterone levels. In turn, higher
corticosterone could induce the brain changes.
However, if one or the other of the above hypotheses is correct,
then it is not obvious why synaptic density was not reduced with
THC, or why no residual effects on maze-reversal learning were
found, since both effects are seen (albeit subtly) in aged rats.
One possibility is that, because the highest dose of THC was not
particularly high in effective terms, the young animals in this
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study were able to compensate for brain changes by learning and/or
an axon-sprouting-dependent increase in multiple synapses. That
is, young rats may be able to compensate more effectively for THC-
induced cell loss than aged rats are able to compensate for age-
related cell loss, perhaps because of an age-related decline in
adaptive capacity. Thus, cell loss in young animals might result
in morphological or behavioral patterns that differ from those
caused by cell loss in aged animals, even if the cell loss results
from relatively similar cellular mechanisms.
As a corollary to this view, it may be that rats chronically
exposed to THC during early life will enter the later stages of
life, e.g., over 20 months of age, with their brains closer to a
"threshold" of pathology than will same-age animals not previously
exposed to THC. Consequently, brain aging may be substantially
more severe in THC-exposed rats than in same-age controls (due to
either additive or synergistic effects between THC exposure and
aging mechanisms), even if the animals have been withdrawn from
THC for prolonged periods. Alternatively, some aspects of THC
effects may be gradually reversible over prolonged periods, or, at
least, normal aging processes may cause brain pathology in non-
exposed animals to "catch up" to the pathology in THC-exposed
animals.
In summary, there is increasing but not yet conclusive evidence
that chronic THC exposure may interact with glucocorticoid systems
and increase the rate at which aginglike anatomical changes devel-
op in the brain. However, the morphological effects of THC on the
brain appear to be subtle and gradual, and testing the various
hypotheses regarding the mechanisms of these changes will likely
require extensive and painstaking quantitative analyses in animals
treated for prolonged periods.
REFERENCES
Adelman, R.C., and Roth, G.S., eds. Endocrine and Neuroendocrine
Mechanisms of Aging. Boca Raton, FL: CRC Press, 1982. 216pp.
Applegate, M.E; Campbell, G.; and Landfield, P.W. Reorganization
of ultrastructure in aging rat hippocampus: A stereological
analysis. Soc Neurosci Abstr 10:450, 1984.
Braude, M.C.,and Ludford, J.P., eds. Marijuana Effects on the
Endocrine and Reproductive Systems. National Institute on Drug
Abuse Research Monograph 44. DHHS Pub. No. (ADM) 84-1278.
Washington, DC: Supt. of Docs., U.S. Govt. Print. Off., 1984.
129pp.
Brody, H. Aging of the vertebrate brain. In: Rockstein, M., and
Sussman, M., eds. Development and Aging in the Central Nervous
System. New York: Academic Press, 1973. pp. 121-133.
Campbell, K.A.; Foster, T.C.; Hampson, R.E.; and Deadwyler, S.A.
Effects of delta-9-tetrahydrocannabinol on sensory evoked dis-
charges of granule cells in the dentate gyrus of behaving rats.
J Pharmacol Exp Ther 3:941-945, 1986.
153
Cook, R.D., and Wisniewski, H.M. The role of oligodendroglia and
astroglia in Wallerian degeneration of the optic nerve. Brain
Res 61:191-206, 1973.
Dewey, W.L.; Peng, T.C.; and Harris, L.S. The effects of 1-trans-
delta-9-tetrahydrocannabinol on the hypothalamo-hypophyseal-
adrenal axis of rats. Eur J Pharmacol 12:382-384, 1970.
Drew. W.G., and Slagel, D.E. Delta-9-THC: Selective impairment
of corticosterone uptake by limbic structures of the rat.
Neuropharmacology 12:909-914, 1973.
Finch, C.E. The regulation of physiological changes during mamma-
lian aging. Rev Biol 51:49-83, 1976.
Finch, C.E., and Landfield, P.W. Neuroendocrine and autonomic
functions in aging mammals. In: Finch, C.E., and Schneider,
E.L., eds. Handbook of the Biology of Aging. 2nd edition. New
York: Van Nostrand Reinhold Company, 1985. pp. 567-594.
Foy, M.R.; Teyler, T.J.; and Vardaris; R.M. Delta-9-THC and 17-ß-
estradiol in hippocampus. Brain Res Bull 8:341-345, 1982.
Gispen, W.H.; van Ree, J.M.; an deWied, D. Lipotropin and the
central nervous system. Int Rev Neurobiol 20:209-250, 1977.
Harris, L.S.; Dewey, W.L.; and Razdan, R. K. Cannabis. In: Born,
G.V.R.; Eichler, O.; Farah, A.; Herken: H.;
eds. Handbook of Experimental Pharmacology. New York:
Springer Verlag, 1976. pp. 371-429. 
and Welch. A.D..
Harper, J.W.; Heath, R.G.; and Myers, W.A. Effects of Cannabis
sativa on ultrastructure of the synapse in monkey brain. J
Neurosci Res 3:87-93. 1977.
Heath, R.G. Fitzjarrel, A.T.; Garey. R.E.; and Myers, W.A.
Chronic marihuana smoking: Its effect on function and structure
of the primate brain. In: Nahas. G.G., and Paton, W.P.M., eds.
Marihuana: Biological Effects. New York: Pergamon Press,
1979. pp. 713-730.
Kolodny, R.C.; Master, W.H.; Kolodny, A.B.; and Toro, G. Depres-
sion of plasma testosterone levels after chronic intensive
marihuana use. New Eng J Med 290:872-874, 1974.
Landfield. P.W. An endocrine hypothesis of brain aging and stud- 
ies of brain-endocrine correlations and monosynaptic neuro-
physiology during aging. In: Finch, C.; Potter, D.; and Kenny,
A., eds. Parkinson's Disease II. Aging and Neuroendocrine 
Relationships: New York: Plenum Press, 1978. pp. 179-197.
Landfield, P.W.; Waymire, J.L.; and Lynch, G.S. Hippocampal aging
and adrenooloiiicoids: Quantitative correlations. Science
202:1098-1102, 1978.
Landfield P.W.; Wurtz, C.; Lindsey, J.D.; and Lynch, G. Long-term
adrenalectomy reduces some morphological correlates of brain
aging. Soc Neurosci Abstr 5:7, 1979.
Landfield, P.W.; Baskin, R.K.; and Pitler, T.A. Brain aging cor-
relates: Retardation by hormonal-pharmacological treatments.
Science 214:581-584, 1981a.
Landfield, P.W.; Braun. L.D.; Pitler, T.A.; Lindsey, J.D.; and
Lynch, G. Hippocampal aging in rats: A morphometric study of
multiple variables in semithin sections. Neurobiol Aging 2:265-
275, 1981b.
154
Lewis, B.K., and Wexler, B.C. Serum insulin changes in male rats
associated with age and reproductive activity. J Gerontol
20:204-212, 1974.
Lindsey, J.D.; Landfield, P.W.; and Lynch, G. Early onset and
topographical distribution of hypertrophied astrocytes in
hippocampus of aging rats: A quantitative study. J Gerontol
34:661-671, 1979.
Maier, R., and Maitre. L. Steroidogenic and lipolytic effects of
cannabinols in the rat and the rabbit. Biochem Pharmacol
24:1695-1699. 1975.
McEwen, B.S.; Gerlach, J.L.; and Micco, D.J. Putative gluco-
corticoid receptors in hippocampus and other regions of the rat
brain. In: Isaacson, R.L., and Pribram. K.H., eds. The
Hippocampus. Vol. 1. New York: Plenum Press, 1975.
pp. 285-313.
McWilliams, J.R., and Lynch, G. Synaptic density and axonal
sprouting in rat hippocampus: Stability in adulthood and
decline in late adulthood. Brain Res 294:152-156, 1984.
Mugnaini, E.; Walberg, R.; and Brodal, A. A mode of termination
of primary vestibular fibres in the lateral vestibular nucleus,
an experimental electron microscopical study in the cat. Exp
Brain Res 4:187-211, 1976.
Nahas, G.G., and Paton, W.P.M., eds. Marihuana: Biological
Effects. New York: Pergamon Press, 1979.
Okey, A.B., and Bondy, G.P. Delta-9-tetrahydrocannabinol and 17ß-
estradiol bind to different macromolecules in estrogen target
tissues. Science 200:312-314, 1978.
Peters, A.; Palay, S.L.; and Webster, H.D. The Fine Structure of
the Nervous System. Philadelphia: W.B. Saunders Company, 1976.
406pp.
Pfaff, D.W.; Silva. M.J.A.; and Weiss, J.M. Telemetered recording
of hormonal effects on hippocampal neurons. Science 172:394-
395, 1971.
Rawitch, A.B.; Schultz, G.S.; Ebner, K.E.; and Vardaris, R.
Competition of delta-9-tetrahydrocannabinol with estrogen in rat
uterine estrogen receptor binding. Science 197:1189-1191, 1977.
Renaud, L.P., and Padjen, A. Electrophysiological analysis of
peptide actions in neural tissue. In: Hughes, J., ed.
Centrally Acting Peptides. Baltimore: University Park Press,
1978.  pp. 59-84.
Rosenkrantz, H.; Sprague, R.A.; Fleischman, R.W.; and Braude, M.C.
Oral delta-9-tetrahydrocannabinol toxicity in rats treated for
periods up to six months.
1975.
Toxicol Appl Pharmacol 32:399-417,
Sapolsky, R.M.; Krey, L.C.; and McEwen, B.S. The adrenocortical
stress-response in the aged male rat: Impairment of recovery
from stress. Exp Gerontol 18:55-64, 1983.
Sapolsky, R.M.; Krey, L.C.; and McEwen, B.S. Prolonged gluco-
corticoid exposure reduces hippocampal neuron number: Implica-
tions for aging. J Neurosci 5:1221-1229, 1985.
155
Scallet. A.C.; Uemura, E.; Andrews, A.; Ali. S.F.; McMillan, D.E.;
Paule, M.G.; Brown, R.M.; and Slikker, W., Jr. Chronic delta-g-
tetrahydrocannabinol (THC) reduces pyramidal neuron size and
synaptic density in rat hippocampus. Soc Neurosci Abstr 12:611,
1986.
Simpkins, J.W., and Estes, K.S. Role of monoaminergic neurons in
the age-related alterations in anterior pituitary hormone secre-
tion. In: Nemeroff, C.B., and Dunn, A.J., eds. Peptides,
Hormones and Behavior. New York: SP Medical and Scientific
Books, 1983. pp. 823-863.
Smiley, K.A.; Karler, R.; and Turkanis, S.A. Effects of cannabi-
noids on the perfused rat heart. Res Commun Chem Pathol
Pharmacol 14:659-675, 1976.
Solomon, J.; Cocchia, M.A.; Gray, R.; Shattuck, D.; and Vossmer,
A. Uterotrophic effect of delta-9-tetrahydrocannabinol in
ovariectomized rats. Science 192:559-561, 1976.
Steward, 0.. and Vinsant, S.L. The process of reinnervation in
the dentate gyrus of the adult rat: A quantitative electron
microscopic analysis of terminal proliferation and reactive
synaptogenesis.
Stiglick, A.,
J Comp Neurol 214:370-386, 1983.
and Kalant, H. Residual effects of prolonged can-
nabis administration on exploration and DRL performance in rats.
Psychopharmacology (Berlin) 77:124-128, 1982.
Swanson, L.W.; Wyss, J.M.; and Cowan, W.M. An autoradiographic
study of the organization of intrahippocampal association path-
ways in the rat. J Comp Neurol 181:681-716, 1978.
Szara, S. Delta-9-tetrahydrocannabinol--potential precursor of
"false hormones"? In: Ban, T.; Boissier, J.; Gessa, G.;
Heimann, H.; and Hollister, L., eds. Psychopharmacology, Sexual
Disorders and Drug Abuse. Amsterdam: North-Holland Publishing,
1973. pp.707-709.
Thompson, G.R.; Fleischman, R.W.; Rosenkrantz, H.; and Braude,
M.C. Oral and intravenous toxicity of delta-9-tetrahydrocanna-
binol in rhesus monkeys.
1974.
Toxicol Appl Pharmacol 27:648-665,
Turkanis, S.A., and Karler, R. Effects of delta-9-tetrahydro-
cannabinol on cat spinal motoneurons. Brain Res 288:283-287,
1983.
Vaughan, D.W., and Peters, A. Neuroglial cells in the cerebral
cortex of rats from young adulthood to old age: An electron
microscope study. J Neurocytol 3:405-439, 1974.
Weibel, E.R. Stereological Methods Vol. 1: Practical Methods for
Biological Morphometry. New York: Academic Press, 1979.
aging. In:
Wexler, B.C. Comparative aspects of hyperadrenocorticism and
Everitt, A.F., and Burgess, J.A., eds.
Hypothalamus Pituitary and Aging. Springfield, IL: Charles C.
Thomas, 1976. pp. 333-361
Wisniewski, H.M. and Terry, R.D. Morphology of the aging brain,
human and animal. In: Ford, D.M., ed. Progress in Brain
Research. Vol. 40. Amsterdam: Elsevier, 19 3. pp. 167-186.
156
ACKNOWLEDGMENTS
Research described in this paper was supported in part by research
grant DA 03637 from the National Institute on Drug Abuse. The
essential and extensive research contributions of Lisa Cadwallader
and Sharon Vinsant are greatly appreciated.
AUTHOR
Philip W. Landfield, Ph.D.
Department of Physiology and Pharmacology
Bowman Gray School of Medicine
Wake Forest University
Winston-Salem, NC 27103
157
Mechanisms of Tolerance to
Opiates in Locus Coeruleus
Neurons
Macdonald J. Christie, John T. Williams, and
R. Alan North
INTRODUCTION
The phenomena of tolerance and physical dependence resulting from
the repeated administration of opioids have been observed in a
variety of experimental models. Despite a considerable research
effort, however, the underlying molecular mechanisms remain to be
described. Difficulties in identifying appropriate biochemical
processes have arisen predominantly from a lack of experimental
models for the study of tolerance and dependence in isolation.
Thus, studies of opioid tolerance are often confounded by the
presence of associated physical dependence, the presence of multi-
ple opioid receptor subtypes, or the measurement of a biological
effect which is either remote from the opioid-sensitive neuron or
is rendered grossly unphysiological by experimental manipulations.
Intracellular recording from neurons of the locus coeruleus (LC)
in vitro provides a method that avoids these difficulties and
thereby offers a useful experimental approach to the mechanisms
underlying opioid tolerance.
MECHANISMS OF ACUTE OPIOID ACTIONS ON LC NEURONS
An inherent advantage of the study of opioid actions using intra-
cellular recordings of membrane potential or ionic conductance
from single neurons is that the measured physiological response is
in close temporal and spatial proximity to opioid receptor activa-
tion. The effects of opioids on single LC neurons are illustrated
in figure 1. Intracellular recordings were made as described in
detail elsewhere (North and Williams 1985). A thin slice of rat
pons containing the nucleus was superfused with a solution similar
in composition to cerebrospinal fluid. When the opioid agonist
Met-enkephalin (ME) was added to this solution, the spontaneous
firing of the neuron was inhibited and the membrane hyperpolarized
in a concentration-dependent manner (figure 1A). Figure 1B illus-
trates membrane currents induced by ME recorded under voltage
clamp. Such measurements of membrane current allow direct calcu-
lation of membrane conductance, which represents the proportion of
open ionic channels. Using these methods, it has been shown that
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FIGURE 1. Intracellular recordings of the action of ME on single
LC neurons
NOTE: (A) This shows that the tiring of a spontaneously active LC neuron is
inhibited and the membrane Is hyperpolarized when ME is present In the
solution that superfuses the brain slice. Upward deflections are action
potentials (full amplitude not shown), and downward deflections are after
hyperpolarizations. (B) Recording of membrane current from a rat LC neuron
voltage clamped at -60 mV. The four traces show the membrane currents
caused by various concentrations of ME (outward current Is upward). Down-
ward deflections on these records are the currents flowing in response to
repeated application of a fixed hyperpolarizing pulse. The increase in
amplitude of the current during the presence of ME indicates that the mem-
brane conductance is increased.
opioids produce a hyperpolarization of LC neurons by increasing
their membrane conductance to potassium ions (Williams et al.
1982; North and Williams 1985).
A further advantage of this procedure for the investigation of
opioid tolerance is that opioids increase potassium conductance in
LC neurons by interacting with a single class of opioid receptors.
This conclusion is largely based on the use of selective opioid
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antagonists to characterize receptors by the method of
Arunlakshana and Schild (1959). Thus, the dissociation equi-
librium constant (Ke) of naloxone, derived from Schild analysis,
using a variety of opioid agonists (ME, [D-Ala2 ,D-Leu5]-enkephalin
(DADLE), normorphine, [D-Ala2,MePhe4,Gly5-ol]-enkephalin (DAGO))
was 2 to 3 nM, indicative of a v-receptor (Williams and Narth
1984; Williams and North, unpublished observations). The Ke of
the selective antagonist bis-alyl-tyr-aib-aib-phe-leu
(ICI 174864) for receptors on LC neurons was 6 µM, which is much
larger than the value obtained for tissues containing only
receptors and is also consistent with the presence of µ-receptors..
Furthermore, the highly selective agonist [D-Pen2,D-pen5]-
enkephalin and the selective K-agonist trans-(+-)3,4-dichloro-N-
methyl-[2-(1-pyrrolidinyl)cyclohexyl] benzeneacetamide methane
sulfonate (U50488H) were ineffective in inhibiting LC neurons and
increasing potassium conductance at concentrations as high as
10 µM (Williams and North 1984; Williams and North, unpublished
observations).
The mechanism of coupling between u-receptors and potassium
channels has not been directly demonstrated in LC neurons, but
several lines of evidence strongly suggest that a pertussis toxin-
sensitive guanine nucleotide-binding protein (G-protein) is
involved (although inhibition of adenylate cyclase is not).
u-Agonist binding to brain membrane preparations is sensitive to
guanosine-triphosphate (GTP) and magnesium (Chang et al. 1981).
suggesting a G-protein interaction , and treatment of rats with
pertussis toxin has been shown to eliminate opioid-induced hyper-
polarization of LC neurons (Aghajanian and Wang 1986). Finally,
although there is evidence that opioid receptors are negatively
coupled to adenylate cyclase in various systems (West and Miller
1983). the hyperpolarization or outward current caused by ME was
not influenced by the adenylate cyclase activator forskolin (North
and Williams 1985). or by the metabolically stable analogs of
cyclic adenosine 3',5'-monophosphate (CAMP) 8-bromo-CAMP and
dibutyryl-CAMP (Williams and North, unpublished observations),
suggesting that changes in intracellular levels of CAMP are not
involved in the coupling of u-receptors to potassium channels. A
report of inhibition of opioid hyperpolarizations of LC neurons by
CAMP analogs (Andrade and Aghajanian 1985) was subsequently shown
to be the result of the activation of an inward current by these
compounds (Wang and Aghajanian 1986).
Adrenoceptors on LC neurons also appear to be coupled via a
pertussis toxin-sensitive G-protein to the same set of potassium
channels as those activated by opioids in LC neurons. Like hyper-
polarizations induced by opioids, those caused by adrenoceptor
agonists were also abolished by pretreatment of animals with
pertussis toxin (Wang and Aghajanian 1986). and adrenoceptor
agonists increased a potassium conductance which had the same
properties and the same maximum value as that caused by opioids
(North and Williams 1985; Williams et al. 1985). Experiments in
which an opioid and an agonist were superfused together indi-
cated that the same potassium conductance is increased by both
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agonists. This permits localization of any adaptive processes
following chronic opioid treatment either to mechanisms common to
receptors, or selectively to µ-receptors (figure 2).
FIGURE 2. Model of the mechanism of action of µ- and -agonists
on LC neurons (see text for details)
NOTE: Both µ- and -receptors (and perhaps other receptors) open potassium chan-
nels. This action involves a G-proteln. Although activation of these
receptors can also be shown under some circumstances to inhibit adenylate
cyclase, this seems not to be Involved in the opening of potassium
channels.
These studies have largely resolved the mechanisms involved in the
primary physiological action of opioids on LC neurons. The aim of
the experiments described below was to use similar procedures to
record membrane currents from LC neurons (isolated from morphine-
tolerant animals) to study the changes in the properties of µ-
receptors, potassium channels, and the coupling between these
elements that occur as a consequence of long-term morphine
administration.
TOLERANCE BUT NOT DEPENDENCE FOLLOWING CHRONIC MORPHINE TREATMENT
Concentration-response relationships to DAGO and normorphine
demonstrated the development of tolerance to opioids following
chronic treatment of rats with morphine (Christie et al., in
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press). Animals were implanted with a total of 16 morphine
pellets (75 mg base) over 7 days. Although the maximal outward
current induced by DAGO was not significantly affected, the EC50
was shifted to the right twofold as a result of chronic morphine
treatment. In control tissue, the maximum outward current induced
by normorphine (30 µM) was similar to that induced by DAGO. The
maximum response evoked by normorphine in tissue from morphine-
treated rats, by contrast, was only about one-half of that pro-
duced by DAGO. and the EC50 was shifted to the right twofold.
Therefore, the degree of tolerance to DAGO was about twofold
throughout the concentration-response curve, whereas the degree of
tolerance to normorphine ranged from about sixfold at the foot of
the concentration-response curve to infinite at about one-half of
the initial maximum response. These results were not a conse-
quence of the presence of residual morphine in the brain slice,
because the observed tolerance persisted for up to 6 hours after
removal of tissue from the animal and could not be mimicked by
preincubation of the slice in morphine (10 µM, 1 hour).
No manifestations of physical dependence were observed in indi-
vidual LC neurons following chronic morphine treatment. In the
absence of opioid agonists, naloxone was without effect on mem-
brane current, or the frequency of spontaneous action potentials
in either control tissue or tissue from morphine-treated rats. In
the presence of opioids, naloxone (1 µM) simply reversed the mem-
brane hyperpolarization or outward current, even when the super-
fusion of the agonist had been continued for up to 4 hours (figure
3). That is to say, at the level of the individual neuron, nalox-
one did not produce any effect on the properties of the cell other
than a simple reversal of the ongoing action of morphine, whether
or not the neuron was removed from a rat which had been chron-
ically treated with morphine. These results are consistent with
extracellular recordings from LC slice preparations (Andrade et
al. 1983). One set of in vivo experiments originally suggested a
modest increase in firing rate of LC neurons following systemic or
iontophoretic application of naloxone in chronically treated ani-
mals (Aghajanian 1978). This excitation probably results from a
reversal of the action of circulating morphine and/or from an
increase in the activity of excitatory afferents to LC during in
vivo experiments. A dissociation of opioid tolerance from physi-
cal dependence has also been reported in preparations of the mouse
vas deferens (Muster et al. 1982).
ELIMINATION OF SPARE RECEPTORS FOLLOWING CHRONIC MORPHINE
TREATMENT?
The observation that tolerance to normorphine was more pronounced
than that to DAGO (Christie et al., in press) might appear anoma-
lous if both agonists were interacting with the same type of opi-
oid receptors on LC neurons. However, such a discrepancy would be
expected if chronic morphine treatment resulted in a loss of the
number of opioid receptors on the neuronal surface, because in
this case the degree of tolerance to a particular agonist would
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FIGURE 3. The effect of naloxone on the membrane properties of
two LC neurons
KEY: Top trace: Record from a cell removed from a naive rat. Bottom trace:
Record from a cell taken from a rat which had been chronically treated with
morphine.
NOTE: Slices from control and treated rats were superfused with morphine for 3 to
4 hours prior to addition of naloxone (Nal) to the superfusion solution.
Naloxone produced a simple reversal of the hyperpolarizing action of mor-
phine in both cells. The longer period of firing in the lower trace pre-
sumably results from the delayed onset of the action of morphine as the
naloxone washes out as a result of the tolerance to morphine.
depend on the fraction of receptors which that agonist must nor-
mally occupy to produce a given effect. For instance, if nor-
morphine is a partial agonist, i.e., it must occupy a large
fraction of the receptors on the cell surface in order to produce
a maximal increase in potassium conductance, and DAGO is a full
agonist, i.e., it can produce a maximal effect on potassium con-
ductance while occupying only a small fraction of the receptors on
the neuron, then the action of normorphine would be more sensitive
than the action of DAGO to the loss of receptors. Such an effect
of chronic morphine treatment would be formally analogous to the
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acute elimination of receptors by treatment with an irreversible
antagonist, which is often done to measure spare receptor popula-
tions (receptor reserve) and to estimate the affinity constant of
agonists (Stephenson 1956; Furchgott and Bursztyn 1967).
Several lines of evidence suggest that the effect of chronic
morphine treatment is very similar to that of acute irreversible
antagonism--reduction of spare receptors or receptor reserve.
First, full activation of potassium channels in normal LC neurons
occurs with low fractional occupancy of u-receptors by full ago-
nists (Williams and North 1984). Second, normorphine must occupy
a greater fraction of p-receptors to elicit an equivalent response
to that produced by DAGO, i.e., it possesses lower efficacy
(Miller et al. 1986). Thus, in control tissue, both normorphine
and DAGO are capable of eliciting the same maximal response, since
there is considerable receptor reserve. In treated tissue, nor-
morphine is not capable of eliciting the same maximal response as
DAGO because fewer recognition sites are present. An alternative
explanation, presented below. is that the coupling of p-receptors
to potassium channels has become less effective.
This interpretation was further tested by irreversible antagonism
of a fraction of the u-receptor population with ß-chlornaltrex-
amine (CNA, 30 nM for 30 minutes). If chronic morphine treatment
eliminates spare u-receptors, then the actions of both normorphine
and DAGO should be more sensitive to CNA in neurons from animals
made tolerant to morphine. This was found to be the case
(Christie et al., in press). The maximal outward current induced
by both DAGO and normorphine was reduced to a greater extent by
CNA in tissue from chronically morphine-treated rats than in
control preparations.
unchanged.
The Ke of naloxone for the µ-receptors was
These results are consistent with the suggestion that
there are fewer µ-receptors available on LC neurons from rats
chronically treated with morphine.
Elimination of spare receptors does not necessarily imply a reduc-
tion of the number of opioid recognition sites on the surface of
the neuron, but could also be due to a less efficient coupling be-
tween u-receptors and potassium channels. If we assume that elim-
ination of surface recognition sites is solely responsible, i.e.,
chronic morphine treatment is equivalent to partial irreversible
antagonism, then Furchgott analysis (Furchgott and Bursztyn 1967)
predicts that a 70 to 80 percent reduction in U-receptor density
would be required to produce the observed shift and reduction in
the maximum of the normorphine concentration-response curve. This
possibility seems unlikely because opioid binding studies have
generally failed to observe any reduction in the density of bind-
ing sites following chronic morphine treatment (Creese and Sibley
1981). Thus, the reduction in u-receptor reserve following chron-
ic treatment appears to be due to a postreceptor adaptation.
Chavkin and Goldstein (1984) and Porecca and Burks (1983) arrived
at similar conclusions using the method of partial irreversible
antagonism in the morphine-tolerant guinea pig ileum preparation.
Because several processes intervene between opioid receptor occu-
pation and tissue response (muscle contraction) in that prepara-
tion, no conclusions could be drawn concerning the nature of the
postreceptor adaptation. Thus, it was not clear if the response
decrement was associated specifically with µ-receptors or opioid-
sensitive neurons, or if it was a more general tissue response.
OPIOID-INDUCED POTASSIUM CONDUCTANCE IS UNCHANGED FOLLOWING
CHRONIC MORPHINE TREATMENT
The membrane properties of LC neurons and the increase in conduct-
ance induced by maximal concentrations of DAGO were unaffected by
chronic morphine treatment, suggesting that the population of
potassium channels activated by opioids was not modified by chron-
ic morphine treatment. Spontaneous action potentials had ampli-
tudes close to 80 mV, rose from a "threshold" potential of -55 mV,
and had durations of about 1.5 ms; these properties were the same
in neurons from both groups of rats. Under voltage clamp, neurons
from both groups had the same conductances and showed the same
types of rectification (Williams et al. 1984).
The increase in conductance induced by maximal concentrations of
DAGO (3 µM) or ME (30 µM) was determined by constructing steady
state current-voltage relationships in the absence and presence of
agonist and then subtracting the resting conductance from that
found in the presence of agonist over the same potential range.
The increase in conductance induced by DAGO or ME was not signif-
icantly affected by chronic morphine treatment (Christie et al.,
in press). These results demonstrate that DAGO and ME were able
to activate fully the potassium conductance of LC neurons follow-
ing chronic morphine treatment and that the mechanism underlying
tolerance in LC neurons is confined to processes prior to the
mechanism by which full p-receptor agonists activate potassium
channels.
ADRENOCEPTOR ACTIONS FOLLOWING CHRONIC MORPHINE TREATMENT
Chronic morphine treatment did not change the effects of agonists
acting at adrenoceptors on LC neurons. The outward currents
induced by maximal concentrations of the full -agonists nor-
adrenaline (10 µM) and 5-bromo-6-[2-imidazolin-2-ylamino]-
quinoxaline (UK14304, 1 µM) were similar to those induced by DAGO
and ME and were not significantly affected by chronic treatment
(Christie et al., in press). The outward current induced by a
maximal concentration of clonidine was consistently less than that
induced by noradrenaline or UK14304 and was also not affected by
chronic morphine treatment. Because clonidine is incapable of
fully activating the receptor-mediated increase in potassium
conductance despite full receptor occupation, i.e., clonidine is a
partial agonist, it should be particularly sensitive to any reduc-
tion in coupling efficiency. Therefore, it can be concluded that
the mechanisms underlying tolerance to morphine are specific to µ-
receptors and/or their coupling to potassium channels, rather than
involving any mechanism common to both µ- and receptors.
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NALOXONE DISSOCIATION CONSTANT FOLLOWING CHRONIC MORPHINE
TREATMENT
Chronic morphine treatment was without effect on the Ke of nalox-
one at the -receptors. Concentration-response relationships for
DAGO or ME were constructed in the presence of increasing concen-
trations of naloxone in both control and treated tissue, and the
naloxone pA2 was determined by Schild analysis (Arunlakshana and
Schild 1959). It was similar in both groups, giving a Ke of 2 nM
(Christie et al., in press). This finding is supported by radio-
ligand binding studies which have also shown no change in antago-
nist binding Ke following chronic morphine treatment (Creese and
Sibley 1981). Several pharmacological studies which utilized
Schild analysis observed changes in naloxone affinity in vivo and
in vitro (Tallarida et al. 1979). but these studies generally
failed to account for the presence of residual morphine in the
tissue, the presence of multiple opioid receptor subtypes, or
signs of physical dependence in the preparations under
investigation.
CONCLUSIONS
In conclusion, the present results demonstrate that chronic treat-
ment of rats with morphine caused opioid tolerance but no signs
indicative of physical dependence in individual neurons of the rat
LC. The tolerance was the result of selective elimination of
spare µ-receptors. There was no effect on the naloxone Ke at the
µ-receptor, and there were no changes in the effects of agonists
at adrenoceptors or in the properties of the potassium conduct-
ance which couples to both of these receptors. Although this spe-
cific elimination of spare µ-receptors could be the consequence of
a reduced density of µ recognition sites on each neuron, available
evidence indicates that it is more likely due to a specific reduc-
tion in the efficiency of coupling of u-receptors to potassium
channels.
The reduction in the efficiency of coupling of µ-receptors to
potassium channels following chronic morphine treatment is con-
fined to mechanisms prior to those common to both µ- and
receptors. Because both µ- and receptors appear to couple to
potassium channels via a pertussis toxin-sensitive G-protein (see
above), one might speculate that the most likely mechanism of tol-
erance is the reduction in the ability of µ-receptors to couple to
the G-protein. Such a mechanism has a parallel in the mechanism
of homologous desensitization of receptors in NG 108-15 cells.
In that system, although receptor internalization occurs, it is
preceded by a homologous desensitization of agonist-induced inhi-
bition of adenylate cyclase (Law et al. 1983). which correlates
with a reduced ability of agonists to stimulate the GTPase
activity of a pertussis toxin-sensitive G-protein (Vachon et al.
1985). Similarly, homologous desensitization of ß-adrenoceptor-
stimulated adenylate cyclase in rat lung membranes precedes recep-
tor internalization and appears to be due to sequestration of
recognition sites into microdomains of the plasma membrane which
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are inaccessible to adenylate cyclase (Strasser et al. 1985). a
process involving receptor phosphorylation (Sibley et al. 1985).
Similar mechanisms could account for the reduced coupling of µ-
receptors to potassium channels in LC neurons following chronic
morphine treatment.
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Cholinergic Modulation of Sensory
Responses in Cerebral Cortex
John P. Donoghue
INTRODUCTION
The cerebral neocortex receives input from a number of systems
that are thought to act as modulators of cortical activity. These
systems are characterized anatomically by their widespread input
to the cortex and, where they have been studied, are associated
functionally with sleep, arousal, vigilance, and more generalized
activities. Widespread systems contrast with specific thalamo-
cortical input systems, such as the geniculostriate visual path-
way, which have highly localized axonal arbors in cortex and are
associated with the transmission of detailed place- and modality-
specific information. While the neurotransmitters of the specific
systems are still unknown, those for at least four widespread in-
put systems have been established: the norepinephrine (NE) input
from the locus coeruleus, the dopaminergic input from the mes-
encephalon, the serotonergic input from the raphe nuclei, and the
cholinergic (ACh) input from the basal forebrain area. The iden-
tification of transmitters for these systems has made it possible
to examine their role as modulators of cortical function by com-
bining pharmacological, behavioral, and electrophysiological
techniques.
This chapter will focus on the function of the cholinergic system
in cerebral cortex. This system has received considerable atten-
tion because it has been repeatedly linked to processes involved
in memory,learning, and synaptic modification in cerebral neo-
cortex.Fibers from the basal forebrain region provide the bulk
of the cortical cholinergic input, although there also appear to
be a small number of cholinergic neurons within the cortex itself,
at least in rodents (Jordan and Phillis 1972; Johnston et al.
1981; Wenk et al. 1980; Lehmann et al. 1980). While basal fore-
brain fibers have a widespread distribution to the entire cerebral
cortex, they exhibit a rough topography in their cortical projec-
tion (Kievit and Kuypers 1975; Divac 1975; Mesulam and Van Hoesen
1976; McKinney et al. 1983; Saper and Loewy 1980; Lamour et al.
1982a).These features of the basal forebrain input suggest that
single cholinergic neurons influence large cortical areas, but the
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system as a whole may be functionally and regionally segregated.
Lesions or drug manipulations that interfere wfth the normal
action of ACh alter the acquisition, storage, or retrieval of
information as measured in a variety of behavioral tasks in man
and other mammals (Davis et al. 1978; Deutsch 1971; Drachman 1977;
Friedman et al. 1983). ACh has also been implicated along with
norepinephrine in controlling the ability of experience to modify
cortical sensory response properties during development (Bear and
Singer 1986). Together, these results suggest that the mechanisms
for selective processing and storage of information in cortex are
closely tied to the cellular actions of ACh in cortex.
In this chapter, I will discuss the role of ACh as a modulator of
cortical cell excitability based on early electrophysiological
analyses of the effect of ACh on cortical spontaneous activity,
then I will present results of more recent experiments that take a
different approach to examine cholinergic function in cerebral
neocortex. These investigations show how the naturally evoked
discharge of neurons in the somatic sensory cortex is altered by
local iontophoretic application of ACh.
CHOLINERGIC EFFECTS ON THE DISCHARGE OF CORTICAL NEURDNS
General Effects on Background Activity
One common means to assay the function of a putative neuro-
transmitter is to test the effect of a local iontophoretic
application of that transmitter and related compounds on the
background discharge of a neuron. This procedure has been used
extensively to study cholinergic action in neocortex. Ionto-
phoretic application of ACh reportedly excites or inhibits the
background discharge of individual cortical neurons (Krnjevic and
Phillis 1963a; Krnjevic and Phillis 1963b; Krnjevic 1971; Krnjevic
et al. 1971; Spehlmann and Smathers 1974; Vazquez et al. 1969;
Randic et al. 1964; Phillis and York 1967). More recent studfes
have emphasized the predominantly excitatory actions of ACh
(Lamour et al. 1982b; Lamour et al. 1983) that appear to be a
consequence of a decrease in two or more specific membrane K+ con-
ductances (Krnjevic et al. 1971; Woody et al. 1978; McCormick and
Prince 1985). Despite the important contribution to our under-
standing of the pharmacological actions of ACh in cortex from
studies of background modulation, it has been difficult to estab-
lish the role of ACh in cortical information processing, learning,
memory, or other complex cortical processes with this type of
analysis.
Modulation of Sensory Responses by ACh
Another strategy has evolved to examine the potential modulatory
role for various widespread cortical inputs. Instead of examining
change in rate of background activity as a measure of drug action,
these studies have focused on the way modulators alter the pattern
of response or receptive field characteristics of cortical
neurons. This form of analysis has as its goal an understanding
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of the role of modulatory substances in cortical information
processing. In a series of seminal studies on transmitter action
in cerebral cortex, Krnjevic (Krnjevfc and Phillis 1961; Krnjevic
and Phillis 1963a; Krnjevic and Phillis 1963b) used local ionto-
phoretic glutamate application to test the ability of ACh to modi-
fy cell excitability. Doses of ACh that were insufficient to
alter spontaneous discharge rate nevertheless enhanced the excita-
tory response of a cortical neuron to glutamate application
(Krnjevic and Phillis 1963b). Since cortical afferent fiber sys-
tems, such as the specific thalamocortical system, are thought to
use transmitters that act in a manner similar to glutamate, these
results suggest an important modulatory role for ACh: the pres-
ence of ACh could enhance the response of cortical neurons to
sensory inputs. This form of modulation of synaptic strength
could form a basis for selective attention, intracortical filter-
ing, or, if synaptic strength changes were to persist, could
provide one mechanism for storing information.
Recent studies in my laboratory (Donoghue and Carroll 1987) have
employed the strategy of combining iontophoresis with single unit
recording to examine the form and distribution of cholinergic
modulation of sensory response properties of neurons located in
the whisker representation of the rat somatic sensory cortex (SI).
The highly ordered and modular organization of this system makes
it an attractive model for studies of functional organization in
cortex. In the rat, each whisker has a distinct representation in
SI cortex that can be visualized in tissue sections as aggregates
of granule cells in layer IV, each termed a "barrel" (Woolsey and
Van der Loos 1970). Each cell within this layer IV barrel re-
ceives its dominant sensory input from a single whisker, and the
actual pattern in which barrels are arranged in the cortex matches
the pattern of whisker follicles on the rat's face (Welker 1971;
Welker 1976; Simons and Woolsey 1979). We have examined choliner-
gic modulation of sensory responses in the SI barrel field be-
cause, using this system, it is possible to study the relationship
between a discrete cortical territory and its peripheral end
organ, because it is easy to deliver a controlled natural stimuli
to the whiskers in the cell's receptive field, and because func-
tional properties of cells in this area are being studied inten-
sively (Ito 1981; Simons 1978; Simons 1983; Simons 1985).
In our experiments, we are using the SI-whisker system as a model
to identify the way modulatory systems alter sensory processing in
the cortex. Specifically, we are examining four aspects of choli-
nergic modulatory action:
(1) How does ACh modify sensory responses of SI neurons?
(2) What receptor type mediates these effects?
(3) Are these effects localized to specific subsets of cortical
neurons?
(4) Does ACh produce a long-term change in sensory response?
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In the following sections, I will present results of some experi-
ments that address the first three questions. Issues related to
the temporal aspects of ACh function (the fourth question) are
addressed in the chapter by Dykes (this volume).
Method of Testing ACh Modulation of Sensory Discharge
Our experiments were carried out in urethane-anesthetized
(1.8 g/kg IP) adult albino rats. Glass, multibarrel electrodes
were used to record single unit activity and to apply drugs
iontophoretically. Drug barrels were filled with ACh chloride
(0.2 M, pH 4), atropine sulfate (0.1 M. pH 5), GABA (0.1 M, pH 4)
or glutamate (0.1 M, pH 8), and 165 mM NaCl. After the whisker
that yielded a maximal discharge of the unit under study had been
identified, precisely controlled air puffs were delivered to the
whisker to quantify its -activity. Each isolated cell was tested
during whisker stimulation under three basic conditions: (a) with
no applied drug, (b) during local application of ACh (mean ejec-
tion current 34±22 nA, range 5 to 100 nA), and (c) after a 3- or
5-minute recovery period. In some cases, atropine was coapplied
with ACh to test for the specificity of ACh action. The laminar
location of each recorded cell was determined from histological
reconstructions of electrode tracts in thionin-stained sections
through the recording area and by electrophysiological features of
recorded neurons.
Features of Response Modification During ACh Application
During ACh application, either enhancement or suppression of the
discharge evoked by whisker stimulation could be observed in SI
neurons. Cells were divided into two general types based on this
difference: Type 1, which showed an increase in sensory-evoked
discharge, and Type 2, which showed a decrease in discharge.
Among the ACh-modulated SI neurons (n=68), Type 1 effects pre-
dominated (figure 1). Seventy-three percent of the ACh-affected
cells increased their peak firing frequency when the sensory
stimulus was delivered during ACh iontophoresis. This change in
peak firing frequency reflected a change in the number of spikes
elicited by each stimulus and, in some cells, also reflected an
increase in the probability that sensory stimulation would evoke
discharge. Type 1 cells were further subdivided into three groups
based on differences in the pattern of discharge modulation by
ACh, The distribution of these types is shown in figure 2. In
the first type (1a), which accounted for most (75 percent) of the
Type 1 cells, the overall discharge of the cell was increased by
ACh (figure 3). Thus, both the mean rate of ongoing (background
or-"spontaneous") discharge and the peak discharge evoked by whis-
ker stimulation increased when ACh was applied. Type lb cells in-
creased peak discharge during ACh application without change (<10
percent) in background discharge rate (figure 4). Thus, for these
cells, which comprised 11.1 percent of all Type 1 cells, ACh
enhanced the response evoked by sensory stimulation without
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FIGURE 1. Distribution of Type 1 (response-enhanced) and Type 2
(response-suppressed) cells
FIGURE 2. Distribution of different forms of Type 1 cells
NOTE: (1a) Increase in background and evoked discharge during ACh application.
(1b) Increase in response without change in background discharge. (1c) No
response to sensory stimulus unless ACh is applied.
affecting the cell's spontaneous discharge. Type 1c cells (13.9
percent of Type 1 cells) were difficult to find because they gen-
erally had low rates of spontaneous activity and did not respond
to air puffs or mechanical stimulation at any peripheral location
in the absence of ACh. Consequently, brief glutamate applications
were used to evoke spontaneous activity and locate these cells.
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FIGURE 3. Example of Type 1a cell
NOTE: These displays show the response of a single layer V neuron before (A) and during (B) the application of 5 nA of Ach. Each
rester (bottom) shows the spike discharge over a 2-second period for 30 presentations of an air puff to the whisker et the
center of the cell’s receptive field. Average spike frequency Is displayed in the histogram above (bin width 1O ms). The
upper trace in each display (arrow) shows the time course end amount of air pressure delivered to the whiskers by the stimu-
lator. Note the Increase In the amount of discharge evoked by the stimulus and In the level of background discharge during
ACh applicatIon. The same general format is used In figures 4-6.
FIGURE 4. Type 1b enhancement
NOTE: (A) Analog signal of the air puff stimulus temporally aligned with histo-
grams below. (B) Control histogram (no applied ACh). (C) Response during
application of 40 nA of ACh. (D) Response during concurrent application of
40 nA ot ACh and 30 nA of atropine. Note the increase in response during
ACh application without change In background discharge. The finding that
l enhancement is blocked by atropine suggests that this effect is mediated
via muscarinic receptors.
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When a sensory stimulus was presented in combination with ACh
iontophoresis (figure 5). these cells were activated by relatively
small deflections of one or a few whiskers. The ACh-dependent
receptive field of these cells was centered about the same whisker
as nearby neurons that were driven by tactile stimulation in the
absence of ACh. ACh had little effect on background discharge for
most of these cells, but increased background discharge was ob-
served in a few instances, as in the cell shown in figure 5.
Unlike other Type 1 cells which show a simple increase in evoked
activity, ACh appears to act like a gate in Type 1c cells:
sensory-evoked activity depends on the presence of ACh.
The three subtypes of ACh enhancement described above may not rep-
resent three distinct categories. These subtypes may be members
of a continuum whose responses appear different because they de-
pend on the membrane potential of the neuron at the time of ACh
application (Adams et al. 1982; Cole and Nicoll 1984b). Cells
with relatively little ACh effect on background discharge might be
hyperpolarized beyond the range at which a voltage-dependent ACh
effect could be expressed. This explanation would clarify the
previously described positive correlation between spontaneous dis-
charge and degree of ACh effect (Jones and Olpe 1984). Peripheral
stimulation could bring the cell into a range where ACh is effec-
tive in increasing excitability, thus accounting for an increase
in evoked response without background modulation. The low ongoing
activity of these cells is consistent with this explanation.
Thus, the form of ACh modulation may reflect the particular mem-
brane potential of a cell rather than effects mediated by separate
receptor types or by different classes of cortical neurons.
Modulatory effects of ACh have also been observed in cat sensory
cortex. Sillito and Kemp (1983) reported that 61 percent of neu-
rons recorded in the visual cortex of anesthetized cats showed a
larger response to visual stimuli in the presence of ACh, much
like our Type la or lb effect. Recently, response enhancement has
been reported in cat SI and auditory cortex as well (Metherate et
al. 1985; McKenna et al. 1986; Dykes, this volume). These results
in two widely separate species and in different sensory areas sug-
gest that ACh has a similar functional role throughout mammalian
cerebral neocortex.
ACh suppressed sensory responses (Type 2 effect) in 27 percent of
all ACh-modulated cells in rat SI cortex (figures 1 and 6). The
decrement in the peak response was generally small, averaging a
decline of 24.6±20 percent compared to pre-ACh controls. One un-
usual finding was that 50 percent of Type 2 cells showed a para-
doxical increase in background discharge that accompanied the
sensory response decrease.
Previous studies have generally reported ACh-induced inhibition
only in a small percentage of cells (Krnjevic et al. 1971; Randic
et al. 1964; Lamour et al. 1982b; Lamour et al. 1983; but see
Phillis and York 1967). However, these cells, identified by the
depression of background discharge by ACh, are different from
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FIGURE 5. Type 1c cell located in layer III
NOTE: Characteristic of these cells, there Is no response to any somatic sensory
stimulus (A). During ACh application, the response to whisker deflection
is evident (B).
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FIGURE 6. Type 2 cell located in layer III
NOTE: Stimulus was presented during the period marked by the two arrowheads.
(A) Control. (B) During the application of 20 nA of ACh. (C) Response
histogram collected beginning 3 minutes after the termination of the ACh
application.
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those presently described as Type 2, which show that suppression
is largely, if not entirely, restricted to the discharge of the
cell evoked by natural stimulation within the cell's receptive
field. General background discharge suppression was not commonly
found in rat SI. Type 2-like changes in visual responses were
observed in 30 percent of the ACh-modulated cells in cat visual
(VI) cortex (Sillito and Kemp 1983). Thus, similar percentages of
cells appear to be suppressed by ACh in cat VI and rat SI cortex.
Amount of Response Modulation by ACh
The extent of response modulation by ACh was calculated as the
[(PeakACh-Peakcontrol)/PeakcontrolX1OO%], where PeakACh=the peak
discharge amplitude (averaged over 20 trials) evoked by whisker
stimulation during ACh application;
before ACh application.
Peakcontrol=peak discharge
The average discharge increase for all
Type 1 cells during ACh application was 72±11 percent, and changes
as high as 278 percent were observed. Cells for which receptive
fields could be found only after ACh application were not included
in this sample. The percent increase in response averaged for all
cells (enhanced and suppressed) is illustrated in figure 7.
FIGURE 7. Average response modulation by ACh shown by layer
NOTE: This histogram shows the mean overall change In response (enhancement or
suppression) by layer, expressed as a percent change In discharge. No
cells were recorded in layer I. Cells In layers II-III were grouped to-
gether. Bars indicate one standard deviation of the mean. Note that ACh
enhancement is found in supra- and infragranular layers and that layer IV
shows the opposite effect of ACh application compared to all other layers.
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The quantitation of peak discharge change may be a somewhat mis-
leading measure of ACh effect, since we do not know whether the
iontophoretically applied ACh in any way approximates the concen-
tration of ACh that acts upon cortical ACh receptors. Dose-
response tests (Lamour et al. 1982b) at least support the idea
that modulation of background discharge is dependent on the amount
of ACh delivered (as measured by iontophoretic current level). We
have also observed in a few cells that the enhancement of peak
discharge by ACh is related to the iontophoretic current level.
It would be of great use to measure and compare the levels of ACh
released by basal forebrain fibers and by iontophoretic electrodes
or to devise methods
fibers.
Receptor Types
A number of previous
to control ACh release from basal forebrain
studies have documented the predominantly
muscarinic nature of ACh-induced increases in background activity
(Krnjevic and Phillis 1963b; Krnjevic et al. 1981; Phillis and
York 1967; Crawford and Curtis 1966; Stone 1972; Lamour et al.
1982b; Lamour et al. 1983; McCormick and Prince 1985). The site
of muscarinic action, however, has been a matter of debate: both
pre- and postsynaptic receptor locations have been suggested
(Rovira et al. 1983; McCormick and Prince 1985). Nicotinic
effects on cortical discharge are thought to be uncommon (Stone
1972; McLennan and Hicks 1978) and in some cases unrelated to ACh
action (Lamour et al. 1982b). This action is discussed further in
the following section on "Predominance of Type 2 effects on
layer IV."
We tested the role of muscarinic receptors in controlling Type 1
and Type 2 modulation of sensory responses with the muscarinic
antagonist atropine. Concurrent application (tested in 29 cells)
of ACh and atropine either markedly diminished or abolished the
increase in background and evoked discharge that was induced by
ACh (figure 4). This effect was demonstrated for all forms of
Type 1 and Type 2 cells. Thus, it appears that muscarinic recep-
tors account for both response enhancement and response decrement.
This suggests that there may be separate subtypes or distributions
of receptors, or that receptors are linked to different ion chan-
nels or second messengers, to account for these differences.
Selective Distribution of Cholinergic Effects
Despite the broad distribution of ACh fibers in cortex, ACh ef-
fects may be restricted to specific classes of cortical neurons.
Lamour and coworkers reported that neurons showing background dis-
charge modulation by ACh in rat SI cortex were mainly localized to
two infragranular bands: one in the deep part of layer V and the
other in the lower part of layer VI (Lamour et al. 1982b; Lamour
et al. 1983). Many of the ACh-responsive neurons in layer V were
identified as pyramidal tract (PT) neurons (Stone 1972; Woody et
al. 1974; Lamour et al. 1982b) which convey output from somatic
sensorimotor cortex to the spinal cord and to brain stem sensory
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relay and motor control structures. Other layer V and VI ACh-
sensitive cells were identified as corticothalamic (CT) neurons,
and more than half of all PT and CT neurons were excited by ACh
(Lamour et al. 1982b). Lamour et al. (1982b) concluded that a
second band of ACh-sensitive neurons in the deep part of layer VI
were interneurons, based largely on their inability to activate
them antidromically from the thalamus, pyramidal tract, or
contralateral cortex. These studies, based on examination of the
ability of ACh to alter background activity, suggested that ACh
modulation is selective for cortical output neurons and one set of
deep-lying local circuit neurons; the background activity of
intrinsic and cortically projecting pyramidal neurons which reside
in the superficial layers were relatively unaffected by ACh.
Laminar Distribution of ACh Effects in Rat SI Cortex
Recent studies that have examined the effect of ACh on sensory-
evoked discharge have identified a much different, but neverthe-
less selective, distribution of ACh-sensitive neurons in cortex.
Most noteworthy are the findings that enhancement is found in
superficial as well as deep layers and that enhancement and sup-
pression effects are segregated by layer.
Type 1 distribution. Our studies in the rat SI cortex showed that
enhancement effects are present in all cortical layers. In layers
II and III, 83 percent (10 of 12) of the cells tested increased
their mean peak response following ACh application, whereas the
sensory-evoked discharge increased for 91 percent (29 of 32) of
layers V and VI cells. The remaining two superficial and three
deep layer cells were Type 2; two Type 1 cells were present in
layer IV.
Other recent reports confirm a broad laminar distribution of ACh-
induced excitation in cortex. McCormick and Prince (1985) found
increases in background discharge in more than 90 percent of the
pyramidal cells studied in a population of 253 intracellularly re-
corded layers II and III neurons in rat cingulate cortex slices.
Sillito and Kemp (1983) also found that ACh enhanced roughly simi-
lar numbers of neurons in superficial and deep layers of cat pri-
mary visual cortex. These recent reports provide strong evidence
for an ACh-mediated modulation of excitability in superficial
cortical layers that was missed when only background discharge
effects were monitored.
Predominance of Type 2 effects on layer IV. Cells showing a sup-
pression of evoked response were largely restricted to the super-
ficial layers; only 9 percent of the ACh-responsive infragranular
cells had Type 2 responses. This finding is consistent with
earlier reports that ACh suppression of glutamate-evoked excita-
tion was primarily observed in the superficial layers (Phillis and
York 1967). In contrast to all other layers, Type 2 effects were
the predominant response type in layer IV. Electrophysio-
logically, cells located in the region of layer IV (about 600 to
800 µm below the cortical surface) exhibit a distinctive set of
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features: they are often more difficult to isolate than cells at
other depths (due to their small size), they are extremely sensi-
tive to low-amplitude deflections of a single whisker, and their
receptive fields include one or, at most, a few whiskers (Simons
1978; Chapin and Lin 1984; Pincince and Donoghue 1986). Re-
constructions of penetrations observed in thionin-stained sections
through SI confirmed that 80 percent of the cells that showed
response suppression were located in layer IV. Thus, the ratio of
response-enhanced to response-suppressed (Type l/Type 2) cells was
reversed for layer IV compared to deeper or more superficial lay-
ers (figure 7). Sillito and Kemp (1983) also found that cortical
cells inhibited by ACh were most common in layers III and IV and
were absent in deep layers of cat visual cortex. Recently it has
been reported that nicotinic receptors are densest in layer IV of
cat visual cortex (Prusky and Cynader 1986). which suggests that
nicotinic receptors may be located presynaptically on thalamo-
cortical afferent fibers. Activation of this presynaptic receptor
could explain our finding that ACh decreases sensory responses in
layer IV of rat SI. However, this interpretation is not consist-
ent with our finding that Type 2 effects can be blocked by atro-
pine or that nicotinic receptors appear to be most dense in layer
III of rhesus monkey cortex (O'Neill et al. 1985), although many
thalamic afferents terminate in layer III in the monkey. Further
studies with specific nicotinic agonists and antagonists are
clearly required to identify the mechanism for Type 2 effects. It
is curious that ACh suppresses evoked discharge in layer IV, the
primary target for specific thalamocortical fibers, while it en-
hances responses in other layers.
Overall, studies of the effect of ACh on sensory-evoked discharge
in cortex demonstrate a markedly broader distribution of choliner-
gic actions than was identified by studies of background modula-
tion. Anatomical studies of the cholinergic input to cortex
support this conclusion. Cholinergic fibers are most dense in
layers I, V, and VI, based on choline acetyltransferase immuno-
reactivity (Chao et al. 1982), acetylcholinesterase staining
(Mesulam and Van Hoesen 1976; Mesulam et al. 1983; Mesulam et al.
1984). and axonal transport studies (Rieck and Carey 1984).
Pyramidal cells in all layers may be modulated by ACh release upon
their apical dendrites that ascend to layer I, and pyramids in the
deeper layers may also be influenced by ACh action on more proxi-
mal dendrites. In contrast to the pronounced effect of ACh in
layer V and the presence of presynaptic cholinergic markers, most
studies agree that muscarinic receptors are lowest in layer V
(Nonaka and Moroji 1984; Rotter et al. 1979; Wamsley et al. 1980;
O'Neill et al. 1985).
Segregation of Cholinergic Effects Among Different Cell Classes
In addition to a distinct laminar segregation of effect, ACh has
distinctly different effects on intrinsic local circuit and pyram-
idal neurons. Using intracellular recording and dye injection in
a cortical slice preparation, McCormick and Prince (1985) found
that ACh application to multipolar, presumably GABA-inhibitory
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neurons resulted in a rapid, relatively brief burst of action
potentials. This activity resulted in an IPSP in adjacent pyram-
idal cells. Excitatory ACh effects on pyramidal neurons were
slower in onset and longer in duration, and this type of response
could be blocked somewhat selectively by pirenzipine, suggesting
that different muscarinic receptor subtypes mediate these two
quite diverse effects. ACh has also been reported to decrease
inhibitory action in the hippocampus, perhaps by direct action on
GABA terminals (Krnjevic et al. 1981; Ben-Ari et al. 1981). Each
of these results suggests that ACh may shape sensory processing
by regulating the effectiveness of local cortical inhibitory
circuits.
CONCLUSIONS
The combination of sensory stimulation and afferent activation to
study the effects of modulators has revealed features of choli-
nergic action that would not have been observed if effects on
background discharge alone had been examined. Based on all avail-
able evidence, we hypothesize that a primary action of ACh in cor-
tex is to enhance sensory responses of neurons in supragranular
and infragranular layers. This effect may result from the
"destabilizing" effect of ACh produced by blockade of an outward
Ca++ dep$ndent K+ current that follows neuronal discharge and a
second K+ current that resembles the M current (Benardo and Prince
1982; Cole and Nicoll 1984a; Cole and Nicoll 1984b; Halliwell and
Adams 1982; Brown 1983; McCormick and Prince 1985). Presynaptic
effects of ACh have also been suggested as a mechanism for choli-
nergic enhancement effects (Krnjevic et al. 1981; Valentino and
Dingledine 1981). In layer IV, there is a reversal of effect so
that sensory responses are suppressed in the presence of ACh. The
net result of these actions on sensory responses in cortex may be
a filtering out of the weakest inputs at the earliest stages of
processing in layer IV and a relative increase in the processing
of the remaining signal in supra- and infragranular layers. Sen-
sory activation of some cortical neurons is dependent on ACh as
shown by our Type 1c cells which responded to sensory inputs only
in the presence of ACh.
It is important to take into consideration that these modulatory
effects in rat SI cortex were described in anesthetized animals.
In awake animals, these same cells may have somewhat different
responses to ACh. However, state-dependent changes in sensory
responsiveness have been identified in SI of awake, behaving rats
(Chapin and Woodward 1981), and the basal forebrain cholinergic
system could be one way that these gating effects are achieved.
It will be critical to show that other means of providing ACh at
cortical synapses, such as direct stimulation of cortically pro-
jecting basal forebrain neurons, produce the same types of effects
as those that have been described here using local iontophoretic
application techniques.
The cellular actions of ACh suggest that the basal forebrain sys-
tem is not a completely generalized system. There appears to be
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selective modulation of certain aspects of sensory signals and a
selective laminar and cell class segregation of ACh effects.
Thus, the type of processing of sensory information in cortex will
be dramatically changed if the basal forebrain or other choliner-
gic inputs are also active. The connection of this form of neural
modulation to selective attention, memory, and other processes is
still unclear. One could hypothesize, however, that activity in
the basal forebrain could selectively enhance certain features of
a sensory input by altering the strengths of synaptic activation
of subsets of cortical neurons and could then facilitate the
storage of those features in cortex.
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Control of the Neuronal Receptive
Field in Somatosensory Cortex
Robert W. Dykes
INTRODUCTION
Classic Receptive Fields
One of the more informative techniques to study the effects of
drugs on the behavior of single neurons is to observe their activ-
ity in relatively normal physiological conditions both before and
after a drug is administered to the neuron under study. By deliv-
ering substances iontophoretically through multibarreled pipettes
into the vicinity of the neuron being studied, one can monitor
changes in neural activity while the cell performs an identifiable
function in a neural circuit under experimental control.
This approach can be illustrated in the somatosensory cortex,
where neurons can be excited in a measurable and reproducible way
by stimuli applied to the cutaneous receptive field. The examples
chosen concern manipulations of two endogenous neurotransmitters,
GABA and acetylcholine, in normal and partially deafferented cor-
tex. To appreciate the findings presented, the following sections
are preceded by a review of some fundamental concepts related to
sensory processing.
Some of the earliest electrophysiological records provided the
first glimpse of the organization of the receptive field.
Hartline (1938) saw the excitatory influence from the omatidium of
a horseshoe crab reduced by simultaneous illumination of adjacent
omatidia. From this beginning came the idea that sensory systems
process information through contrast enhancement between an exci-
tatory center and an inhibitory surround (Hartline et al. 1952).
This concept was so powerful that it not only won its discoverers
the Nobel Prize but continues to be useful today. The first
description of the center-surround organization of the receptive
field in the mammalian nervous system was provided by Kuffler
(1953) when he recorded the excitatory center and inhibitory sur-
round of ganglion cells in the cat retina. These observations
were followed by reports of center-surround organization in the
somatosensory system. Investigators (Mountcastle 1957;
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Mountcastle and Powell 1959) reported this organization in corti-
cal neurons and in subcortical relays (Mountcastle and Darian-
Smith 1968; Mountcastle 1986). Although it has become a basic
tenet of models for processing of sensory information, after the
initial discovery, the interaction of excitatory and inhibitory
influences on somatosensory neurons has seldom been studied.
The Modern View: Dynamic Receptive Fields
To this, a notion of relatively static, concentric (but antago-
nistic) influences that shape the afferent signal at each relay
from the periphery to the cortex, we must add some of the more
recently described dynamic properties of somatosensory receptive
fields.
Although it was originally thought that the change of state
between wakefulness and sleep was sufficient to cause dramatic
changes in the receptive fields of cortical neurons (McKenna et
al. 1982), at least in primary somatosensory cortex, this does not
seem to occur. The responses of more than 80 percent of cortical
neurons in alert animals seem to be influenced only slightly by
changes in attention or arousal. Hyvarinen et al. (1980) reported
a general increase in activity and an enhancement of responsive-
ness to somatic stimuli in 16 percent of 160 neurons studied dur-
ing a task requiring the attention of behaving monkeys. Chapin
and Woodward (1981) showed that strong arousal produced only a
slight decrease in spontaneous discharge and a slight increase in
responsiveness of most neurons studied in rat somatosensory
cortex.
In contrast, motor activity produces much more dramatic changes in
responsiveness of somatosensory neurons. Generally, the respon-
siveness of somatosensory neurons was strongly suppressed during
both grooming and treadmill locomotion (Chapin and Woodward 1981).
Of 108 cells tested, 89 showed at least a 10 percent decline in
the evoked response during running. Subsequent work demonstrated
that the suppression observed during walking was phase-locked to
the movement, so that suppression began just before the foot con-
tacted the floor and was removed later in the step cycle (Chapin
and Woodward 1982a; Chapin and Woodward 1982b). This kind of
modulation of the sensory input may explain why receptive field
organization assessed from observations of behaving monkeys manip-
ulating test objects appears to be more variable in location and
size than the organization seen in anesthetized or passive animals
(Iwamura et al. 1983; Iwamura et al. 1985a; Iwamura et al. 1985b).
Thus, it appears that large changes in receptive field organiza-
tion may occur in behaving animals, but they are attributable to
factors other than wakefulness or sleep.
Another important variable is the cytoarchitectonic area in which
the neuron is located. Area 3b has the most stable receptive
fields. Receptive fields in the adjacent area 1 seem to be more
labile than those in area 3b and have more convergent inputs
(Iwamura et al. 1983). Areas 5 and 7, which are further along in
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the processing sequence, are known to be even more dependent on
the motivational and attentional states of the animal (Mountcastle
et al. 1975; Robinson et al. 1978; Bushnell et al. 1981). This
discussion will be limited principally to neurons in area 3b,
where receptive fields are less labile but more is known about
both their inputs and the factors controlling receptive field
organization. In this apparently less labile region of cortex,
changes occur that can be related to neuronal plasticity and even
to learning.
In examining changes that can occur in receptive fields, it is
instructive to see how they change when a region of cortex loses
its sensory inputs. Deafferentation induces rapid and dramatic
changes in the somatotopic organization of sensory cortex in mam-
mals (Kalaska and Pomeranz 1979; Rasmusson 1982; Kelahan et al.
1981; Wall and Cusick 1984; Merzenich et al. 1983a). These
changes are progressive and reach new stable states only after a
few months (Merzenich et al. 1983b). Studies of single neurons in
deafferented regions suggest that, following deafferentation, many
neurons acquire novel receptive fields; that neurons in many zones
of the deafferented cortex remain responsive to cutaneous inputs
(Kalaska and Pomeranz 1979); and that the proportion of neurons
driven by cutaneous inputs attains the same level as in normal
cortex (Dykes and Lamour, in press(a)). In monkeys (Merzenich et
al. 1983a) and raccoons (Rasmusson and Turnbull 1983). the shift
in receptive field locus following deafferentation begins to occur
within hours or even minutes. If these changes occur through
mechanisms comparable to those producing changes in receptive
field loci in the spinal cord, then a novel receptive field can
appear within seconds following loss of the afferent signal that
provided the original receptive field (Metzler and Marks 1979).
This argues strongly that sprouting of new terminals should be
ruled out as a mechanism to explain the appearance of at least the
first of the new receptive fields. Another point important for
the following discussion is that the first receptive fields ob-
served following deafferentation are not necessarily the final
ones (Merzenich et al. 1983b), nor do the neuronal response prop-
erties immediately after deafferentation necessarily reflect the
responses the neurons will have several days later (Rasmussen and
Turnbull 1983).
BICUCULLINE
From the preceding discussion, it seems reasonable to infer that
the receptive field of a somatosensory cortical neuron consists of
some balance of excitation and inhibition, having a preferred spa-
tial distribution but organized so that the relative strengths of
the two processes can change rapidly in ways related to the behav-
ior of the animal. These influences from nonsensory inputs seem
to distort the preferred receptive field observed when the animal
is at rest or unconscious. In the cortex, the predominant inhibi-
tory neurotransmitter appears to be GABA. Existing histochemical
evidence suggests that nearly all cortical interneurons contain
this substance (Jones, in press), which plays an important role in
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the control of receptive field size. As a consequence, blocking
the inhibitory action of GABA shifts the balance between excita-
tion and inhibition dramatically towards excitation.
In a series of experiments in cat somatosensory cortex (Hicks and
Dykes 1983; Dykes et al. 1984), bicuculline (a GABA receptor
blocker) was administered iontophoretically, and changes in neu-
ronal behavior were recorded. Bicuculline had four different
effects: (1) It increased the magnitude of the neuronal response
elicited by stimulation of the cutaneous receptive field; (2)
shortened the latency of the first action potential elicited by
somatic stimuli; (3) enlarged the cutaneous receptive field; and
(4) uncovered receptive fields in previously silent cells. These
effects are summarized in figure 1.
The intensity of the response elicited from a cortical neuron was
near maximum in the presence of bicuculline even when activated by
very small somatic stimuli, such as the movement of a few hairs on
the forearm, suggesting that GABA plays a role in controlling the
amplification of the afferent signal within the cortex. Normally,
stimuli applied near the edge of a receptive field produce weak
responses (Mountcastle and Powell 1959; Gardener and Costanzo
1980), whereas the same stimuli applied to the center of the field
produce larger and longer lasting responses. After bicuculline,
large, long-lasting responses could be elicited by small stimuli
on the edge of the receptive field, suggesting that the normal
gain-control of the cell had been lost. The shortened latency of
the responses (figure 1) observed in the presence of bicuculline
suggests that GABA-mediated inhibition delays considerably the
onset of the first action potentials in cortical neurons. The
delay may be as much as 2 or 3 milliseconds, providing an oppor-
tunity for intracortical information processing to occur before a
neuron discharges. This point has been amplified elsewhere (Dykes
et al. 1988; Landry et al., submitted). Intracellular records
have shown that sufficient time elapsed between the arrival of the
thalamocortical input and the first spike to permit significant
interactions among cortically generated excitatory postsynaptic
potentials and inhibitory postsynaptic potentials.
The most striking change produced by bicuculline was an increase
in the receptive field diameter of cortical neurons. In the pres-
ence of bicuculline, the size of the receptive field increased an
average of 6.4 times the area of the control receptive field
(Dykes et al. 1984). This average value masked some important
differences in the degree of enlargement seen in different cells.
Some receptive fields increased little more than twice their orig-
inal size, whereas others increased as much as 20 times. Final
receptive field size after enlargement was relatively constant,
and size increases seemed to be related to the layer in which the
receptive field was located. Figure 2 shows the original size of
the receptive field expressed as a percentage of the receptive
field observed after treatment with bicuculline. It can be seen
that the control receptive field was less than 16 percent of the
expanded field in the upper and lower layers but as much as 35
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FIGURE 1. Effects of biculculline administered iontophoretically
to single neuron in cat somatosensory cortex
NOTE: (A1) A histogram of responses to 10 stlmuli applied to the center of a
cutaneous receptive field indicated as polnt A on the inset of the cat’s
forearm. (A2) A histogram of responses to 10 stimuli applied to the same
point during bicuculline administratlon. (B1) No responses to 10 stimuli
applied at polnt B outside the control receptive field on the cat’s fore-
arm, and (B2) a histogram of responses to 1O stimuli applied at point B
during bicuculline adminilstratilon. Notice that the receptive field becomes
enlarged during bicuculline admlnlstratlon. In addition, the response
latency is shortened, and the magnitude and duration of the response are
Increased. (C) Illustrations of other receptive fields affected by bicu-
culline administration. Some cells, having no (C, top left) or very hlgh
(C, top right) threshold receptive fields, were converted to low threshold
receptive fields, where movements of a few hairs could discharge the cells.
Other previously existing receptive fields were enlarged (C, bottom left
and right).
SOURCE: Modified from Dykes et al. (1984), Copyright 1984, the American
Physiological Society.
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FIGURE 2. Receptive field size as a function of cortical depth
before bicuculline administration
NOTE: The values plotted are those for the control receptive field expressed as a
percentage of the area of the enlarged receptive field observed during GABA
blockade by bicuculline. The greater enlargements observed In the upper
and lower layers are attributable to a greater release of neurons In these
layers from the effects of GABA-mediated inhibition. Numbers In paren-
theses indicate the number of receptive fields contributing to each mean
and its standard error.
SOURCE: Replotted from Dykes et al. (1984), Copyright 1984, the American
Physiological Society.
percent of the enlarged field in middle layers. The variable
degree to which the receptive field increased appears to be due to
the fact that GABA-mediated inhibition was more important in the
upper and lower layers than in the middle ones.
It should be noted that bicuculline produces receptive field en-
largements only in regions of cortex receiving inputs from rapidly
adapting receptors. In regions that receive slowly adapting in-
puts, the responses to somatic stimuli are enhanced and their
latencies decreased by administration of bicuculline, but the
receptive field size remains unchanged. This implies that another
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inhibitory neurotransmitter may control receptive field site or
that receptive field size in slowly adapting areas is controlled
by GABA through receptors insensitive to bicuculline. An effort
to test the first hypothesis (Tremblay et al. 1986) has ruled out
glycine, taurine, and ß-alanine as the unknown mediator of the
inhibitory control. The lack of an effective GABA-A receptor
blocker makes the second hypothesis difficult to test.
The data presented above provide no information about the dynamics
of receptive field control. However, they show that, under normal
circumstances, the observed receptive field is only a small part
of the total excitatory drive on a cortical neuron, and they dem-
onstrate that the major part of the excitatory convergence on a
cell can be suppressed by intracortical inhibitory processes.
Thus, factors that modify the inhibitory drive on a cortical neu-
ron have the potential to alter the receptive field significantly.
Similarly, if the excitatory drive could be enhanced sufficiently
to overcome inhibitory influences, the receptive field would be
changed. Thus, the rapid changes in receptive field organization
which occur during an animal's behavior must arise from rapid,
transient changes in this balance.
The last characteristic of somatosensory neurons important for the
understanding of the dynamic properties of somatosensory cortex is
that a large number of neurons (between 40 and 70 percent of those
encountered in somatosensory cortex (Dykes et al. 1984; Dykes and
Lamour, in press(b); see also Baker et al. 1971; Simons 1978) have
no obvious receptive fields under most experimental conditions.
However, many neurons without receptive fields developed them in
the presence of bicuculline. Unresponsive neurons are most readi-
ly studied by administering glutamate through iontophoretic
pipettes to show that a cell is present at the recording electrode
and is capable of being discharged, even when somatic stimuli
and/or thalamic electrical stimuli are unable to excite the neu-
ron. By using iontophoretically administered glutamate to raise
the level of excitability in the silent neurons or bicuculline to
remove inhibition from them, it was possible to demonstrate that
many silent neurons received excitatory inputs.
ACETYLCHOLINE
The large number of unresponsive neurons raises the question of
what useful function such a neuron might have in somatosensory
cortex. Some of the possibilities have been discussed by Dykes et
al. (1984), Dykes and Metherate (in press), and Lamour and Dykes
(in press). Here it is useful to discuss how these less than
optimally excited neurons might play a role in two different
circumstances where the cortex is known to undergo changes in
receptive field organization. One such circumstance is that of
directed attention, the other is deafferentation.
It is well known that conditions affecting alertness and atten-
tion, such as those involving the performance of a specific task
for a reward or to avoid punishment, will double or triple the
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amount of acetylcholine (ACh) released in the cerebral cortex
(Rasmusson 1975). It was clearly demonstrated some years ago that
iontophoretically administered ACh can cause 20 to 30 percent of
cortical neurons to discharge (Krnjevic and Phillis 1963; Krnjevic
1975) and that many neurons have cholinergic binding sites, pre-
dominantly of the muscarinic type. In the visual cortex, Sillito
(1977; Sillito 1979) showed that iontophoretic applications of ACh
could alter the response properties of neurons so that their re-
ceptive fields were sharpened or changed in ways that enhance the
signal-to-noise ratio of the response. In the cat somatosensory
cortex, about 16 percent of the neurons (n=203) are excited by ACh
(Metherate et al., in press), and in the rat, 37 percent (n=360)
of the somatosensory cortical neurons are Similarly excited
(Lamour et al. 1982; Lamour et al., submitted). These values
encompass the range reported in earlier work on other cortical
regions.
When the effects of somatic stimuli were studied during ionto-
phoretic administration of ACh to cortical neurons, several inter-
esting phenomena were observed. First, the responsiveness of a
neuron to a somatic stimulus could be enhanced; thus, a larger
response was generated to a fixed-amplitude stimulus, and the
receptive field was defined more readily. In some cases, the
threshold was lowered by iontophoretically administered ACh.
Second, during ACh iontophoresis, neurons previously unresponsive
to somatic stimuli began to respond. Thus, ACh, like bicuculline,
uncovered receptive fields in previously unresponsive neurons.
The previously unresponsive cells had receptive fields of normal
dimensions with appropriate locations for the region of cortex
studied. Figure 3 illustrates some of the receptive fields un-
covered in both cat (Metherate et al., in press) and rat (Lamour
and Dykes, in press) somatosensory cortex. The uncovered receptor
fields were approximately the same as those seen in neurons nor-
mally having receptor fields, with respect to size, thresholds,
and response properties. In this way, iontophoretically adminis-
tered ACh differed from iontophoretically administered bicucul-
line. Although bicuculline also uncovered receptive fields in
previously silent neurons (Dykes et al. 1984; Dykes and Lamour, in
press(b)), the receptive fields uncovered by bicuculline were
abnormally large, and even very weak stimuli produced paroxysmal
discharges in the neurons. In contrast, those uncovered by ACh
had relatively normal sizes and response properties.
Hypothetically, the release of ACh which accompanies attention and
directed effort enhances the responsiveness of most somatosensory
neurons, making them better able to encode arriving sensory mes-
sages, and brings into action silent neurons that otherwise would
be unresponsive to somatic inputs.
DEAFFERENTATION
The effects described above disappear soon after ACh administra-
tion stops. Previously silent neurons become unresponsive again;
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FIGURE 3. Receptive fields of previously unresponsive neurons
NOTE: Iontophoretic administration of ACh to (A) single cells In the primary
somatosensory cortex of the cat and (B) neurons in rat somatosensory cortex
uncovered low-threshold cutaneous Inputs capable of activating the cells.
SOURCE: Modified from Metherate et al. (in press), Copyright 1987, Pergamon
Press; and Lamour and Dykes (in press), Copyright 1987, Elsevier Science
Publishers B.V.
other neurons begin to generate fewer impulses and their
thresholds often become elevated, returning to control levels.
Such transitions may be comparable, in certain respects, to the
changes that occur when attention is selectively shifted from one
sensory modality to another or when motor actions involve a par-
ticular sensory surface. However, these kinds of reversible
changes in excitability are insufficient to account for the
reorganization seen in somatosensory cortex after a major de-
afferentation. After such a loss, some new responses are immedi-
ately unmasked, but the full sequence of changes following
deafferentation often takes days to develop, following a slower
time course and appearing to be relatively permanent.
Significant changes seen after deafferentation are:
(1) Neurons become less inhibited: They often discharge at high-
er than normal spontaneous rates and are depolarized more
frequently by glutamate (Dykes and Lamour, in press(a);
Lamour and Dykes, in press). They often respond with a
rebound discharge to the release from inhibition (Rasmusson
and Turnbull 1983).
(2) Neurons acquire new receptive fields in cutaneous regions
adjacent to the region of deafferentation (Merzenich et al.
1983a; Wall and Cusick 1984).
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(3) The somatotopic order which includes these new receptive
fields becomes a new and apparently stable order within about
3 months (Merzenich et al. 1983b). Thus, relatively perma-
nent changes occur in neuronal response properties related to
receptive field organization.
ACh may also be involved in these relatively long-lasting changes
in excitability of neurons in somatosensory cortex. It has been
known for some time that ACh reduces potassium permeability in
neurons (Krnjevic and Phillis 1963), and when ACh administration
is combined with depolarization of the cell, to the point where
the cell is discharged, the reduction of potassium permeability
becomes relatively long lasting (Woody et al. 1978). In some
cases, it may last for as long as the electrode can be kept inside
the cell (up to 1.5 hours). This phenomenon occurs in neurons of
cat motor cortex during the learning of a conditioned reflex,
thereby enhancing the excitability of the neurons involved in the
reflex (Woody and Engel 1972; Brons and Woody 1980).
To determine whether or not this effect has characteristics useful
for explaining the reorganization of somatosensory cortex follow-
ing deafferentation, the long-lasting effects of ACh were studied
in cat cortex. The first experiments were designed to reproduce,
in somatosensory cortex, the phenomenon described by Woody et al.
(1978). Neurons were depolarized by iontophoretically applied
glutanate, and ACh was administered. In 61 percent of 41 cells,
this treatment produced enhanced responses to subsequent glutamate
applications. This effect lasted for more than 5 minutes in 36
percent, and, in some, the enhanced responsiveness lasted for more
than 45 minutes. In contrast, when the neuron was treated either
with glutamate alone or ACh alone, very seldom was a prolonged
change in excitability observed (figure 4).
The next step was to examine the effects of ACh on the respon-
siveness of neurons to somatic stimuli (figure 5). The excitatory
glutamate test pulses were replaced by mechanical pulses applied
to the cat's skin surface. In a series of 47 neurons having
cutaneous receptive fields, 79 percent showed enhancement of the
neural response, and 30 percent of these enhancements lasted for
periods ranging from 8 minutes to 1 hour, and often for as long as
the cell was studied. Thus, when ACh was combined with excitatory
afferent drive, it caused long-term enhancement of neuronal excit-
ability. Neurons originally poorly driven from the periphery de-
veloped well-defined cutaneous receptive fields, and light tactile
stimuli within those fields effectively discharged them. In con-
trast, the excitability of a neuron was seldom changed by either
somatic stimulation alone or ACh alone. In addition to the long-
term enhancement of previously existing receptive fields, ACh
treatment, when combined with neuronal excitation, uncovered re-
ceptive fields in previously silent neurons that, once expressed,
remained for a long time. These appeared relatively normal in
size and had normal response properties.
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FIGURE 4. Prolonged increases in excitability of somatosensory
cortical neurons following iontophoretic application
of ACh
NOTE: (A) The experimental paradigm used to test the altered excitability to
glutamate produced by ACh. During the Interval when repeated pulses of
glutamate were released from one barrel, the ACh could be delivered from
another barrel to see how it changed excitability. (B) The long-term
enhancement of neuronal excitability when ACh was administered to a somato-
sensory cortical neuron during somatic stimulation. Before treatment,
there was no response. When ACh was administered between stimuli, there
was no enhancement. Subsequently, when ACh was administered during stimu-
lation, the responses were enhanced severalfold and remained elevated for
about 45 minutes. The calibration bar In part (A) indicates 1 minute.
Although ACh treatment produced rather dramatic effects in some
cells, not all cells were affected by ACh; only about one-third of
the cells underwent prolonged changes in excitabi1ity. For
others, changes endured only as long as ACh was present, and for
some there was neither a prolonged nor a short-term effect of ACh.
Occasionally, ACh treatment reduced the excitability of somato-
sensory cortical neurons.
Thus, ACh may act as a permissive agent that can bring about
selective enhancement of those neuronal responses that most
strongly excite a cell. However, ACh itself does not cause the
enhancement: the enhancement of a neuronal response depends upon
excitatory input that is present while ACh is present, and only
those inputs activated while ACh is present are enhanced. When
this mechanism is combined with the release from inhfbition that
follows deafferentation (allowing neurons to respond to previously
ineffective inputs), it may play an important role in building new
receptive fields for deafferented neurons. The release from inhi-
bition that follows deafferentation could allow many additional
inputs to drive the cell; then, those inputs that are actually
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FIGURE 5. Comparison of the effects of acetylcholine in normal
and partially deafferented cortex
NOTE: (A) A rate meter record of the excitatory responses to ACh and glutamate
obtained from neurons In norma1 rat hindlimb somatosensory cortex. (B) A
rate meter record of the excitatory effect of ACh and carbachol In de-
afferented rat hindlimb somatosensory cortex.
used would be the ones that are enhanced. This mechanism requires
that ACh be released following deafferentation or that binding
sites for ACh on the neurons in deafferented cortex become more
numerous. Both possibilities remain to be explored.
CONCLUSION
The receptive field of a cortical neuron consists of a balance of
excitation and inhibition which allows only a small fraction of
the excitatory drive to be expressed at any one time. Often the
inhibition appears to be mediated by GABA. In some cases, it is
sufficiently powerful to completely prevent a cell from being
driven from the periphery. The static organization of the recep-
tive field, as seen in tests with bicuculline, suggests that the
balance of excitation and inhibition sharpens a somatotopic order
that is only roughly specified by the underlying pattern of
partially shifted, overlapping thalamic arbours and axonal proc-
esses of cortical neurons. The resolution of the somatotopic map
depends upon postsynaptic inhibitory processes.
The dynamic properties of receptive fields of cortical neurons may
be attributed to transient changes in the local balance of excita-
tion and inhibition that cause the excitatory focus of a neuron to
shift. Similarly, the excitatory drive on a previously silent
neuron may be enhanced by shifts in GABA-mediated inhibition until
some part of the excitatory drive is expressed by the discharge of
that cell. Obviously, the activity of inhibitory interneurons
will play a key role in these rapid changes.
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ACh can also play an important role in the dynamic processes of
somatosensory cortex because it is released by brain stem mecha-
nisms during motivated behaviors and states of selective atten-
tion. Although ACh may have a slower time course (measured in
seconds rather than the milliseconds attributed to GABA-mediated
processes), in its presence the excitability of most neurons is
enhanced, and previously silent neurons become active, following a
time course compatible with ACh involvement in cortical functions
related to motivated behaviors.
ACh can also play a role in the even slower, longer term changes
in excitability of somatosensory cortical neurons that occur fol-
lowing deafferentation. When neurons are depolarized in the pres-
ence of ACh, they become more responsive, for long periods after
ACh is removed, to those inputs which produced the original exci-
tation, thereby allowing ACh to bring about potentially important
long-term changes in cortical organization.
It is clear from recent work on other neurotransmitters that sub-
stances such as noradrenalin, serotonin, and dopamine can also
modulate neuronal excitability as does ACh. Thus, there are sev-
eral routes by which drugs may alter the responsiveness of neurons
on a long-term basis. These findings demonstrate that, in order
to detect some of the plastic changes produced by drugs, it is
often necessary to study neurons that are responding to their
natural inputs. Moreover, if the system can be "stressed," drug
effects which were not apparent in the normally functioning system
may be uncovered.
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